SUNAGA Noriaki(Allergy and Respiratory Medicine) | Researcher Directory

Researcher Database

SUNAGA Noriaki
Allergy and Respiratory Medicine
Lecturer

Last Updated :2025/03/26

Researcher Profile and Settings

Researcher

Name
SUNAGA Noriaki

Profile and Settings

Name
Sunaga, Noriaki

Foreign language

Use in presentation
English
Use in publication
English

Affiliation

Gunma University, Lecturer

Education

2007, Gunma University

1993, Gunma University, Faculty of Medicine

2007, Gunma University

Association Memberships

American Association for Cancer Research

International Association for the Study of Lung Cancer

Research Experience

2001, 2004, Postdoctoral Fellow, University of Texas Southwestern Medical Center

1999, 2001

Research Activities

Research Areas

Life sciences, Respiratory Medicine

Research Interests

lung cancer

Research Themes

Molecular abnormalities in the development of lung cancer, Personal, Respiratory Organ Internal Medicine, Grant-in-Aid for Scientific Research

Published Papers

Rare Case of Fusobacterium necrophorum Bacteremia and Pleural Empyema Originating from a Burn Ulcer in a 16-Year-Old Female Patient, Yatomi M, Hashimoto C, Kouno S, Hoshino Y, Yoshida Y, Hara K, Uno S, Masubuchi H, Miura Y, Tsurumaki H, Koga Y, Sunaga N, Hisada T, Maeno T, 10 Dec. 2024, Am J Case Rep, Scientific journal
DOI

A case of autoimmune pulmonary alveolar proteinosis during the course of treatment of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositis, Yatomi M, Akasaka K, Sato S, Chida M, Kanbe M, Sawada H, Yokota I, Wakamatsu I, Muto S, Sato M, Yamaguchi K, Miura Y, Tsurumaki H, Sakurai R, Hara K, Koga Y, Sunaga N, Yamakawa H, Matsushima H, Yamazaki S, Endo Y, Motegi SI, Hisada T, Maeno T., 08 Apr. 2024, BMC Pulm Med, 24, 1, 170, 170, Scientific journal

The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer, Sunaga N, Kaira K, Shimizu K, Tanaka I, Miura Y, Nakazawa S, Ohtaki Y, Kawabata-Iwakawa R, Sato M, Girard L, Minna JD, Hisada T., 28 Nov. 2023, Thorac Cancer, 15, 2, 131, 141, Scientific journal
DOI

Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib, Yamaguchi O, Kasahara N, Soda H, Imai H, Naruse I, Yamaguchi H, Itai M, Taguchi K, Uchida M, Sunaga N, Maeno T, Minato K, Tomono H, Ogawara D, Mukae H, Miura Y, Shiono A, Mouri A, Kagamu H, Kaira K., Nov. 2023, Sci Rep, 13, 1, 20848, Scientific journal
DOI

Silencing of GRHL2 induces epithelial‑to‑mesenchymal transition in lung cancer cell lines with different effects on proliferation and clonogenic growth, Kawabe N, Matsuoka K, Komeda K, Muraki N, Takaba M, Togami Y, Ito Y, Yamada M, Sunaga N, Girard L, Minna JD, Cai L, Xie Y, Tanaka I, Morise M, Sato M, Jul. 2023, Oncol Lett, 26, 3, 391, Scientific journal
DOI

Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations, Kanbe M, Sunaga N, Hara K, Sawada H, Wakamatsu I, Hara K, Muto S, Sawada Y, Masubuchi H, Sato M, Miura Y, Tsurumaki H, Yatomi M, Sakurai R, Koga Y, Ohtaki Y, Nagashima T, Okano N, Kubo N, Maeno T, Hisada T, 04 Oct. 2022, Thoracic Cancer, 13, 22, 3225, 3228, Scientific journal
DOI

過敏性肺炎パターンを呈した、低温加熱式タバコにより短期間に肺障害が進行した1例, 武藤壮平, 鶴巻寛朗, 豊田正昂, 申悠樹, 相川政紀, 佐藤麻里, 三浦陽介, 矢冨正清, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, Jun. 2022, 29, 2, 43, 48, Scientific journal

イソシアネートによる過敏性肺炎が疑われ、nintedanibが奏功したと考えられた1例, 反町百花, 古賀康彦, 伊藤優志, 宇野翔吾, 武藤壮平, 佐藤麻里, 三浦陽介, 鶴巻寛朗, 矢冨正清, 土屋智, 砂長則明, 前野敏孝, 久田剛志, Jun. 2022, 29, 2, 49, 57, Scientific journal

Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis, Sunaga N, Koga Y, Hachisu Y, Yamaguchi K, Aikawa M, Kasahara N, Miura Y, Tsurumaki H, Yatomi M, Sakurai R, Maeno T, Hisada T., May 2022, Can Respir J, Scientific journal
DOI

Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies, Yamaguchi K, Fukushima Y, Yamaguchi A, Itai M, Shin Y, Uno S, Muto S, Kouno S, Tsurumaki H, Yatomi M, Aoki-Saito H, Hara K, Koga Y, Sunaga N, Endo Y, Motegi SI, Nakasatomi M, Sakairi T, Ikeuchi H, Hir, 13 Jan. 2022, Respir Med, 193, 106741, Scientific journal
DOI

Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Takehara K, Koga Y, Hachisu Y, Utsugi M, Sawada Y, Saito Y, Yoshimi S, Yatomi M, Shin Y, Wakamatsu I, Umetsu K, Kouno S, Nakagawa J, Sunaga N, Maeno T, Hisada T., 02 Jan. 2022, Cells, 11, 143
DOI

Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer, Sunaga N, Miura Y, Kasahara N, Sakurai R., 26 Nov. 2021, Cancers, 13, 23, 5956
DOI

A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia, Wakamatsu I, Yatomi M, Uno S, Oishi Y, Ikeuchi H, Hanazato C, Sawada Y, Saito H, Yamaguchi K, Kasahara N, Miura Y, Tsurumaki H, Hara K, Koga Y, Sunaga N, Hisada T, Hiromura K, Maeno T., 17 Aug. 2021, Radiol Case Rep., 16, 11, 3504, 3508
DOI

Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study, Kasahara, Norimitsu;Sunaga, Noriaki;Kuwako, Tomohito;Naruse, Ichiro;Imai, Hisao;Jingu, Asuka;Tsukagoshi, Yusuke;Masuda, Tomomi;Kitahara, Shinsuke;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Hara, Kenichiro;Koga, Yasuhiko;Sakurai, Reiko;Mori, Keita;Kaira, Kyoichi;Maeno, Toshitaka;Asao, Takayuki;Hisada, Takeshi, Oct. 2020, SUPPORTIVE CARE IN CANCER, 28, 10, 4825, 4831
DOI

Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment, Kasahara, Norimitsu;Imai, Hisao;Naruse, Ichiro;Tsukagoshi, Yusuke;Kotake, Mie;Sunaga, Noriaki;Kaira, Kyoichi;Maeno, Toshitaka;Asao, Takayuki;Hisada, Takeshi, Aug. 2020, THORACIC CANCER, 11, 8, 2188, 2195
DOI

Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations, Masuda, Tomomi;Sunaga, Noriaki;Kasahara, Norimitsu;Takehara, Kazutaka;Yatomi, Masakiyo;Hara, Kenichiro;Koga, Yasuhiko;Maeno, Toshitaka;Hisada, Takeshi, Aug. 2020, THORACIC CANCER, 11, 8, 2351, 2356
DOI

FAM83G Is a Novel Inducer of Apoptosis, Okada, Junichi;Sunaga, Noriaki;Yamada, Eijiro;Saito, Tsugumichi;Ozawa, Atsushi;Nakajima, Yasuyo;Okada, Kazuya;Pessin, Jeffrey E.;Okada, Shuichi;Yamada, Masanobu, Jun. 2020, MOLECULES, 25, 12, E2810, E2810
DOI

Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC, Imai, Hisao;Kaira, Kyoichi;Naruse, Ichiro;Kasahara, Norimitsu;Kamide, Yosuke;Ono, Akihiro;Masuda, Tomomi;Sunaga, Noriaki;Minato, Koichi;Hisada, Takeshi, Mar. 2020, ANTICANCER RESEARCH, 40, 3, 1571, 1578
DOI

Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin, Sakurai, Reiko;Kaira, Kyoichi;Miura, Yosuke;Sunaga, Noriaki;Saito, Ryusei;Oyama, Tetsunari;Hisada, Takeshi;Yamada, Masanobu, Feb. 2020, THORACIC CANCER, 11, 2, 426, 435
DOI

Treatment with Tumor Necrosis Factor-alpha Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients, Hachisu, Yoshimasa;Koga, Yasuhiko;Kasama, Shu;Kaira, Kyoichi;Yatomi, Masakiyo;Aoki-Saito, Haruka;Tsurumaki, Hiroaki;Kamide, Yosuke;Sunaga, Noriaki;Maeno, Toshitaka;Ishizuka, Tamotsu;Hisada, Takeshi, Dec. 2019, JOURNAL OF CLINICAL MEDICINE, 9, 1, 96, 96
DOI

線維筋痛症、全身性強皮症、シェーグレン症候群に合併した気管気管支アミロイドーシスの1例, 塚越優介澤田友里蜂巣克昌笠原礼光鶴巻寛朗矢冨正清櫻井麗子砂長則明前野敏孝久田剛志, Mar. 2019, 41, 2, 160, 163

Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1, Kasahara, Norimitsu;Sunaga, Noriaki;Tsukagoshi, Yusuke;Miura, Yosuke;Sakurai, Reiko;Kitahara, Shinsuke;Yokobori, Takehiko;Kaira, Kyoichi;Mogi, Akira;Maeno, Toshitaka;Asao, Takayuki;Hisada, Takeshi, 2019, ANTICANCER RESEARCH, 39, 3, 1455, 1461
DOI

Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer, Sunaga, Noriaki;Miura, Yosuke;Tsukagoshi, Yusuke;Kasahara, Norimitsu;Masuda, Tomomi;Sakurai, Reiko;Kaira, Kyoichi;Hisada, Takeshi, 2019, ONCOLOGY LETTERS, 17, 3, 3569, 3575
DOI

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non-small-cell lung cancer, Kaira, Kyoichi;Ono, Akihiro;Kamide, Yosuke;Sunaga, Noriaki;Koga, Yasuhiko;Saitoh, Jun-ichi;Shirai, Katsuyuki;Ebara, Takeshi;Hisada, Takeshi;Ishizuka, Tamotsu, 2019, JOURNAL OF RADIATION RESEARCH, 60, 2, 228, 233
DOI

Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer, Miura, Yosuke;Kasahara, Norimitsu;Sunaga, Noriaki, 2019, TRANSLATIONAL CANCER RESEARCH, 8, S628, S632
DOI

An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer, Kaira, Kyoichi;Imai, Hisao;Souma, Ryousuke;Sakurai, Reiko;Miura, Yosuke;Sunaga, Noriaki;Kasahara, Norimitsu;Tsukagoshi, Yusuke;Koga, Yasuhiko;Kitahara, Shinsuke;Kotake, Mie;Minato, Koichi;Naruse, Ichiro;Fukushima, Yasutsugu;Hisada, Takeshi;Ishizuka, Tamotsu, 2019, ANTICANCER RESEARCH, 39, 5, 2483, 2491
DOI

Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment, Yasuda, Masahito;Morimoto, Naoko;Yonemoto, Yukio;Sunaga, Noriaki;Ishikawa, Osamu, 2019, EUROPEAN JOURNAL OF DERMATOLOGY, 29, 1, 81, 82
DOI

外来化学療法センターにおける過敏症反応・インフュージョンリアクションの後方視的検討, 関根宏美、赤岩鮎美、小野澤由美子、金城妙子、中村仁美、中村理恵、名和三重子、吉田静香、荒木伸生、飯塚誠、清水啓明、砂長則明、塚本憲史, Nov. 2018, 45, 11, 1625 - 1629

Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer, Miura, Yosuke;Sunaga, Noriaki, 2018, CANCERS, 10, 8
DOI

Small Cell Lung Cancer with Sarcoidosis in Spontaneous Remission: A Case Report, Sasaki, Yumeka;Koga, Yasuhiko;Kasahara, Norimitsu;Hachisu, Yoshimasa;Murata, Keisuke;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Tsukagoshi, Yusuke;Sawada, Yuri;Sakurai, Reiko;Ono, Akihiro;Sunaga, Noriaki;Kaira, Kyoichi;Hirato, Junko;Maeno, Toshitaka;Dobashi, Kunio;Hisada, Takeshi, 2018, JOURNAL OF NIPPON MEDICAL SCHOOL, 85, 5, 291, 296

A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer, Sakurai, Reiko;Tomizawa, Yoshio;Yoshii, Akihiro;Miura, Yosuke;Tsurumaki, Hiroaki;Kaira, Kyoichi;Sunaga, Noriaki;Kawashima, Osamu;Hisada, Takeshi;Yamada, Masanobu;Saito, Ryusei, 2018, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81, 1, 103, 109
DOI

The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer, Miura, Yosuke;Imai, Hisao;Sakurai, Reiko;Kaira, Kyoichi;Sunaga, Noriaki;Minato, Koichi;Saito, Ryusei;Hisada, Takeshi, 2018, MEDICAL ONCOLOGY, 35, 4
DOI

Metabolic activity by F-18-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC, Kaira, Kyoichi;Higuchi, Tetsuya;Naruse, Ichiro;Arisaka, Yukiko;Tokue, Azusa;Altan, Bolag;Suda, Satoshi;Mogi, Akira;Shimizu, Kimihiro;Sunaga, Noriaki;Hisada, Takeshi;Kitano, Shigehisa;Obinata, Hideru;Yokobori, Takehiko;Mori, Keita;Nishiyama, Masahiko;Tsushima, Yoshihito;Asao, Takayuki, 2018, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, 1, 56, 66
DOI

The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome, Hachisu, Yoshimasa;Koga, Yasuhiko;Sunaga, Noriaki;Kashiwagi, Chiharu;Sawada, Yuri;Saito, Yasuyuki;Tsukagoshi, Yusuke;Kasahara, Norimitsu;Sakurai, Reiko;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Kaira, Kyoichi;Ono, Akihiro;Maeno, Toshitaka;Hisada, Takeshi, 2018, INTERNAL MEDICINE, 57, 2, 247, 251
DOI

High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin, Miura, Yosuke;Kaira, Kyoichi;Sakurai, Reiko;Sunaga, Noriaki;Saito, Ryusei;Hisada, Takeshi;Yamada, Masanobu, 2018, LUNG CANCER, 115, 42, 48
DOI

Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma, Kasahara, Norimitsu;Kaira, Kyoichi;Bao, Pinjie;Higuchi, Tetsuya;Arisaka, Yukiko;Erkhem-Ochir, Bilguun;Sunaga, Noriaki;Ohtaki, Yoichi;Yajima, Toshiki;Kosaka, Takayuki;Oyama, Tetsunari;Yokobori, Takehiko;Asao, Takayuki;Nishiyama, Masahiko;Tsushima, Yoshito;Kuwano, Hiroyuki;Shimizu, Kimihiro;Mogi, Akira, 2018, LUNG CANCER, 119, 71, 77
DOI

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer, Yoshioka H, Katakami N, Okamoto H, Iwamoto Y, Seto T, Takahashi T, Sunaga N, Kudoh S, Chikamori K, Takeda K, Masuda N, Kitagawa H, Horio H, Yamanaka T, Fukuoka M, Yamamoto N, Nakagawa K., Feb. 2017, Ann Oncol, 28, 2, 285, 291
DOI

Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature, Saito, Yasuyuki;Sawada, Yuri;Koga, Yasuhiko;Sunaga, Noriaki;Tsukagoshi, Yusuke;Hachisu, Yoshimasa;Osaki, Takashi;Sakurai, Reiko;Kaira, Kyoichi;Ono, Akihiro;Sato, Ken;Koiso, Hiromi;Oyama, Tetsunari;Hisada, Takeshi;Yamada, Masanobu, 2017, INTERNAL MEDICINE, 56, 20, 2753, 2757
DOI

High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma, Miura, Yosuke;Kaira, Kyoichi;Sakurai, Reiko;Imai, Hisao;Tomizawa, Yoshio;Sunaga, Noriaki;Minato, Koichi;Hisada, Takeshi;Oyama, Tetsunari;Yamada, Masanobu, 2017, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 5, 872, 879
DOI

Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer, Kaira, Kyoichi;Yanagitani, Noriko;Sunaga, Noriaki;Imai, Hisao;Ono, Akihiro;Koga, Yasuhiko;Hisada, Takeshi;Ishizuka, Tamotsu;Yamada, Masanobu, 2017, ONCOLOGY LETTERS, 14, 1, 1123, 1128
DOI

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer, Imai, Hisao;Kuwako, Tomohito;Kaira, Kyoichi;Masuda, Tomomi;Miura, Yosuke;Seki, Kaori;Sakurai, Reiko;Utsugi, Mitsuyoshi;Shimizu, Kimihiro;Sunaga, Noriaki;Tomizawa, Yoshio;Ishihara, Shinichi;Ishizuka, Takao;Mogi, Akira;Hisada, Takeshi;Minato, Koichi;Takise, Atsushi;Saito, Ryusei;Yamada, Masanobu, 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 3, 497, 505, Scientific journal
DOI

Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer, Kaira, Kyoichi;Tomizawa, Yoshio;Imai, Hisao;Sakurai, Reiko;Matsuura, Masana;Yoshii, Akihiro;Ochiai, Mai;Kotake, Mie;Ebara, Takeshi;Saitoh, Jun-ichi;Sunaga, Noriaki;Minato, Koichi;Saito, Ryusei;Hisada, Takeshi, 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 1, 165, 171
DOI

Prognostic effect of class III beta-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors, Miura, Yosuke;Kaira, Kyoichi;Sakurai, Reiko;Imai, Hisao;Tomizawa, Yoshio;Sunaga, Noriaki;Minato, Koichi;Hisada, Takeshi;Oyama, Tetsunari;Yamada, Masanobu, 2017, ONCOLOGY LETTERS, 14, 2, 2369, 2378
DOI

Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer, Kaira, Kyoichi;Sunaga, Noriaki;Imai, Hisao;Kamide, Yosuke;Koga, Yasuhiko;Ono, Akihiro;Kuwako, Tomohito;Masuda, Tomomi;Hisada, Takeshi;Ishizuka, Tamotsu;Yamada, Masanobu, 2016, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21, 2, 240, 247
DOI

Usefulness of F-18-alpha-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer, Kaira, Kyoichi;Higuchi, Tetsuya;Sunaga, Noriaki;Arisaka, Yukiko;Hisada, Takeshi;Tominaga, Hideyuki;Oriuchi, Noboru;Asao, Takayuki;Tsushima, Yoshihito;Yamada, Masanobu, 2016, ANTICANCER RESEARCH, 36, 12, 6481, 6490
DOI

17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice, Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F., Dec. 2015, Physiol Rep, 3, 12, e12628, e12628
DOI

Epiregulin as a therapeutic target in non-small-cell lung cancer., Sunaga Noriaki;Kaira Kyoichi, 12 Oct. 2015, Lung Cancer (Auckland, N.Z.), 6
DOI

Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer., Kaira Kyoichi;Naruse Ichiro;Imai Hisao;Sunaga Noriaki;Hisada Takeshi;Motegi Masahiko;Asao Takayuki;Yamada Masanobu, 22 Sep. 2015, Chemotherapy, 60, 5-6
DOI

Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations., Masuda T, Imai H, Kuwako T, Miura Y, Yoshino R, Kaira K, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Mogi A, Hisada T, Minato K, Takise A, Saito R, Yamada M., Sep. 2015, Clin Transl Oncol, 17, 9, 702, 709
DOI

First-line gefitinib treatment in elderly patients (aged >= 75 years) with non-small cell lung cancer harboring EGFR mutations, Kuwako, Tomohito;Imai, Hisao;Masuda, Tomomi;Miura, Yosuke;Seki, Kaori;Yoshino, Reiko;Kaira, Kyoichi;Utsugi, Mitsuyoshi;Shimizu, Kimihiro;Sunaga, Noriaki;Tomizawa, Yoshio;Ishihara, Shinichi;Ishizuka, Takao;Mogi, Akira;Hisada, Takeshi;Minato, Koichi;Takise, Atsushi;Saito, Ryusei;Yamada, Masanobu, 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 761, 769
DOI

Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case, Imai, Hisao;Matsumura, Nozomi;Yamazaki, Yuichi;Kanayama, Yuki;Masuda, Tomomi;Kuwako, Tomohito;Kamide, Yosuke;Tomizawa, Taku;Matsumoto, Shunichi;Mitsui, Takeki;Kaira, Kyoichi;Ono, Akihiro;Koga, Yasuhiko;Shibusawa, Nobuyuki;Sunaga, Noriaki;Hisada, Takeshi;Yokoo, Hideaki;Yamada, Masanobu, 2015, INTERNAL MEDICINE, 54, 24, 3171, 3176
DOI

Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma, Kamide, Yosuke;Kaira, Kyoichi;Watanabe, Takuya;Kuribayashi, Shiko;Ozawa, Atsushi;Koga, Yasuhiko;Ono, Akihiro;Sunaga, Noriaki;Hisada, Takeshi;Oyama, Tetsunari;Yamada, Masanobu, 2015, INTERNAL MEDICINE, 54, 22, 2905, 2909
DOI

Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma, Kaira, Kyoichi;Sunose, Yutaka;Arakawa, Kazuhisa;Sunaga, Noriaki;Shimizu, Kimihiro;Tominaga, Hideyuki;Oriuchi, Noboru;Nagamori, Shushi;Kanai, Yoshikatsu;Oyama, Tetsunari;Takeyoshi, Izumi, 2015, HISTOPATHOLOGY, 66, 2, 234, 243
DOI

Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk, YASUAKI ENOKIDA, KIMIHIRO SHIMIZU, SEIICHI KAKEGAWA, JUN ATSUMI, YOSHIAKI TAKASE, YOHEI MIYAMAE, TOSHITERU NAGASHIMA, YOICHI OHTAKI, KYOICHI KAIRA, NORIAKI SUNAGA, NORIKO YANAGITANI, REIKO YOSHINO, KATSUHIKO TSUNEKAWA, HITOSHI IGAI, MITSUHIRO KAMIYOSHIHARA, KENGO USUI, ALEXANDER LEZHAVA, YOSHIO TOMIZAWA, TOSHIHISA ISHIKAWA, MASAMI MURAKAMI, YOSHIHIDE HAYASHIZAKI, IZUMI TAKEYOSHI, 2014, Biomedical Reports
DOI

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer, Shimizu, K.; Kaira, K.; Tomizawa, Y.; Sunaga, N.; Kawashima, O.; Oriuchi, N.; Tominaga, H.; Nagamori, S.; Kanai, Y.; Yamada, M.; Oyama, T.; Takeyoshi, I., 2014, BRITISH JOURNAL OF CANCER
DOI

Solitary pituitary metastasis resulting from pulmonary large cell neuroendocrine carcinoma., WatanabeT, Kaira K, Mizuide M, Sunaga N, Shibusawa N, Hisada T, Satoh T, Mori M, Yamada M., 2014, World Journal of Respirology

Small-cell lung cancer with voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis: a case report., Kaira Kyoichi;Okamura Takashi;Takahashi Hiroki;Horiguchi Norio;Sunaga Noriaki;Hisada Takeshi;Yamada Masanobu, 08 Apr. 2014, Journal of medical case reports, 8
DOI

Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma, Sunaga N, Kaira K, Tomizawa Y, Shimizu K, Imai H, Takahashi G, Kakegawa S, Ohtaki Y, Nagashima T, Kasahara N, Kawashima O, Hisada T, Saito R, Yamada M., Apr. 2014, Br J Cancer, 110, 8, 2047, 2053
DOI

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Ishizuka, Tamotsu;Hisada, Takeshi;Hatori, Motoaki;Koike, Akio;Hanabuchi, Kikuo;Matsuzaki, Shinichi;Kamide, Yosuke;Utsugi, Mitsuyoshi;Aoki, Haruka;Yoshino, Reiko;Yanagitani, Noriko;Koga, Yasuhiko;Ono, Akihiro;Kaira, Kyoichi;Sunaga, Noriaki;Dobashi, Kunio;Tsuburai, Takahiro;Akiyama, Kazuo;Yamada, Masanobu;Suzuki, Kazuhiro;Mori, Masatomo, 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796
DOI

Acidic pH increases cGMP accumulation through the OGR1/phospholipase C/Ca2+/neuronal NOS pathway in N1E-115 neuronal cells, Kotake, Mie;Sato, Koichi;Mogi, Chihiro;Tobo, Masayuki;Aoki, Haruka;Ishizuka, Tamotsu;Sunaga, Noriaki;Imai, Hisao;Kaira, Kyoichi;Hisada, Takeshi;Yamada, Masanobu;Okajima, Fumikazu, 2014, CELLULAR SIGNALLING, 26, 11, 2326, 2332
DOI

Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status., Ohtaki Yoichi;Shimizu Kimihiro;Kakegawa Seiichi;Nagashima Toshiteru;Nakano Tetsuhiro;Atsumi Jun;Enokida Yasuaki;Igai Hitoshi;Ibe Takashi;Sugano Masayuki;Kamiyoshihara Mitsuhiro;Kawashima Osamu;Kaira Kyoichi;Sunaga Noriaki;Takeyoshi Izumi, 31 Dec. 2013, Molecular and clinical oncology, 2, 2
DOI

FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer., Sunaga N, Kaira K, Hisada T, Yamada M., Nov. 2013, World J Respirol, 3, 3, 104, 109
DOI

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer., Sunaga N, Kaira K, Imai H, Shimizu K, Nakano T, Shames DS, Girard L, Soh J, Sato M, Iwasaki Y, Ishizuka T, Gazdar AF, Minna JD, Mori M., Aug. 2013, Oncogene, 32, 34, 4034, 4042
DOI

Perfusion Evaluation of Lung Cancer: Assessment Using Dual-input Perfusion Computed Tomography, Nakano, Sachiko;Gibo, Junko;Fukushima, Yasuhiro;Kaira, Kyoichi;Sunaga, Noriaki;Taketomi-Takahashi, Ayako;Tsushima, Yoshito;Mori, Masatomo, 2013, JOURNAL OF THORACIC IMAGING, 28, 4, 253, 262
DOI

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer, Kaira, Kyoichi;Tomizawa, Yoshio;Yoshino, Reiko;Miura, Yosuke;Yoshii, Akihiro;Iwasaki, Yasuki;Koga, Yasuhiko;Ono, Akihiro;Hisada, Takeshi;Minato, Koichi;Sato, Koji;Kazama, Toshifumi;Ishihara, Shinichi;Kohyama, Kenya;Fueki, Naoto;Saito, Ryusei;Sunaga, Noriaki, 2013, LUNG CANCER, 82, 1, 103, 108
DOI

Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer, Kaira, Kyoichi;Tomizawa, Yoshio;Yoshino, Reiko;Yoshii, Akihiro;Matsuura, Masana;Iwasaki, Yasuki;Koga, Yasuhiko;Ono, Akihiro;Nishioka, Masaki;Kamide, Yosuke;Hisada, Takeshi;Ishizuka, Tamotsu;Shirai, Katsuyuki;Ebara, Takeshi;Saitoh, Jun-ichi;Nakano, Takashi;Sunaga, Noriaki, 2013, LUNG CANCER, 82, 3, 449, 454
DOI

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer, Kaira, Kyoichi;Sunose, Yutaka;Ohshima, Yasuhiro;Ishioka, Noriko S.;Arakawa, Kazuhisa;Ogawa, Tetsushi;Sunaga, Noriaki;Shimizu, Kimihiro;Tominaga, Hideyuki;Oriuchi, Noboru;Itoh, Hideaki;Nagamori, Shushi;Kanai, Yoshikatsu;Yamaguchi, Aiko;Segawa, Atsuki;Ide, Munenori;Mori, Masatomo;Oyama, Tetsunari;Takeyoshi, Izumi, 2013, BMC CANCER, 13
DOI

Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer, Kaira K, Sunose Y, Arakawa K, Ogawa T, Sunaga N, Shimizu K, Tominaga H, Oriuchi N, Itoh H, Nagamori S, Kanai Y, Segawa A, Furuya M, Mori M, Oyama T, Takeyoshi I., Aug. 2012, Br J Cancer, 107, 4, 632, 638
DOI

ベバシズマブを含む化学療法施行中に気胸を発症した肺腺癌の1例, 吉野麗子、砂長則明、岩崎靖樹、久田剛志、石塚全、森昌朋, Feb. 2012, 1, 2, 141-145

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer, Sunaga, Noriaki;Imai, Hisao;Shimizu, Kimihiro;Shames, David S.;Kakegawa, Seiichi;Girard, Luc;Sato, Mitsuo;Kaira, Kyoichi;Ishizuka, Tamotsu;Gazdar, Adi F.;Minna, John D.;Mori, Masatomo, 2012, INTERNATIONAL JOURNAL OF CANCER, 130, 8, 1733, 1744
DOI

Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: Gene expression associated with metastatic potential in human lung cancer, Nakano, Tetsuhiro;Shimizu, Kimihiro;Kawashima, Osamu;Kamiyoshihara, Mitsuhiro;Kakegawa, Seiichi;Sugano, Masayuki;Ibe, Takashi;Nagashima, Toshiteru;Kaira, Kyoichi;Sunaga, Noriaki;Ohtaki, Youichi;Atsumi, Jun;Takeyoshi, Izumi, 2012, ONCOLOGY REPORTS, 28, 5, 1727, 1735
DOI

Interaction of Radiation and Gefitinib on a Human Lung Cancer Cell Line with Mutant EGFR Gene In Vitro, Sato, Yumi;Ebara, Takeshi;Sunaga, Noriaki;Takahashi, Takeo;Nakano, Takashi, 2012, ANTICANCER RESEARCH, 32, 11, 4877, 4881

Gefitinib and Gemcitabine Coordinately Inhibited the Proliferation of Cholangiocarcinoma Cells, Nakajima, Yoshimi;Takagi, Hitoshi;Kakizaki, Satoru;Horiguchi, Norio;Sato, Ken;Sunaga, Noriaki;Mori, Masatomo, 2012, ANTICANCER RESEARCH, 32, 12, 5251, 5262, Scientific journal

The role of [18F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors., Kaira K, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N., Nov. 2011, Cancer Imaging.

A systemic review of PET and biology in lung cancer., Kaira K, Oriuchi N, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N., Aug. 2011, Am J Transl Res.

Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy., Sunaga N, Shames DS, Girard L, Peyton M, Larsen JE, Imai H, Soh J, Sato M, Yanagitani N, Kaira K, Xie Y, Gazdar AF, Mori M, Minna JD., Feb. 2011, Mol Cancer Ther., 10, 2, 336, 346

多発消化管転移を来した低分化肺腺癌の1例, 柳谷典子, 石塚全, 平戸純子, 解良恭一, 岩崎靖樹, 砂長則明, 久田剛志, 森昌朋, 2011, 70, 186-191

Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer., Imai H, Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Nagamori S, Promchan K, Nakajima T, Yamamoto N, Mori M, Kanai Y., Dec. 2010

Assessment of therapy response in lung cancer with 18F-α-methyl tyrosine PET., Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Mori M, Endo K., Nov. 2010, AJR Am J Roentgenol

Comparison of l-type amino acid transporter 1 expression and l-[3-(18)F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer., Kaira K, Oriuchi N, Shimizu K, Imai H, Tominaga H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Oyama T, Mori M, Endo K., Nov. 2010, Nucl Med Biol

Protective effect of resolvin E1 on the development of asthmatic airway inflammation., Aoki H, Hisada T, Ishizuka T, Utsugi M, Ono A, Koga Y, Sunaga N, Nakakura T, Okajima F, Dobashi K, Mori M., Sep. 2010, Biochem Biophys Res Commun

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer., Kaira K, Sunaga N, Tomizawa Y, Yanagitani N, Shimizu K, Imai H, Utsugi M, Iwasaki Y, Iijima H, Tsurumaki H, Yoshii A, Fueki N, Hisada T, Ishizuka T, Saito R, Mori M., Jul. 2010, Lung Cancer, 69, 1, 99, 104

Epigenetic Inactivation of the Thyroid Hormone Receptor beta1 Gene at 3p24.2 in Lung Cancer., Iwasaki Y, Sunaga N, Tomizawa Y, Imai H, Iijima H, Yanagitani N, Horiguchi K, Yamada M, Mori M., Feb. 2010, Ann Surg Oncol. , 17, 8, 2222, 2228

Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer, ImaiH, Sunaga N, Shimizu Y, Kakegawa S, Shimizu K, Sano T, Ishizuka T, Oyama T, Saito R, Minna JD, Mori M, 2010, International Journal of Immunopathology and Pharmacology, 23, 1, 153, 164, Scientific journal

胸痛にて発症した神経サルコイドーシスの１例, 柳谷典子、小竹美絵、石塚全、岩崎靖樹、砂長則明、森昌朋, Dec. 2009, 47, 12, 1087

CD98 Expression Is Associated with Poor Prognosis in Resected Non-Small-Cell Lung Cancer with Lymph Node Metastases. , Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Kamide Y, Ishizuka T, Kanai Y, Nakajima T, Mori M., Dec. 2009, Ann Surg Oncol

18F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non-Small Cell Lung Cancer., Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Mori M, Endo K., Nov. 2009, J Nucl Med

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. , Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Nakajima T, Mori M., Oct. 2009, Lung Cancer.

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer. , Kaira K, Sunaga N, Yanagitani N, Imai H, Utsugi M, Iwasaki Y, Shimizu K, Iijima H, Tsurumaki H, Tomizawa Y, Hisada T, Ishizuka T, Saito R, Mori M., Jul. 2009, Lung Cancer, 68, 2, 253, 257, Scientific journal

Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations. , Morita S, Okamoto I, Kobayashi K, Yamazaki K, Asahina H, Inoue A, Hagiwara K, Sunaga N, Yanagitani N, Hida T, Yoshida K, Hirashima T, Yasumoto K, Sugio K, Mitsudomi T, Fukuoka M, Nukiwa T., Jul. 2009, Clin Cancer Res, 15, 13, 4493, 4498

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. , Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M., Jun. 2009, Histopathology.

L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas. , Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M., Jun. 2009, J Surg Oncol.

Multiple lung metastases presenting as ground-glass opacities in a pulmonary adenocarcinoma: a case report., Yanagitani N, Kaira K, Ishizuka T, Aoki H, Utsugi M, Shimizu Y, Sunaga N, Endou K, Hisada T, Mori M., May 2009, Cases J

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. , Shimizu Y, Sunaga N, Dobashi K, Fueki M, Fueki N, Makino S, Mori M., Apr. 2009, BMC Infect Dis

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. , Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M. , Apr. 2009, Cancer Sci.

非特異的間質性肺炎との鑑別が困難であった好酸球浸潤を伴う器質化肺炎の1例, 柳谷典子, 石塚全, 弘中貢, 解良恭一, 今井久雄, 川田忠嘉, 宇津木光克, 清水泰生, 砂長則明, 久田剛志, 森昌朋, Apr. 2009

CXCR4+FOXP3+CD25+ lymphocytes accumulate in CXCL12-expressing malignant pleural mesothelioma. , Shimizu Y, Dobashi K, Imai H, Sunaga N, Ono A, Sano T, Hikino T, Shimizu K, Tanaka S, Ishizuka T, Utsugi M, Mori M., Mar. 2009, Int J Immunopathol Pharmacol.

Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma. , Imai H, Sunaga N, Kaira K, Kawashima O, Yanagitani N, Sato K, Tomizawa Y, Hisada T, Ishizuka T, Hirato J, Saito R, Nakajima T, Mori M., Mar. 2009, Intern Med.

Evaluation of thoracic tumors with (18)F-FMT and (18)F-FDG PET-CT: a clinicopathological study. , Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M. , Mar. 2009, Int J Cancer.

Pulmonary traumatic pneumatocele and hematoma. , Kaira K, Ishizuka T, Yanagitani N, Sunaga N, Hisada T, Mori M., Feb. 2009, Jpn J Radiol.

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. , Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. , Feb. 2009, Cancer Sci.

GemcitabineとS-1の併用療法にて多発骨転移が著明に改善した高齢者肺癌の1例, 解良恭一, 柳谷典子, 砂長則明, 今井久雄, 宇津木光克, 川田忠嘉, 久田剛志, 清水公裕, 石塚全, 森昌朋, Feb. 2009

慢性閉塞性肺疾患の急性増悪に対するgarenoxacinの臨床効果, 久田剛志, 石塚全, 青木悠, 柳谷典子, 小野昭浩, 今井久雄, 砂長則明, 宇津木光克, 古賀康彦, 岩崎靖樹, 吉野麗子, 土橋邦生, 桑原英眞, 森昌朋, 2009, 58, 1808-1820

L-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. , Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. , 17 Nov. 2008, Cancer Sci., 99, 12, 2380, 2386

Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer., Kaira Kyoichi;Sunaga Noriaki;Yanagitani Noriko;Kawata Tadayoshi;Utsugi Mitsuyoshi;Shimizu Kimihiro;Ebara Takeshi;Kawamura Hidemasa;Nonaka Tetsuo;Ishikawa Hitoshi;Sakurai Hideyuki;Suga Tatsuo;Hara Kenichiro;Hisada Takeshi;Ishizuka Tamotsu;Nakano Takashi;Mori Masatomo, 15 Oct. 2008, International journal of radiation oncology, biology, physics, 75, 1, Scientific journal
DOI

Lung cancer producing granulocyte colony-stimulating factor and rapid spreading to peritoneal cavity. , Kaira K, Ishizuka T, Tanaka H, Tanaka Y, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Mori M. , Sep. 2008, J Thorac Oncol.

サルコイドーシス患者にLarge cell neuroendocrine carcinomaを合併した1例, 柳谷典子, 解良恭一, 石塚全, 青木悠, 川田忠嘉, 宇津木光克, 清水泰生, 砂長則明, 久田剛志, 森昌朋, Jul. 2008

Primary mediastinal synovial sarcoma: a report of 2 cases. , Kaira K, Ishizuka T, Sunaga N, Hashimoto K, Yanagitani N, Nonaka T, Ebara T, Hisada T, Mori M. , Apr. 2008, J Comput Assist Tomogr.

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. , Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. , Feb. 2008, Br J Cancer.

外科的肺生検で膠原病肺が疑われた特発性間質性肺炎の1例, 松崎晋一, 飯島浩宣, 川田忠嘉, 柳谷典子, 解良恭一, 宇津木光克, 清水泰生, 砂長則明, 富澤由雄, 久田剛志, 石塚全, 土橋邦生, 田中優子, 中里洋一, 河端美則, 森昌朋, 2008, 67, 528-534

Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer, Kaira, Kyoichi;Sunaga, Noriaki;Yanagitani, Noriko;Aoki, Haruka;Kawata, Tadayoshi;Utsugi, Mitsuyoshi;Shimizu, Yasuo;Shimizu, Kimihiro;Hisada, Takeshi;Ishizuka, Tamotsu;Mori, Masatomo, 2008, ANTI-CANCER DRUGS, 19, 3, 289, 294

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer, Sunaga, Noriaki;Oriuchi, Noboru;Kaira, Kyoichi;Yanagitani, Noriko;Tomizawa, Yoshio;Hisada, Takeshi;Ishizuka, Tamotsu;Endo, Keigo;Mori, Masatomo, 2008, LUNG CANCER, 59, 2, 203, 210
DOI

Primary mediastinal synovial sarcoma: A report of 2 cases, Kaira, Kyoichi;Ishizuka, Tamotsu;Sunaga, Noriaki;Hashimoto, Koshi;Yanagitani, Noriko;Nonaka, Tetsuo;Ebara, Takeshi;Hisada, Takeshi;Mori, Masatomo, 2008, JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 32, 2, 238, 241

B-Cell non-Hodgkin lymphoma presenting as an endobronchial polypoid mass, Kaira, Kyoichi;Ishizuka, Takahiro;Tanaka, Hiroto;Tanaka, Yoshiki;Ishizuka, Tamotsu;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Mori, Masatomo, 2008, JOURNAL OF THORACIC ONCOLOGY, 3, 5, 530, 531

Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Kawashima, Osamu;Iijima, Hironobu;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Mori, Masatomo, 2008, PATHOLOGY RESEARCH AND PRACTICE, 204, 8, 553, 561
DOI

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Tanaka, Shigebumi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Mori, Masatomo, 2008, CANCER SCIENCE, 99, 12, 2380, 2386
DOI

Laryngeal Sarcoidosis Detected by FDG Positron Emission Tomography, Kaira, Kyoichi;Ishizuka, Tamotsu;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Mori, Masatomo, 2008, CLINICAL NUCLEAR MEDICINE, 33, 12, 878, 879

Pseudomesotheliomatous adenocarcinoma of the lung with synchronous gastric and esophageal cancer. , Kaira K, Sunaga N, Yanagitani N, Hisada T, Ishizuka T, Mori M. , Dec. 2007, Australas Radiol.

Rapid growth of malignant pleural mesothelioma. , Kaira K, Dobashi K, Yanagitani N, Sunaga N, Shimizu Y, Hisada T, Ishizuka T, Nakajima T, Mori M. , Oct. 2007, J Thorac Oncol.

Coinfection of invasive pulmonary aspergillosis and pneumocystis jiroveci pneumonia in a non-HIV patient. , Kaira K, Shinomiya Y, Takahashi Y, Iida T, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Mori M. , Aug. 2007, Acta Med Okayama.

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers. , Kaira K, Sunaga N, Tomizawa Y, Yanagitani N, Ishizuka T, Saito R, Nakajima T, Mori M. , Jul. 2007, Int J Oncol. , 31, 1, 169, 173

Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer? , Yanagitani N, Kaira K, Sunaga N, Naito Y, Koike Y, Ishihara S, Ishizuka T, Saito R, Mori M. , Jun. 2007, Int J Clin Oncol.

Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers. , Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Minna JD, Fujisawa T, Gazdar AF. , Apr. 2007, Ann Surg Oncol.

Expectoration of bronchogenic tumour tissue. , Kaira K, Shimizu Y, Sunaga N, Hisada T, Ishizuka T, Mori M. , Mar. 2007, Intern Med J.

A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer. , Kaira K, Tsuchiya S, Sunaga N, Yanagitani N, Watanabe S, Imai H, Hisada T, Ishizuka T, Saito R, Mori M. , Feb. 2007, Am J Clin Oncol.

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis. , Kaira K, Ishizuka T, Yanagitani N, Sunaga N, Hisada T, Mori M. , Feb. 2007, Clin Nucl Med.

若年者肺癌に合併しゲフィチニブが有効であった肺性肥大性骨関節症の1例, 今井久雄, 富澤由雄, 石原真一, 砂長則明, 青木悠, 飯島浩宣, 岩崎靖樹, 渡辺覚, 斎藤龍生, 森昌朋, Feb. 2007

TS-1が奏効した抗癌剤多剤抵抗性非小細胞肺癌の1例, 今井久雄, 砂長則明, 解良恭一, 石原真一, 青木悠, 飯島浩宣, 柳谷典子, 岩崎靖樹, 富澤由雄, 斎藤龍生, 森昌朋, Feb. 2007

Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. , Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY. , Jan. 2007, Reprod Sci.

化学療法中に発症したニューモシスチス肺炎の1例, 解良恭一, 砂長則明, 森昌朋, Jan. 2007

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer, Kaira, Kyoichi;Sunaga, Noriaki;Yanagitani, Noriko;Imai, Hisao;Utsugi, Mitsuyoshi;Shimizu, Yasuo;Iijima, Hironobu;Tomizawa, Yoshio;Hisada, Takeshi;Ishizuka, Tamotsu;Saito, Ryusei;Mori, Masatomo, 2007, ANTI-CANCER DRUGS, 18, 4, 471, 476

Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with F-18-fluorodeoxyglucose in sarcoidosis patients, Kaira, Kyoichi;Orinchi, Noboni;Otani, Yoshimi;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Endo, Keigo;Mori, Masatomo, 2007, CHEST, 131, 4, 1019, 1027
DOI

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy, Sunaga, Noriaki;Tomizawa, Yoshio;Yanagitani, Noriko;Iijima, Hironobu;Kaira, Kyoichi;Shimizu, Kimihiro;Tanaka, Shigebumi;Suga, Tatsuo;Hisada, Takeshi;Ishizuka, Tamotsu;Saito, Ryusei;Dobashi, Kunio;Mori, Masatomo, 2007, LUNG CANCER, 56, 3, 383, 389, Scientific journal
DOI

Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer, Yanagitani, Noriko;Tsuchiya, Satoshi;Kaira, Kyoichi;Sunaga, Noriaki;Tsuchiya, Yukiko;Sato, Koji;Watanabe, Satoru;Nomura, Shiro;Sakai, Shuzo;Saito, Ryusei;Mori, Masatomo, 2007, AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 30, 5, 487, 491, Scientific journal
DOI

Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: A clinicopathologic study, Kaira, Kyoichi;Oriuchi, Noboru;Otani, Yoshimi;Shimizu, Kimihiro;Tanaka, Shigebumi;Imai, Hisao;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Dobashi, Kunio;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Endo, Keigo;Mori, Masatomo, 2007, CLINICAL CANCER RESEARCH, 13, 21, 6369, 6378
DOI

Gender and age risks for hoarseness and dysphonia with use of a dry powder fluticasone propionate inhaler in asthma, Ishizuka, Tamotsu;Hisada, Takeshi;Aoki, Haruka;Yanagitani, Noriko;Kaira, Kyoichi;Utsugi, Mitsuyoshi;Shimizu, Yasuo;Sunaga, Noriaki;Dobashi, Kunio;Mori, Masatomo, 2007, ALLERGY AND ASTHMA PROCEEDINGS, 28, 5, 550, 556, Scientific journal

A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. , Shimizu Y, Dobashi K, Kobayashi S, Ohki I, Tokushima M, Kusano M, Kawamura O, Shimoyama Y, Utsugi M, Sunaga N, Ishizuka T, Mori M. , Jul. 2006, Tohoku J Exp Med.

Small cell carcinoma of the larynx in a long-term survivor of small-cell lung cancer. , Kaira K, Ishizuka T, Sohara N, Yanagitani N, Sunaga N, Tsuchiya T, Mori M. , Jun. 2006, J Clin Oncol.

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. , Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW, Minna JD. , Feb. 2006, Cancer Res.

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers. , Iijima H, Tomizawa Y, Iwasaki Y, Sato K, Sunaga N, Dobashi K, Saito R, Nakajima T, Minna JD, Mori M. , Feb. 2006, Int J Cancer

A case of primary peritoneal serous papillary carcinoma initially presented by massive bilateral pleural effusions. , Kaira K, Takise A, Endou K, Yanagitani N, Sunaga N, Mori M. , 2006, Eur J Gynaecol Oncol.

DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. , Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Frenkel EP, Minna JD, Fujisawa T, Gazdar AF. , Oct. 2005, Br J Cancer.

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. , Tomizawa Y, Iijima H, Sunaga N, Sato K, Takise A, Otani Y, Tanaka S, Suga T, Saito R, Ishizuka T, Dobashi K, Minna JD, Nakajima T, Mori M. , Oct. 2005, Clin Cancer Res. , 11, 19, 6816, 6822

The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer. , Sekine I, Sato M, Sunaga N, Toyooka S, Peyton M, Parsons R, Wang W, Gazdar AF, Minna JD. , Apr. 2005, Oncogene.

Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. , Yamane A, Kohno T, Ito K, Sunaga N, Aoki K, Yoshimura K, Murakami H, Nojima Y, Yokota J. , Sep. 2004, Carcinogenesis., Scientific journal

Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. , Sunaga N, Miyajima K, Suzuki M, Sato M, White MA, Ramirez RD, Shay JW, Gazdar AF, Minna JD. , Jun. 2004, Cancer Res., 64, 12, 4277, 4285

RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. , Suzuki M, Sunaga N, Shames DS, Toyooka S, Gazdar AF, Minna JD. , May 2004, Cancer Res. , 64, 9, 3137, 3143

Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer. , Sato M, Girard L, Sekine I, Sunaga N, Ramirez RD, Kamibayashi C, Minna JD. , Oct. 2003, Oncogene.

Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo. , Yamane A, Shinmura K, Sunaga N, Saitoh T, Yamaguchi S, Shinmura Y, Yoshimura K, Murakami H, Nojima Y, Kohno T, Yokota J. , Jun. 2003, Carcinogenesis.

Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. , Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, Takei Y, Tsuchiya S, Saito R, Yokota J. , Aug. 2002, Cancer Epidemiol Biomarkers Prev. , 11, 8, 730, 738

Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1. , Yanagitani N, Kohno T, Sunaga N, Kunitoh H, Tamura T, Tsuchiya S, Saito R, Yokota J. , Jul. 2002, Carcinogenesis.

OGG1 protein suppresses G:C-->T:A mutation in a shuttle vector containing 8-hydroxyguanine in human cells. , Sunaga N, Kohno T, Shinmura K, Saitoh T, Matsuda T, Saito R, Yokota J. , Sep. 2001, Carcinogenesis., 22, 9, 1355, 1362

Physical and transcriptional map of a 311-kb segment of chromosome 18q21, a candidate lung tumor suppressor locus. , Yanaihara N, Kohno T, Takakura S, Takei K, Otsuka A, Sunaga N, Takahashi M, Yamazaki M, Tashiro H, Fukuzumi Y, Fujimori Y, Hagiwara K, Tanaka T, Yokota J. , May 2001, Genomics.

Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. , Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R, Yokota J. , Mar. 2001, Genes Chromosomes Cancer. , 30, 3, 316, 321

Weekly CODE chemotherapy with recombinant human granulocyte colony-stimulating factor for relapsed or refractory small cell lung cancer. , Sato K, Tsuchiya S, Minato K, Sunaga N, Ishihara SI, Makimoto T, Naruse I, Hoshino H, Watanabe S, Saitoh R, Mori M. , Oct. 2000, Oncol Rep. , 7, 5, 1135, 1139

A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer. , Ishihara S, Tsuchiya S, Minato K, Watanabe S, Sunaga N, Sato K, Kobayashi G, Hoshino H, Naruse I, Makimoto T, Nomoto T, Takei Y, Fueki N, Takise A, Saito R, Mori M. , Apr. 2000, Am J Clin Oncol.

肺性肥大性骨関節症を合併した肺癌の1例, 佐藤浩二, 岩崎靖樹, 小林剛, 砂長則明, 石原真一, 渡辺覚, 土屋智, 斎藤龍生, 森昌朋, Jan. 2000

Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer. , Sunaga N, Tsuchiya S, Minato K, Watanabe S, Fueki N, Hoshino H, Makimoto T, Ishihara S, Saito R, Mori M. , 1999, Oncology. , 57, 2, 143, 148

Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis, Hachisu Y, Koga Y, Kasama S, Kaira K, Uno S, Yatomi M, Aoki-Saito H, Tsurumaki H, Jingu A, Sunaga N, Maeno T, Hisada T., Jun. 2022, Medicina (Kaunas), 58, 6, 768, Scientific journal
DOI

Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report, Sunaga N, Miura Y, Sakurai R, Ohshima S, Uno S, Muto S, Sato M, Tsurumaki H, Yatomi M, Koga Y, Ohtaki Y, Nagashima T, Okano N, Kubo N, Maeno T, Hisada T, Apr. 2023, Anticancer Drugs, 34, 4, 605, 608, Scientific journal
DOI

A pregnant woman with severe dyspnoea, Kanbe M, Yatomi M, Wakamatsu I, Uno S, Hanazato C, Aoki-Saito H, Masuda T, Yamaguchi K, Kasahara N, Miura Y, Tsurumaki H, Hara K, Koga Y, Sunaga N, Higeta D, Kameda T, Hisada T, Maeno T, Jun. 2022, Breathe (Sheff), 18, 2, 220012, Scientific journal
DOI

Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease, Ito M, Koga Y, Hachisu Y, Murata K, Sunaga N, Maeno T, Hisada T, Sep. 2022, Respir Investig, 60, 5, 613, 624, Scientific journal
DOI

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation, Sato M, Yatomi M, Wakamatsu I, Uno S, Hanazato C, Masuda T, Yamaguchi K, Aoki-Saito H, Kasahara N, Miura Y, Tsurumaki H, Hara K, Koga Y, Sunaga N, Okada T, Ikota H, Hisada T, Maeno T, Feb. 2023, Respir Med Case Rep, 43, 101818, 101818, Scientific journal
DOI

Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine a trial, Fujita K, Arai R, Shoji S, Saito R, Nomura M, Hotta T, Asahina H, Kawakami M, Nakachi I, Hasegawa Y, Okafuji K, Suzuki A, Miyanaga A, Sunaga N, Nagashima H, Ikeda N, Watanabe S, Nagai Y, Furuta M, Kage H, Arai D, Fukuhara T, Nakayama M, Morita S, Kobayashi K, Hagiwara K, May 2023, Cancer Sci, Scientific journal
DOI

CXCL12 and its receptors CXCR4 and CXCR7 as potential molecular targets for lung cancer, Imai, Hisao;Sunaga, Noriaki;Shimizu, Yasuo;Yanagitani, Noriko;Kaira, Kyoichi;Tomizawa, Yoshio;Ishizuka, Tamotsu;Saito, Ryusei;Minna, John;Mori, Masatomo, 2009, CANCER RESEARCH, 69

CXCL12 and its receptors CXCR4 and CXCR7 as potential molecular targets for lung cancer, Imai, Hisao;Sunaga, Noriaki;Shimizu, Yasuo;Yanagitani, Noriko;Kaira, Kyoichi;Tomizawa, Yoshio;Ishizuka, Tamotsu;Saito, Ryusei;Minna, John;Mori, Masatomo, 2009, CANCER RESEARCH, 69

IL-8 overexpression induced by oncogenic KRAS mutation in non-small cell lung cancer, Sunaga, Noriaki;Shames, David;Imai, Hisao;Yanagitani, Noriko;Kaira, Kyoichi;Girard, Luc;Minna, John;Mori, Masatomo, 2009, CANCER RESEARCH, 69

IL-8 overexpression induced by oncogenic KRAS mutation in non-small cell lung cancer, Sunaga, Noriaki;Shames, David;Imai, Hisao;Yanagitani, Noriko;Kaira, Kyoichi;Girard, Luc;Minna, John;Mori, Masatomo, 2009, CANCER RESEARCH, 69

A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease, Shimizu, Yasuo;Dobashi, Kunio;Kobayashi, Setsuo;Ohki, Ichiro;Tokushima, Masahiko;Kusano, Motoyasu;Kawamura, Osamu;Shimoyama, Yasuyuki;Utsugi, Mitsuyoshi;Sunaga, Noriaki;Ishizuka, Tamotsu;Mori, Masatomo, 2006, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 209, 3, 181, 189

A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease, Shimizu, Yasuo;Dobashi, Kunio;Kobayashi, Setsuo;Ohki, Ichiro;Tokushima, Masahiko;Kusano, Motoyasu;Kawamura, Osamu;Shimoyama, Yasuyuki;Utsugi, Mitsuyoshi;Sunaga, Noriaki;Ishizuka, Tamotsu;Mori, Masatomo, 2006, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 209, 3, 181, 189

Spontaneous regression of hepatic inflammatory pseudotumor with primary biliary cirrhosis: Case report and literature review, Koide, Hiroshi;Sato, Ken;Fukusato, Toshio;Kashiwabara, Kenji;Sunaga, Noriaki;Tsuchiya, Takafumi;Morino, Saeko;Sohara, Naondo;Kakizaki, Satoru;Takagi, Hitoshi;Mori, Masatomo, 2006, WORLD JOURNAL OF GASTROENTEROLOGY, 12, 10, 1645, 1648

Spontaneous regression of hepatic inflammatory pseudotumor with primary biliary cirrhosis: Case report and literature review, Koide, Hiroshi;Sato, Ken;Fukusato, Toshio;Kashiwabara, Kenji;Sunaga, Noriaki;Tsuchiya, Takafumi;Morino, Saeko;Sohara, Naondo;Kakizaki, Satoru;Takagi, Hitoshi;Mori, Masatomo, 2006, WORLD JOURNAL OF GASTROENTEROLOGY, 12, 10, 1645, 1648

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis, Kaira, Kyoichi;Ishizuka, Tamotsu;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Mori, Masatomo, 2007, CLINICAL NUCLEAR MEDICINE, 32, 2, 114, 116

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis, Kaira, Kyoichi;Ishizuka, Tamotsu;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Mori, Masatomo, 2007, CLINICAL NUCLEAR MEDICINE, 32, 2, 114, 116

A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer, Kaira, Kyoichi;Tsuchiya, Satoshi;Sunaga, Noriaki;Watanabe, Satoru;Imai, Hisao;Hisada, Takeshi;Ishizuka, Tamotsu;Saito, Ryusei;Mori, Masatomo, 2007, AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 30, 1, 51, 56
DOI

A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer, Kaira, Kyoichi;Tsuchiya, Satoshi;Sunaga, Noriaki;Watanabe, Satoru;Imai, Hisao;Hisada, Takeshi;Ishizuka, Tamotsu;Saito, Ryusei;Mori, Masatomo, 2007, AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 30, 1, 51, 56
DOI

Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers, Suzuki, Makoto;Shigematsu, Hisayuki;Shames, David S.;Sunaga, Noriaki;Takahashi, Takao;Shivapurkar, Narayan;Iizasa, Toshihiko;Minna, John D.;Fujisawa, Takehiko;Gazdar, Adi F., 2007, ANNALS OF SURGICAL ONCOLOGY, 14, 4, 1397, 1404
DOI

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer, Kaira, Kyoichi;Sunaga, Noriaki;Yanagitani, Noriko;Imai, Hisao;Utsugi, Mitsuyoshi;Shimizu, Yasuo;Iijima, Hironobu;Tomizawa, Yoshio;Hisada, Takeshi;Ishizuka, Tamotsu;Saito, Ryusei;Mori, Masatomo, 2007, ANTI-CANCER DRUGS, 18, 4, 471, 476

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer, Kaira, Kyoichi;Sunaga, Noriaki;Yanagitani, Noriko;Imai, Hisao;Utsugi, Mitsuyoshi;Shimizu, Yasuo;Iijima, Hironobu;Tomizawa, Yoshio;Hisada, Takeshi;Ishizuka, Tamotsu;Saito, Ryusei;Mori, Masatomo, 2007, ANTI-CANCER DRUGS, 18, 4, 471, 476

Diagnostic usefulness of fluorine-18-α-methyltyrosine positron emission tomography in combination with ¹⁸F-fluorodeoxyglucose in sarcoidosis patients, Kaira, Kyoichi;Orinchi, Noboni;Otani, Yoshimi;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Endo, Keigo;Mori, Masatomo, 2007, CHEST, 131, 4, 1019, 1027
DOI

Diagnostic usefulness of fluorine-18-α-methyltyrosine positron emission tomography in combination with ¹⁸F-fluorodeoxyglucose in sarcoidosis patients, Kaira, Kyoichi;Orinchi, Noboni;Otani, Yoshimi;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Endo, Keigo;Mori, Masatomo, 2007, CHEST, 131, 4, 1019, 1027
DOI

Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells, Lea, Jayanthi S.;Sunaga, Noriaki;Sato, Mitsuo;Kalahasti, Geetha;Miller, David S.;Minna, John D.;Muller, Carolyn Y., 2007, REPRODUCTIVE SCIENCES, 14, 1, 20, 28
DOI

Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer?, Yanagitani, Noriko;Kaira, Kyoichi;Sunaga, Noriaki;Naito, Yoichi;Koike, Yoko;Ishihara, Shinichi;Ishizuka, Tamotsu;Saito, Ryusei;Mori, Masatomo, 2007, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 12, 3, 231, 233
DOI

Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer?, Yanagitani, Noriko;Kaira, Kyoichi;Sunaga, Noriaki;Naito, Yoichi;Koike, Yoko;Ishihara, Shinichi;Ishizuka, Tamotsu;Saito, Ryusei;Mori, Masatomo, 2007, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 12, 3, 231, 233
DOI

Lung cancer producing granulocyte colony-stimulating factor and rapid spreading to peritoneal cavity, Kaira, Kyoichi;Ishizuka, Takahiro;Tanaka, Hiroto;Tanaka, Yoshiki;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Mori, Masatomo, 2008, JOURNAL OF THORACIC ONCOLOGY, 3, 9, 1054, 1055

Lung cancer producing granulocyte colony-stimulating factor and rapid spreading to peritoneal cavity, Kaira, Kyoichi;Ishizuka, Takahiro;Tanaka, Hiroto;Tanaka, Yoshiki;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Mori, Masatomo, 2008, JOURNAL OF THORACIC ONCOLOGY, 3, 9, 1054, 1055

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Tanaka, Shigebumi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Mori, Masatomo, 2008, CANCER SCIENCE, 99, 12, 2380, 2386
DOI

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Tanaka, Shigebumi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Mori, Masatomo, 2008, CANCER SCIENCE, 99, 12, 2380, 2386
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Mori, Masatomo, 2009, CANCER SCIENCE, 100, 2, 249, 254
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Mori, Masatomo, 2009, CANCER SCIENCE, 100, 2, 249, 254
DOI

Forearm Muscle Metastasis as an Initial Clinical Manifestation of Lung Cancer, Kaira, Kyoichi;Ishizuka, Tamotsu;Yanagitani, Noriko;Sunaga, Noriaki;Tsuchiya, Takafumi;Hisada, Takeshi;Mori, Masatomo, 2009, SOUTHERN MEDICAL JOURNAL, 102, 1, 79, 81

Forearm Muscle Metastasis as an Initial Clinical Manifestation of Lung Cancer, Kaira, Kyoichi;Ishizuka, Tamotsu;Yanagitani, Noriko;Sunaga, Noriaki;Tsuchiya, Takafumi;Hisada, Takeshi;Mori, Masatomo, 2009, SOUTHERN MEDICAL JOURNAL, 102, 1, 79, 81

Clinicopathological Features of Patients with Bronchial-Associated Lymphoid Tissue Lymphoma, Imai, Hisao;Sunaga, Noriaki;Kaira, Kyoichi;Kawashima, Osamu;Yanagitani, Noriko;Sato, Koji;Tomizawa, Yoshio;Hisada, Takeshi;Ishizuka, Tamotsu;Hirato, Junko;Saito, Ryusei;Nakajima, Takashi;Mori, Masatomo, 2009, INTERNAL MEDICINE, 48, 5, 301, 306
DOI

Clinicopathological Features of Patients with Bronchial-Associated Lymphoid Tissue Lymphoma, Imai, Hisao;Sunaga, Noriaki;Kaira, Kyoichi;Kawashima, Osamu;Yanagitani, Noriko;Sato, Koji;Tomizawa, Yoshio;Hisada, Takeshi;Ishizuka, Tamotsu;Hirato, Junko;Saito, Ryusei;Nakajima, Takashi;Mori, Masatomo, 2009, INTERNAL MEDICINE, 48, 5, 301, 306
DOI

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study, Shimizu, Yasuo;Sunaga, Noriaki;Dobashi, Kunio;Fueki, Makoto;Fueki, Naoto;Makino, Sohei;Mori, Masatomo, 2009, BMC INFECTIOUS DISEASES, 9
DOI

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study, Shimizu, Yasuo;Sunaga, Noriaki;Dobashi, Kunio;Fueki, Makoto;Fueki, Naoto;Makino, Sohei;Mori, Masatomo, 2009, BMC INFECTIOUS DISEASES, 9
DOI

L-Type Amino Acid Transporter 1 (LAT1) Is Frequently Expressed in Thymic Carcinomas but Is Absent in Thymomas, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Mori, Masatomo, 2009, JOURNAL OF SURGICAL ONCOLOGY, 99, 7, 433, 438
DOI

L-Type Amino Acid Transporter 1 (LAT1) Is Frequently Expressed in Thymic Carcinomas but Is Absent in Thymomas, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Endou, Hitoshi;Nakajima, Takashi;Mori, Masatomo, 2009, JOURNAL OF SURGICAL ONCOLOGY, 99, 7, 433, 438
DOI

¹⁸F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non-Small Cell Lung Cancer, Kaira, Kyoichi;Oriuchi, Noboru;Shimizu, Kimihiro;Tominaga, Hideyuki;Yanagitani, Noriko;Sunaga, Noriaki;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Mori, Masatomo;Endo, Keigo, 2009, JOURNAL OF NUCLEAR MEDICINE, 50, 11, 1770, 1776
DOI

¹⁸F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non-Small Cell Lung Cancer, Kaira, Kyoichi;Oriuchi, Noboru;Shimizu, Kimihiro;Tominaga, Hideyuki;Yanagitani, Noriko;Sunaga, Noriaki;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Mori, Masatomo;Endo, Keigo, 2009, JOURNAL OF NUCLEAR MEDICINE, 50, 11, 1770, 1776
DOI

Comparison of L-type amino acid transporter 1 expression and L-[3-¹⁸F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer, Kaira, Kyoichi;Oriuchi, Noboru;Shimizu, Kimihiro;Imai, Hisao;Tominaga, Hideyuki;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Oyama, Tetsunari;Mori, Masatomo;Endo, Keigo, 2010, NUCLEAR MEDICINE AND BIOLOGY, 37, 8, 911, 916
DOI

Comparison of L-type amino acid transporter 1 expression and L-[3-¹⁸F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer, Kaira, Kyoichi;Oriuchi, Noboru;Shimizu, Kimihiro;Imai, Hisao;Tominaga, Hideyuki;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Oyama, Tetsunari;Mori, Masatomo;Endo, Keigo, 2010, NUCLEAR MEDICINE AND BIOLOGY, 37, 8, 911, 916
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Kawashima, Osamu;Kamide, Yosuke;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Nakajima, Takashi;Mori, Masatomo, 2010, EXPERIMENTAL AND THERAPEUTIC MEDICINE, 1, 5, 799, 808
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer, Kaira, Kyoichi;Oriuchi, Noboru;Imai, Hisao;Shimizu, Kimihiro;Yanagitani, Noriko;Sunaga, Noriaki;Hisada, Takeshi;Kawashima, Osamu;Kamide, Yosuke;Ishizuka, Tamotsu;Kanai, Yoshikatsu;Nakajima, Takashi;Mori, Masatomo, 2010, EXPERIMENTAL AND THERAPEUTIC MEDICINE, 1, 5, 799, 808
DOI

Inhibition of L-type Amino Acid Transporter 1 Has Antitumor Activity in Non-small Cell Lung Cancer, Imai, Hisao;Kaira, Kyoichi;Oriuchi, Noboru;Shimizu, Kimihiro;Tominaga, Hideyuki;Yanagitani, Noriko;Sunaga, Noriaki;Ishizuka, Tamotsu;Nagamori, Shushi;Promchan, Kanyarat;Nakajima, Takashi;Yamamoto, Nobuyuki;Mori, Masatomo;Kanai, Yoshikatsu, 2010, ANTICANCER RESEARCH, 30, 12, 4819, 4828

Inhibition of L-type Amino Acid Transporter 1 Has Antitumor Activity in Non-small Cell Lung Cancer, Imai, Hisao;Kaira, Kyoichi;Oriuchi, Noboru;Shimizu, Kimihiro;Tominaga, Hideyuki;Yanagitani, Noriko;Sunaga, Noriaki;Ishizuka, Tamotsu;Nagamori, Shushi;Promchan, Kanyarat;Nakajima, Takashi;Yamamoto, Nobuyuki;Mori, Masatomo;Kanai, Yoshikatsu, 2010, ANTICANCER RESEARCH, 30, 12, 4819, 4828

THE EFFECT OF 17(R)-RESOLVIN D1 ON BLEOMYCIN-INDUCED LUNG FIBROSIS IN MICE, Yatomi, Masakiyo;Hisada, Takeshi;Nishioka, Masaki;Kamide, Yosuke;Tsurumaki, Hiroaki;Aoki, Haruka;Seki, Kaori;Kaira, Kyoichi;Ono, Akihiro;Koga, Yasuhiko;Sunaga, Noriaki;Dobashi, Kunio;Ishizuka, Tamotsu;Mori, Masatomo;Okajima, Fumikazu;Yamada, Masanobu, 2013, RESPIROLOGY, 18, 73, 73

THE EFFECT OF 17(R)-RESOLVIN D1 ON BLEOMYCIN-INDUCED LUNG FIBROSIS IN MICE, Yatomi, Masakiyo;Hisada, Takeshi;Nishioka, Masaki;Kamide, Yosuke;Tsurumaki, Hiroaki;Aoki, Haruka;Seki, Kaori;Kaira, Kyoichi;Ono, Akihiro;Koga, Yasuhiko;Sunaga, Noriaki;Dobashi, Kunio;Ishizuka, Tamotsu;Mori, Masatomo;Okajima, Fumikazu;Yamada, Masanobu, 2013, RESPIROLOGY, 18, 73, 73

Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer, Kaira, Kyoichi;Naruse, Ichiro;Imai, Hisao;Sunaga, Noriaki;Hisada, Takeshi;Motegi, Masahiko;Asao, Takayuki;Yamada, Masanobu, 2014, CHEMOTHERAPY, 60, 5-6, 356, 359
DOI

Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer, Kaira, Kyoichi;Naruse, Ichiro;Imai, Hisao;Sunaga, Noriaki;Hisada, Takeshi;Motegi, Masahiko;Asao, Takayuki;Yamada, Masanobu, 2014, CHEMOTHERAPY, 60, 5-6, 356, 359
DOI

Clinical outcomes of 1st-line gefitinib for patients with advanced NSCLC harboring EGFR mutations and poor PS, Miura, Yosuke;Minato, Koichi;Fujimoto, Sakae;Sunaga, Noriaki;Yamada, Masanobu, 2015, ANNALS OF ONCOLOGY, 26, 136, 136

Clinical outcomes of 1st-line gefitinib for patients with advanced NSCLC harboring EGFR mutations and poor PS, Miura, Yosuke;Minato, Koichi;Fujimoto, Sakae;Sunaga, Noriaki;Yamada, Masanobu, 2015, ANNALS OF ONCOLOGY, 26, 136, 136

Clinical Impact of Post-Progression Survival for Overall Survival in Patients with Sensitive Relapse of Small Cell Lung Cancer, Miura, Yosuke;Imai, Hisao;Yoshino, Reiko;Fujimoto, Sakae;Kaira, Kyoichi;Sunaga, Noriaki;Tomizawa, Yoshio;Minato, Koichi;Hisada, Takeshi;Saito, Ryusei;Yamada, Masanobu, 2015, JOURNAL OF THORACIC ONCOLOGY, 10, 9, S741, S742

Clinical Impact of Post-Progression Survival for Overall Survival in Patients with Sensitive Relapse of Small Cell Lung Cancer, Miura, Yosuke;Imai, Hisao;Yoshino, Reiko;Fujimoto, Sakae;Kaira, Kyoichi;Sunaga, Noriaki;Tomizawa, Yoshio;Minato, Koichi;Hisada, Takeshi;Saito, Ryusei;Yamada, Masanobu, 2015, JOURNAL OF THORACIC ONCOLOGY, 10, 9, S741, S742

The polymorphisms of XRCC1 Arg194Trp and the XRCC1Arg399Gln affect the clinical features and the prognosis of MDS, Norjmaa, Batchimeg;Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Minato, Yusuke;Sunaga, Noriaki;Murakami, Hirokazu, 2015, CANCER RESEARCH, 75
DOI

Prognostic significance of GRP78/BiP expression in advanced thymic cancer, Miura, Yosuke;Kaira, Kyoichi;Sakurai, Reiko;Imai, Hisao;Minato, Koichi;Tomizawa, Yoshio;Sunaga, Noriaki;Maeno, Toshitaka;Hisada, Takeshi;Yamada, Masanobu, 2016, ANNALS OF ONCOLOGY, 27

Prognostic significance of GRP78/BiP expression in advanced thymic cancer, Miura, Yosuke;Kaira, Kyoichi;Sakurai, Reiko;Imai, Hisao;Minato, Koichi;Tomizawa, Yoshio;Sunaga, Noriaki;Maeno, Toshitaka;Hisada, Takeshi;Yamada, Masanobu, 2016, ANNALS OF ONCOLOGY, 27

Metabolic activity by F-18-FDG-PET/CT to predict for early response after nivolumab in previously treated NSCLC, Kaira, Kyoichi;Naruse, Ichiro;Higuchi, Tetsuya;Alltan, Bolag;Mogi, Akira;Shimizu, Kimihiro;Sunaga, Noriaki;Hisada, Takeshi;Asao, Takayuki, 2017, JOURNAL OF CLINICAL ONCOLOGY, 35
DOI

17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA, Yatomi, Masakiyo;Hisada, Takeshi;Koga, Yasuhiko;Ono, Akihiro;Kamide, Yosuke;Aoki, Haruka;Hiroaki, Tsurumaki;Seki, Kaori;Sunaga, Noriaki;Kaira, Kyoichi;Ishizuka, Tamotsu;Dobashi, Kunio;Yamada, Masanobu;Okajima, Fumikazu, 2015, EUROPEAN RESPIRATORY JOURNAL, 46
DOI

17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA, Yatomi, Masakiyo;Hisada, Takeshi;Koga, Yasuhiko;Ono, Akihiro;Kamide, Yosuke;Aoki, Haruka;Hiroaki, Tsurumaki;Seki, Kaori;Sunaga, Noriaki;Kaira, Kyoichi;Ishizuka, Tamotsu;Dobashi, Kunio;Yamada, Masanobu;Okajima, Fumikazu, 2015, EUROPEAN RESPIRATORY JOURNAL, 46
DOI

LGR6 overexpression induced by constitutive activation of the Wnt signaling pathway in NSCLC cells, Sunaga, Noriaki;Miura, Yosuke;Kaira, Kyoichi;Tsukagoshi, Yusuke;Sakurai, Reiko;Hisada, Takeshi, 2018, CANCER SCIENCE, 109, 895, 895

LGR6 overexpression induced by constitutive activation of the Wnt signaling pathway in NSCLC cells, Sunaga, Noriaki;Miura, Yosuke;Kaira, Kyoichi;Tsukagoshi, Yusuke;Sakurai, Reiko;Hisada, Takeshi, 2018, CANCER SCIENCE, 109, 895, 895

17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice., Yatomi, Masakiyo;Hisada, Takeshi;Hachisu, Yoshimasa;Tsukagoshi, Yusuke;Kasahara, Norimitsu;Sato, Makiko;Tsurumaki, Hiroaki;Saito, Haruka;Hara, Kenichiro;Koga, Yasuhiko;Sunaga, Noriaki;Maeno, Toshitaka;Dobashi, Kunio, 2018, EUROPEAN RESPIRATORY JOURNAL, 52
DOI

17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice., Yatomi, Masakiyo;Hisada, Takeshi;Hachisu, Yoshimasa;Tsukagoshi, Yusuke;Kasahara, Norimitsu;Sato, Makiko;Tsurumaki, Hiroaki;Saito, Haruka;Hara, Kenichiro;Koga, Yasuhiko;Sunaga, Noriaki;Maeno, Toshitaka;Dobashi, Kunio, 2018, EUROPEAN RESPIRATORY JOURNAL, 52
DOI

CLINICAL FEATURES IN RECURRENCE OF ANTI-MDA5 AUTOANTIBODIES POSITIVE DERMATOMYOSITIS, Yamaguchi, Koichi;Yamaguchi, Aya;Kashiwagi, Chiharu;Masubuchi, Hiroaki;Hara, Kenichiro;Koga, Yasuhiko;Sunaga, Noriaki;Maeno, Toshiaki, 2019, RESPIROLOGY, 24, 81, 82

CLINICAL FEATURES IN RECURRENCE OF ANTI-MDA5 AUTOANTIBODIES POSITIVE DERMATOMYOSITIS, Yamaguchi, Koichi;Yamaguchi, Aya;Kashiwagi, Chiharu;Masubuchi, Hiroaki;Hara, Kenichiro;Koga, Yasuhiko;Sunaga, Noriaki;Maeno, Toshiaki, 2019, RESPIROLOGY, 24, 81, 82

Resolvin E1 and E3 dampens asthmatic inflammation in a murine model, Sato, Makiko;Aoki-Saito, Haruka;Yatomi, Masakiyo;Tsurumaki, Hiroaki;Koga, Yasuhiko;Sunaga, Noriaki;Maeno, Toshitaka;Dobashi, Kunio;Shuto, Satoshi;Yamada, Masataka;Hisada, Takeshi, 2020, EUROPEAN RESPIRATORY JOURNAL, 56
DOI

Resolvin E1 and E3 dampens asthmatic inflammation in a murine model, Sato, Makiko;Aoki-Saito, Haruka;Yatomi, Masakiyo;Tsurumaki, Hiroaki;Koga, Yasuhiko;Sunaga, Noriaki;Maeno, Toshitaka;Dobashi, Kunio;Shuto, Satoshi;Yamada, Masataka;Hisada, Takeshi, 2020, EUROPEAN RESPIRATORY JOURNAL, 56
DOI

Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies, Yamaguchi, Koichi;Fukushima, Yasuhiro;Yamaguchi, Aya;Itai, Miki;Shin, Yuki;Uno, Shogo;Muto, Sohei;Kouno, Shunichi;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Aoki-Saito, Haruka;Hara, Kenichiro;Koga, Yasuhiko;Sunaga, Noriaki;Endo, Yukie;Motegi, Sei-ichiro;Nakasatomi, Masao;Sakairi, Toru;Ikeuchi, Hidekazu;Hiromura, Keiju;Hisada, Takeshi;Tsushima, Yoshito;Kuwana, Masataka;Maeno, Toshitaka, 2022, RESPIRATORY MEDICINE, 193
DOI

Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis, Sunaga, Noriaki;Koga, Yasuhiko;Hachisu, Yoshimasa;Yamaguchi, Koichi;Aikawa, Masaki;Kasahara, Norimitsu;Miura, Yosuke;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Sakurai, Reiko;Maeno, Toshitaka;Hisada, Takeshi, 2022, CANADIAN RESPIRATORY JOURNAL, 2022
DOI

Pulmonary Hypertrophic Osteoarthropathy Associated with Primary Lung Cancer, SATO Koji;IWASAKI Yasuki;KOBAYASHI Go;SUNAGA Noriaki;ISHIHARA Shinichi;WATANABE Satoru;TSUCHIYA Satoshi;SAITO Ryusei;MORI Masatomo, Jan. 2000, 38, 1, 73, 77

A Proton Pump Inhibitor, Lansoprazole, Ameliorates Asthma Symptoms in Asthmatic Patients with Gastroesophageal Reflux Disease, SHIMIZU YASUO;DOBASHI KUNIO;KOBAYASHI SETSUO;OHKI ICHIRO;TOKUSHIMA MASAHIKO;KUSANO MOTOYASU;KAWAMURA OSAMU;SHIMOYAMA YASUYUKI;UTSUGI MITSUYOSHI;SUNAGA NORIAKI;ISHIZUKA TAMOTSU;MORI MASATOMO, Jul. 2006, Tohoku J Exp Med., 209, 3, 181, 189

A case of large cell neuroendocrine carcinoma in a patient with sarcoidosis, YANAGITANI Noriko;KAIRA Kyoichi;ISHIZUKA Tamotsu;AOKI Haruka;KAWATA Tadayoshi;UTSUGI Mitsuyoshi;SHIMIZU Yasuo;SUNAGA Noriaki;HISADA Takeshi;MORI Masatomo, Jul. 2008, 46, 7, 574, 577

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung, KAIRA Kyoichi;ORIUCHI Noboru;IMAI Hisao;SHIMIZU Kimihiro;YANAGITANI Noriko;SUNAGA Noriaki;HISADA Takeshi;ISHIZUKA Tamotsu;KANAI Yoshikatsu;ENDOU Hitoshi;NAKAJIMA Takashi;MORI Masatomo, Feb. 2009, 100, 2, 249, 254

A case of cryptogenic organizing pneumonia with eosinophilic infiltration which was difficult to distinguish from nonspecific interstitial pneumonia, YANAGITANI Noriko;ISHIZUKA Tamotsu;HIRONAKA Mitsugu;KAIRA Kyoichi;IMAI Hisao;KAWATA Tadayoshi;UTSUGI Mitsuyoshi;SHIMIZU Yasuo;SUNAGA Noriaki;HISADA Takeshi;MORI Masatomo, Apr. 2009, 47, 4, 286, 290

A case of neurosarcoidosis discovered in a patient complaining of chest pain, YANAGITANI Noriko;KOTAKE Mie;ISHIZUKA Tamotsu;IWASAKI Yasuki;SUNAGA Noriaki;MORI Masatomo, Dec. 2009, 47, 12, 1087, 1092

Pneumothorax in lung adenocarcinoma on chemotherapy with bevaciuzumab, YOSHINO Reiko;SUNAGA Noriaki;IWASAKI Yasuki;HISADA Takeshi;ISHIZUKA Tamotsu;MORI Masatomo, Feb. 2012, 1, 2, 141, 145

Three Cases of Primary Non-Small Cell Lung Carcinoma with Mutation of the Epidermal Growth Factor Receptor Gene that Responded to Gefitinib, Tomizawa Yoshio;Iijima Hironobu;Tanaka Shigefumi;Suga Tatsuo;Ito Tomokazu;Nakagawa Jun-ichi;Sunaga Noriaki;Sato Koji;Hisada Takeshi;Ishizuka Tamotsu;Dobashi Kunio;Kuwano Hiroyuki;Kurabayashi Masahiko;Nakajima Takashi;Mori Masatomo, 2005, The Kitakanto Medical Journal, 55, 2, 169, 176
DOI

P-287 肺腺がんの発がん感受性に関与するNQO1とGSTT1の遺伝子多型, ;;;;;;;;;, Sep. 2001, Japanese Journal of Lung Cancer, 41, 5

P-292 第12染色体短腕D12S1034座近傍に存在するPAS1座の遺伝子多型はヒト肺腺がんの発がん感受性に関与する, ;;;;;;;, Sep. 2001, Japanese Journal of Lung Cancer, 41, 5

E-56 肺癌の放射線単独あるいは放射線・化学療法併用療法に合併した重症肺臓炎の検討, ;;;;;;;;;;;, Oct. 1997, Japanese Journal of Lung Cancer, 37, 5

呼吸困難を有する肺癌患者におけるモルヒネの至適用量の検討 : ワークショップ8 : 進行肺癌患者のQOL向上のためのStrategy, ;;;;;;;;;;;;;;;, Sep. 1998, Japanese Journal of Lung Cancer, 38, 5

肺未分化癌と診断された症例の臨床像についての検討, ;;;;;;;;;;;;;;, Sep. 1998, Japanese Journal of Lung Cancer, 38, 5

声門下腫瘍による喘鳴で再発した肺小細胞癌の1例(31 症例・肉腫・小細胞癌, 第46回日本肺癌学会総会), ;;;;;;, Nov. 2005, Japanese Journal of Lung Cancer, 45, 5

後縦隔原発滑膜肉腫の2例, ;;;;;;;, 2006, Japanese Journal of Lung Cancer, 46, 606

P-646 若年者肺癌に合併しゲフィチニブが有効であった肺性肥大性骨関節症の一例(症例8, 第47回日本肺癌学会総会), ;;;;;;;;;;;, Nov. 2006, Japanese Journal of Lung Cancer, 46, 5

278 気管支喘息,COPDにおける胃食道逆流(GERD)の合併について(気管支喘息-病態生理6,一般演題(デジタルポスター),第57回日本アレルギー学会秋季学術大会), ;;;;;;;;;;;;;, 2007, Japanese Journal of Allergology, 56, 8
DOI

C-2 当院における切除不能肺癌の臨床試験非登録例の検討(非小細胞癌の治療1,第40回日本肺癌学会総会号), ;;;;;;;;;;;;;;;, Sep. 1999, Japanese Journal of Lung Cancer, 39, 5

C-7 進行非小細胞肺癌に対するCisplatin(CDDP)+weekly Docetaxel(TXT)併用第1相試験(非小細胞肺癌の治療2,第40回日本肺癌学会総会号), ;;;;;;;;;;;;;;, Sep. 1999, Japanese Journal of Lung Cancer, 39, 5

P45 チオトロピウムが有効であった重症気管支喘息の一例(気管支喘息治療1,第20回日本アレルギー学会春季臨床大会), ;;;;;;;;, 2008, Japanese Journal of Allergology, 57, 3
DOI

WS4-2 EGFR遺伝子変異を有する進行非小細胞肺癌患者を対象としたgefitinib治療prospective試験統合解析(分子標的治療2(臨床),第49回日本肺癌学会総会号), ;;;;;;;;;;;;;;;;, Oct. 2008, Japanese Journal of Lung Cancer, 48, 5

MS14-5 LPA受容体を介したヒト気道上皮細胞におけるRANTES産生抑制機序(基礎:気道上皮細胞/線維芽細胞/血管内皮細胞,第58回日本アレルギー学会秋季学術大会), ;;;;;;;;, 2008, Japanese Journal of Allergology, 57, 9
DOI

135 成人喘息患者のQOLにおける吸入ステロイド薬シクレソニドの有用性(気管支喘息-治療6,第58回日本アレルギー学会秋季学術大会), ;;;;;;;;;;;;;;, 2008, Japanese Journal of Allergology, 57, 9
DOI

340 2つのアゾール系抗真菌剤による薬剤性肺障害の1例(薬物アレルギー,不耐症1,第58回日本アレルギー学会秋季学術大会), ;;;;;;;;;, 2008, Japanese Journal of Allergology, 57, 9
DOI

MS13-#4 難治性喘息に対する高用量白血球除去療法による治療の試み(気管支喘息-治療2,第59回日本アレルギー学会秋季学術大会), ;;;;;;;;;, 2009, Japanese Journal of Allergology, 58, 8
DOI

P16-5 放射線治療が奏功し呼吸困難の改善を認めた,食道癌術後縦隔リンパ節再発の一例(胸膜/胸壁/縦隔,ポスター16,第34回日本呼吸器内視鏡学会学術集会), ;;;;;;;, 2011, The Journal of the Japan Society for Respiratory Endoscopy, 33, Special, S262
DOI

P25-6 悪性腫瘍が疑われ,気管支鏡検査を施行したところ,植物性気管支異物であった一例(異物,ポスター25,第34回日本呼吸器内視鏡学会学術集会), ;;;;;;;;;, 2011, The Journal of the Japan Society for Respiratory Endoscopy, 33, Special, S282
DOI

P34-4 気管支肺胞洗浄液にて診断,救命し得たARDS合併新型swine-origin influenza A (H1N1)重症肺炎の1例(膿胸/感染症,ポスター34,第34回日本呼吸器内視鏡学会学術集会), ;;;;;;;;;, 2011, The Journal of the Japan Society for Respiratory Endoscopy, 33, Special, S301
DOI

O76-2 剖検にて著明なリモデリングを認めたステロイド抵抗性重症気管支喘息の一例(アレルギー疾患症例2,口演,第62回日本アレルギー学会秋季学術大会), ;;;;;;;;;;;, 2012, Japanese Journal of Allergology, 61, 9-10, 1568
DOI

O78-2 喘息患者における胃食道逆流症状,鼻副鼻腔炎症状,喘息症状の相互関係(鼻炎合併喘息2,口演,第62回日本アレルギー学会秋季学術大会), ;;;;;;;;;;, 2012, Japanese Journal of Allergology, 61, 9-10, 1571
DOI

O11-6 当科における好酸球性肉芽腫性多発血管炎(Churg-Strauss症候群)の臨床的検討(O11 リウマチ・膠原病,口演,第63回日本アレルギー学会秋季学術大会), ;;;;;;;;;;;;;;;;;, 2013, Japanese Journal of Allergology, 62, 9-10, 1330
DOI

O52-4 p116Rip proteinの培養細胞でのgene silencingの影響について(O52 気道上皮細胞,口演,第63回日本アレルギー学会秋季学術大会), ;;;;;;;;;;;;;;, 2013, Japanese Journal of Allergology, 62, 9-10, 1393
DOI

P2-2-5 EBUS-TBNA後に発症した医原性縦隔炎の一例(合併症,一般演題(ポスター),第37回日本呼吸器内視鏡学会学術集会), ;;;;;;, 2014, The Journal of the Japan Society for Respiratory Endoscopy, 36, Special, S268
DOI

P-124 p116Rip proteinの気道培養細胞での炎症性サイトカイン分泌に及ぼす影響について(気道上皮細胞・樹状細胞,口演18,第26回日本アレルギー学会春季臨床大会), ;;;;;;;;;;;;, 2014, Japanese Journal of Allergology, 63, 3-4, 573
DOI

Clinicopathological Features of Patients with Bronchial-Associated Lymphoid Tissue Lymphoma, Imai Hisao;Hirato Junko;Saito Ryusei;Nakajima Takashi;Mori Masatomo;Sunaga Noriaki;Kaira Kyoichi;Kawashima Osamu;Yanagitani Noriko;Sato Koji;Tomizawa Yoshio;Hisada Takeshi;Ishizuka Tamotsu, 2009, Internal Medicine, 48, 5, 301, 306
DOI

Role of epiregulin in lung tumorigenesis and therapeutic resistance, Sunaga N, Miura Y, Masuda T, Sakurai R., 07 Feb. 2024, Cancers, 16, 4, 710, Scientific journal
DOI

A Case of Paragonimiasis Miyazakii with Various Chest Shadows on CT, Imai Hisao;Horiguchi Norio;Iwasaki Yasuki;Nagashima Tamon;Tsurumaki Hiroaki;Yanagisawa Kunio;Ohi Shinsuke;Kaira Kyoichi;Ono Akihiro;Koga Yasuhiko;Sunaga Noriaki;Hisaeda Hajime;Hisada Takeshi;Sato Tetsuro;Ishizuka Tamotsu;Dobashi Kunio;Mori Masatomo, 2011, The Kitakanto Medical Journal, 61, 2, 179, 185
DOI

A Proton Pump Inhibitor, Lansoprazole, Ameliorates Asthma Symptoms in Asthmatic Patients with Gastroesophageal Reflux Disease, Shimizu Yasuo;Sunaga Noriaki;Ishizuka Tamotsu;Mori Masatomo;Dobashi Kunio;Kobayashi Setsuo;Ohki Ichiro;Tokushima Masahiko;Kusano Motoyasu;Kawamura Osamu;Shimoyama Yasuyuki;Utsugi Mitsuyoshi, 2006, The Tohoku Journal of Experimental Medicine, 209, 3, 181, 189
DOI

Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma, Kamide Yosuke;Kaira Kyoichi;Watanabe Takuya;Kuribayashi Shiko;Ozawa Atsushi;Koga Yasuhiko;Ono Akihiro;Sunaga Noriaki;Hisada Takeshi;Oyama Tetsunari;Yamada Masanobu, 2015, Internal Medicine, 54, 22, 2905, 2909
DOI

Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case, Imai Hisao;Matsumura Nozomi;Yamazaki Yuichi;Kanayama Yuki;Masuda Tomomi;Kuwako Tomohito;Kamide Yosuke;Tomizawa Taku;Matsumoto Shunichi;Mitsui Takeki;Kaira Kyoichi;Ono Akihiro;Koga Yasuhiko;Shibusawa Nobuyuki;Sunaga Noriaki;Hisada Takeshi;Yokoo Hideaki;Yamada Masanobu, 2015, Internal Medicine, 54, 24, 3171, 3176
DOI

The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome, Hachisu Yoshimasa;Koga Yasuhiko;Sunaga Noriaki;Kashiwagi Chiharu;Sawada Yuri;Saito Yasuyuki;Tsukagoshi Yusuke;Kasahara Norimitsu;Sakurai Reiko;Tsurumaki Hiroaki;Yatomi Masakiyo;Kaira Kyoichi;Ono Akihiro;Maeno Toshitaka;Hisada Takeshi, 2018, Internal Medicine, 57, 2, 247, 251
DOI

Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature, Saito Yasuyuki;Sawada Yuri;Koga Yasuhiko;Sunaga Noriaki;Tsukagoshi Yusuke;Hachisu Yoshimasa;Osaki Takashi;Sakurai Reiko;Kaira Kyoichi;Ono Akihiro;Sato Ken;Koiso Hiromi;Oyama Tetsunari;Hisada Takeshi;Yamada Masanobu, 2017, Internal Medicine, 56, 20, 2753, 2757
DOI

Small Cell Lung Cancer with Sarcoidosis in Spontaneous Remission: A Case Report, Sasaki Yumeka;Koga Yasuhiko;Kasahara Norimitsu;Hachisu Yoshimasa;Murata Keisuke;Tsurumaki Hiroaki;Yatomi Masakiyo;Tsukagoshi Yusuke;Sawada Yuri;Sakurai Reiko;Ono Akihiro;Sunaga Noriaki;Kaira Kyoichi;Hirato Junko;Maeno Toshitaka;Dobashi Kunio;Hisada Takeshi, Oct. 2018, Journal of Nippon Medical School, 85, 5, 291, 296
DOI

A Case of Tracheobronchial Amyloidosis Complicated with Fibromyalgia, Systemic Scleroderma, and Sjögren Syndrome, Tsukagoshi Yusuke;Sawada Yuri;Hachisu Yoshimasa;Kasahara Norimitsu;Tsurumaki Hiroaki;Yatomi Masakiyo;Sakurai Reiko;Sunaga Noriaki;Maeno Toshitaka;Hisada Takeshi, Mar. 2019, The Journal of the Japan Society for Respiratory Endoscopy, 41, 2, 160, 163
DOI

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers., Iijima Hironobu;Tomizawa Yoshio;Iwasaki Yasuki;Sato Koji;Sunaga Noriaki;Dobashi Kunio;Saito Ryusei;Nakajima Takashi;Minna John D;Mori Masatomo, International journal of cancer, 118, 4
DOI

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer., Tomizawa Yoshio;Iijima Hironobu;Sunaga Noriaki;Sato Koji;Takise Atsushi;Otani Yoshimi;Tanaka Shigefumi;Suga Tatsuo;Saito Ryusei;Ishizuka Tamotsu;Dobashi Kunio;Minna John D;Nakajima Takashi;Mori Masatomo, Clinical cancer research : an official journal of the American Association for Cancer Research, 11, 19 Pt 1
DOI

Spontaneous regression of hepatic inflammatory pseudotumor with primary biliary cirrhosis: case report and literature review., Koide Hiroshi;Sato Ken;Fukusato Toshio;Kashiwabara Kenji;Sunaga Noriaki;Tsuchiya Takafumi;Morino Saeko;Sohara Naondo;Kakizaki Satoru;Takagi Hitoshi;Mori Masatomo, World journal of gastroenterology, 12, 10
DOI

A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease., Shimizu Yasuo;Dobashi Kunio;Kobayashi Setsuo;Ohki Ichiro;Tokushima Masahiko;Kusano Motoyasu;Kawamura Osamu;Shimoyama Yasuyuki;Utsugi Mitsuyoshi;Sunaga Noriaki;Ishizuka Tamotsu;Mori Masatomo, The Tohoku journal of experimental medicine, 209, 3
DOI

Small cell carcinoma of the larynx in a long-term survivor of small-cell lung cancer., Kaira Kyoichi;Ishizuka Tamotsu;Sohara Naondo;Yanagitani Noriko;Sunaga Noriaki;Tsuchiya Takafumi;Mori Masatomo, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24, 18
DOI

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis., Kaira Kyoichi;Ishizuka Tamotsu;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Mori Masatomo, Clinical nuclear medicine, 32, 2
DOI

A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer., Kaira Kyoichi;Tsuchiya Satoshi;Sunaga Noriaki;Yanagitani Noriko;Watanabe Satoru;Imai Hisao;Hisada Takeshi;Ishizuka Tamotsu;Saito Ryusei;Mori Masatomo, American journal of clinical oncology, 30, 1
DOI

[A case of multidrug-resistant non-small cell lung cancer responding to TS-1]., Imai Hisao;Sunaga Noriaki;Kaira Kyoichi;Ishihara Shinichi;Aoki Haruka;Iijima Hironobu;Yanagitani Noriko;Iwasaki Yasuki;Tomizawa Yoshio;Saito Ryusei;Mori Masatomo, Gan to kagaku ryoho. Cancer & chemotherapy, 34, 2

Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient., Kaira Kyoichi;Ishizuka Tamotsu;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Mori Masatomo, Gan to kagaku ryoho. Cancer & chemotherapy, 34, 2

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer., Kaira Kyoichi;Sunaga Noriaki;Yanagitani Noriko;Imai Hisao;Utsugi Mitsuyoshi;Shimizu Yasuo;Iijima Hironobu;Tomizawa Yoshio;Hisada Takeshi;Ishizuka Tamotsu;Saito Ryusei;Mori Masatomo, Anti-cancer drugs, 18, 4
DOI

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy., Sunaga Noriaki;Tomizawa Yoshio;Yanagitani Noriko;Iijima Hironobu;Kaira Kyoichi;Shimizu Kimihiro;Tanaka Shigebumi;Suga Tatsuo;Hisada Takeshi;Ishizuka Tamotsu;Saito Ryusei;Dobashi Kunio;Mori Masatomo, Mar. 2007, Lung cancer (Amsterdam, Netherlands), 56, 3
DOI

Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients., Kaira Kyoichi;Oriuchi Noboru;Otani Yoshimi;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Endo Keigo;Mori Masatomo, Chest, 131, 4
DOI

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers., Kaira Kyoichi;Sunaga Noriaki;Tomizawa Yoshio;Yanagitani Noriko;Ishizuka Tamotsu;Saito Ryusei;Nakajima Takashi;Mori Masatomo, International journal of oncology, 31, 1

Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer?, Yanagitani Noriko;Kaira Kyoichi;Sunaga Noriaki;Naito Yoichi;Koike Yoko;Ishihara Shinichi;Ishizuka Tamotsu;Saito Ryusei;Mori Masatomo, Jun. 2007, International journal of clinical oncology, 12, 3
DOI

Coinfection of invasive pulmonary aspergillosis and pneumocystis jiroveci pneumonia in a non-HIV patient., Kaira Kyoichi;Shinomiya Yasuyuki;Takahashi Yuga;Iida Tomohiro;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Mori Masatomo, Acta medica Okayama, 61, 4
DOI

Rapid growth of malignant pleural mesothelioma., Kaira Kyoichi;Dobashi Kunio;Yanagitani Noriko;Sunaga Noriaki;Shimizu Yasuo;Hisada Takeshi;Ishizuka Tamotsu;Nakajima Takashi;Mori Masatomo, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2, 10
DOI

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer., Sunaga Noriaki;Oriuchi Noboru;Kaira Kyoichi;Yanagitani Noriko;Tomizawa Yoshio;Hisada Takeshi;Ishizuka Tamotsu;Endo Keigo;Mori Masatomo, Oct. 2007, Lung cancer (Amsterdam, Netherlands), 59, 2
DOI

Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer., Yanagitani Noriko;Tsuchiya Satoshi;Kaira Kyoichi;Sunaga Noriaki;Tsuchiya Yukiko;Sato Koji;Watanabe Satoru;Nomura Shiro;Sakai Shuzo;Saito Ryusei;Mori Masatomo, American journal of clinical oncology, 30, 5
DOI

Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study., Kaira Kyoichi;Oriuchi Noboru;Otani Yoshimi;Shimizu Kimihiro;Tanaka Shigebumi;Imai Hisao;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Dobashi Kunio;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Endo Keigo;Mori Masatomo, Clinical cancer research : an official journal of the American Association for Cancer Research, 13, 21
DOI

Gender and age risks for hoarseness and dysphonia with use of a dry powder fluticasone propionate inhaler in asthma., Ishizuka Tamotsu;Hisada Takeshi;Aoki Haruka;Yanagitani Noriko;Kaira Kyoichi;Utsugi Mitsuyoshi;Shimizu Yasuo;Sunaga Noriaki;Dobashi Kunio;Mori Masatomo, Allergy and asthma proceedings, 28, 5
DOI

Primary mediastinal synovial sarcoma: a report of 2 cases., Kaira Kyoichi;Ishizuka Tamotsu;Sunaga Noriaki;Hashimoto Koshi;Yanagitani Noriko;Nonaka Tetsuo;Ebara Takeshi;Hisada Takeshi;Mori Masatomo, Journal of computer assisted tomography, 32, 2
DOI

Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung., Kaira Kyoichi;Oriuchi Noboru;Imai Hisao;Shimizu Kimihiro;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Kawashima Osamu;Iijima Hironobu;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Mori Masatomo, Apr. 2008, Pathology, research and practice, 204, 8
DOI

B-cell non-Hodgkin lymphoma presenting as an endobronchial polypoid mass., Kaira Kyoichi;Ishizuka Takahiro;Tanaka Hiroto;Tanaka Yoshiki;Ishizuka Tamotsu;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Mori Masatomo, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 3, 5
DOI

Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer., Kaira Kyoichi;Sunaga Noriaki;Yanagitani Noriko;Aoki Haruka;Kawata Tadayoshi;Utsugi Mitsuyoshi;Shimizu Yasuo;Shimizu Kimihiro;Hisada Takeshi;Ishizuka Tamotsu;Mori Masatomo, Anti-cancer drugs, 19, 3
DOI

[A case of large cell neuroendocrine carcinoma in a patient with sarcoidosis]., Yanagitani Noriko;Kaira Kyoichi;Ishizuka Tamotsu;Aoki Haruka;Kawata Tadayoshi;Utsugi Mitsuyoshi;Shimizu Yasuo;Sunaga Noriaki;Hisada Takeshi;Mori Masatomo, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 46, 7

Lung cancer producing granulocyte colony-stimulating factor and rapid spreading to peritoneal cavity., Kaira Kyoichi;Ishizuka Takahiro;Tanaka Hiroto;Tanaka Yoshiki;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Mori Masatomo, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 3, 9
DOI

[A case of elderly non-small cell lung cancer effectively treated by combined chemotherapy of gemcitabine and S-1]., Kaira Kyoichi;Sunaga Noriaki;Yanagitani Noriko;Imai Hisao;Utsugi Mitsuyoshi;Shimizu Yasuo;Kawata Tadayoshi;Hisada Takeshi;Shimizu Kimihiro;Tsuchiya Takafumi;Ishizuka Tamotsu;Mori Masatomo, Gan to kagaku ryoho. Cancer & chemotherapy, 35, 9

Pulmonary toxicity associated with vinorelbine-based chemotherapy in breast cancer., Yanagitani Noriko;Shimizu Yasuo;Kaira Kyoichi;Tatsuno Sayaka;Sunaga Noriaki;Ishizuka Tamotsu;Mori Masatomo, Gan to kagaku ryoho. Cancer & chemotherapy, 35, 9

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms., Kaira Kyoichi;Oriuchi Noboru;Imai Hisao;Shimizu Kimihiro;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Tanaka Shigebumi;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Mori Masatomo, Nov. 2008, Cancer science, 99, 12
DOI

Laryngeal sarcoidosis detected by FDG positron emission tomography., Kaira Kyoichi;Ishizuka Tamotsu;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Mori Masatomo, Clinical nuclear medicine, 33, 12
DOI

Evaluation of thoracic tumors with (18)F-FMT and (18)F-FDG PET-CT: a clinicopathological study., Kaira Kyoichi;Oriuchi Noboru;Shimizu Kimihiro;Ishikita Tomohiro;Higuchi Tetsuya;Imai Hisao;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Endo Keigo;Mori Masatomo, International journal of cancer, 124, 5
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung., Kaira Kyoichi;Oriuchi Noboru;Imai Hisao;Shimizu Kimihiro;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Mori Masatomo, Cancer science, 100, 2
DOI

Forearm muscle metastasis as an initial clinical manifestation of lung cancer., Kaira Kyoichi;Ishizuka Tamotsu;Yanagitani Noriko;Sunaga Noriaki;Tsuchiya Takafumi;Hisada Takeshi;Mori Masatomo, Southern medical journal, 102, 1
DOI

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer., Kaira Kyoichi;Oriuchi Noboru;Shimizu Kimihiro;Ishikita Tomohiro;Higuchi Tetsuya;Imai Hisao;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Endo Keigo;Mori Masatomo, Jan. 2009, Cancer science, 100, 4
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma., Kaira Kyoichi;Oriuchi Noboru;Imai Hisao;Shimizu Kimihiro;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Kanai Yoshikatsu;Nakajima Takashi;Mori Masatomo, Jan. 2009, Lung cancer (Amsterdam, Netherlands), 66, 1
DOI

[Effective gemcitabine plus S-1 treatment in elderly non-small cell lung cancer patients with multiple bone metastases]., Kaira Kyoichi;Yanagitani Noriko;Sunaga Noriaki;Imai Hisao;Utsugi Mitsuyoshi;Kawata Tadayoshi;Hisada Takeshi;Shimizu Kimihiro;Ishizuka Tamotsu;Mori Masatomo, Gan to kagaku ryoho. Cancer & chemotherapy, 36, 2

Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma., Imai Hisao;Sunaga Noriaki;Kaira Kyoichi;Kawashima Osamu;Yanagitani Noriko;Sato Koji;Tomizawa Yoshio;Hisada Takeshi;Ishizuka Tamotsu;Hirato Junko;Saito Ryusei;Nakajima Takashi;Mori Masatomo, Mar. 2009, Internal medicine (Tokyo, Japan), 48, 5
DOI

L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas., Kaira Kyoichi;Oriuchi Noboru;Imai Hisao;Shimizu Kimihiro;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Mori Masatomo, Journal of surgical oncology, 99, 7
DOI

Pulmonary traumatic pneumatocele and hematoma., Kaira Kyoichi;Ishizuka Tamotsu;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Mori Masatomo, Mar. 2009, Japanese journal of radiology, 27, 2
DOI

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study., Shimizu Yasuo;Sunaga Noriaki;Dobashi Kunio;Fueki Makoto;Fueki Naoto;Makino Sohei;Mori Masatomo, Apr. 2009, BMC infectious diseases, 9
DOI

[A case of cryptogenic organizing pneumonia with eosinophilic infiltration which was difficult to distinguish from nonspecific interstitial pneumonia]., Yanagitani Noriko;Ishizuka Tamotsu;Hironaka Mitsugu;Kaira Kyoichi;Imai Hisao;Kawata Tadayoshi;Utsugi Mitsuyoshi;Shimizu Yasuo;Sunaga Noriaki;Hisada Takeshi;Mori Masatomo, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 47, 4

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer., Kaira Kyoichi;Sunaga Noriaki;Yanagitani Noriko;Imai Hisao;Utsugi Mitsuyoshi;Iwasaki Yasuki;Shimizu Kimihiro;Iijima Hironobu;Tsurumaki Hiroaki;Tomizawa Yoshio;Hisada Takeshi;Ishizuka Tamotsu;Saito Ryusei;Mori Masatomo, Jul. 2009, Lung cancer (Amsterdam, Netherlands), 68, 2
DOI

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer., Imai Hisao;Kaira Kyoichi;Oriuchi Noboru;Yanagitani Noriko;Sunaga Noriaki;Ishizuka Tamotsu;Kanai Yoshikatsu;Endou Hitoshi;Nakajima Takashi;Mori Masatomo, Histopathology, 54, 7
DOI

CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases., Kaira Kyoichi;Oriuchi Noboru;Imai Hisao;Shimizu Kimihiro;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Kawashima Osamu;Kamide Yosuke;Ishizuka Tamotsu;Kanai Yoshikatsu;Nakajima Takashi;Mori Masatomo, Sep. 2009, Annals of surgical oncology, 16, 12
DOI

Multiple lung metastases presenting as ground-glass opacities in a pulmonary adenocarcinoma: a case report., Yanagitani Noriko;Kaira Kyoichi;Ishizuka Tamotsu;Aoki Haruka;Utsugi Mitsuyoshi;Shimizu Yasuo;Sunaga Noriaki;Endou Katsuaki;Hisada Takeshi;Mori Masatomo, May 2009, Cases journal, 2
DOI

18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer., Kaira Kyoichi;Oriuchi Noboru;Shimizu Kimihiro;Tominaga Hideyuki;Yanagitani Noriko;Sunaga Noriaki;Ishizuka Tamotsu;Kanai Yoshikatsu;Mori Masatomo;Endo Keigo, Oct. 2009, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 50, 11
DOI

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer., Kaira Kyoichi;Sunaga Noriaki;Tomizawa Yoshio;Yanagitani Noriko;Shimizu Kimihiro;Imai Hisao;Utsugi Mitsuyoshi;Iwasaki Yasuki;Iijima Hironobu;Tsurumaki Hiroaki;Yoshii Akihiro;Fueki Naoto;Hisada Takeshi;Ishizuka Tamotsu;Saito Ryusei;Mori Masatomo, Oct. 2009, Lung cancer (Amsterdam, Netherlands), 69, 1
DOI

[A case of neurosarcoidosis discovered in a patient complaining of chest pain]., Yanagitani Noriko;Kotake Mie;Ishizuka Tamotsu;Iwasaki Yasuki;Sunaga Noriaki;Mori Masatomo, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 47, 12

Epigenetic inactivation of the thyroid hormone receptor beta1 gene at 3p24.2 in lung cancer., Iwasaki Yasuki;Sunaga Noriaki;Tomizawa Yoshio;Imai Hisao;Iijima Hironobu;Yanagitani Noriko;Horiguchi Kazuhiko;Yamada Masanobu;Mori Masatomo, Feb. 2010, Annals of surgical oncology, 17, 8
DOI

小腸転移による穿孔をきたした肺扁平上皮癌の1剖検例, ;;;;;;;;;, May 2016, 623回, 23

当院における外科的肺生検で病理学的に指摘された間質性肺炎症例の臨床的検討, ;;;;;;;;;;;;;;, Mar. 2016, 5, 増刊, 347

非小細胞肺癌細胞においてKRAS遺伝子変異によるMAPK/ERK経路を介したPD-L1の発現誘導, ;;;;;;;;;, Nov. 2016, 56, 6, 639

肺動脈内膜肉腫との鑑別を要した心臓原発未分化型多型肉腫の一例, ;;;;;;;;;;;, Nov. 2016, 56, 6, 758

左中葉肺小細胞癌の経過中に転移性膵腫瘍を来し、膵炎を反復した一例, ;;;;;;;;;;;, Nov. 2016, 56, 6, 778

強皮症、シェーグレン症候群経過中に生じた気管気管支アミロイドーシスの一例, ;;;;;;;;;;;;, May 2017, 39, Suppl., S317

当院におけるサルコイドーシス気管支鏡診断の解析, ;;;;;;;;, May 2017, 39, Suppl., S319

血液透析中にアファチニブ投与した進行非小細胞肺癌の検討, ;;;;;;;;, Mar. 2017, 6, 増刊, 190

気管支喘息と間質性肺炎合併例の診断・経過の考察, ;;;;;;;;;;;;;, Mar. 2017, 6, 増刊, 270

肺非結核性抗酸菌症加療中に慢性進行性アスペルギルス症を合併しリファンピシンをリファプチンへ切り替えて抗真菌治療を行った1例, ;;;;;;;;;;;;;, Mar. 2017, 6, 増刊, 293

血管炎・その他の免疫疾患　当院治療中の結核患者に起きた免疫再構築症候群の検討, ;;;;;;;;;;;;, May 2017, 66, 4-5, 622

胸痛を契機として診断された再発性多発軟骨炎の1例, ;;;;;;;;;, Sep. 2017, 635回, 20

MEKとp38の同時阻害はKRAS変異陽性非小細胞肺癌の細胞増殖を効率的に抑制する, ;;;;;;, Sep. 2017, 76回, P

インシデントレポートからみた血管外漏出の現状と予防対策, ;;;;;, Oct. 2017, 55回, P114

EGFR-TKI治療後にT790M変異および扁平上皮癌への形質転換が疑われたEGFR遺伝子変異陽性肺腺癌の一例, ;;;;;;;;;;;, Sep. 2017, 57, 5, 527

アムルビシン療法が行われた既治療小細胞肺癌症例におけるGRP78/BiP発現の臨床的意義, ;;;;;;;;;, Sep. 2017, 57, 5, 542

Amrubicin投与非小細胞肺癌症例におけるTopoisomerase II発現の臨床学的検討, ;;;;;;;;;, Sep. 2017, 57, 5, 542

EGFR陽性肺腺癌に対するエルロチニブ治療中に生じた悪性リンパ腫による小腸穿孔を来した一例, ;;;;;;;;;;;, Sep. 2017, 57, 5, 575

分子標的薬とは何か　肺癌における分子標的薬, 砂長則明, May 2018, 34, 5, 616

Amrubicin投与非小細胞肺癌症例におけるTopoisomerase-I/II発現の臨床学的検討, ;;;;;;;, Mar. 2018, 7, 増刊, 149

既治療進行非小細胞肺癌におけるニボルマブ療法の早期治療効果判定としてのFDG-PETの役割, ;;;;, Mar. 2018, 7, 増刊, 172

Pasteurella multocidaによる慢性肺炎の一例, ;;;;;;;;;;;;;;, Mar. 2018, 7, 増刊, 188

閉塞性呼吸器疾患の増悪入院に影響を及ぼす肺機能、心機能パラメーターの検討, ;;;;;;;;;;;;;;;;, Mar. 2018, 7, 増刊, 219

17(R)-ResolvinD1の肺線維症モデルにおける線維化抑制作用の検討, ;;;;;;;;;;;;;;, Mar. 2018, 7, 増刊, 232

非小細胞肺癌細胞においてKRAS/BRAF変異はMAPK/ERK経路を介してPD-L1発現を誘導する, ;;;;;;;;;, Mar. 2018, 7, 増刊, 267

骨盤内リンパ管腫に対する塞栓術後に縮小したヌーナン症候群合併縦隔内リンパ管腫の一例, ;;;;;;;;;;;;;;;;;;;, Sep. 2018, 174回・231回, 14

外来化学療法センターにおける過敏症反応・インフュージョンリアクションの後方視的検討, ;;;;;;;;;;;;, Nov. 2018, 45, 11, 1625

EGFR変異陽性非小細胞肺癌における治療前悪液質関連因子の予後予測因子としての意義, ;;;;;;, Oct. 2018, 58, 6, 590

アファチニブのrechallengeが奏効したEGFR-G719C/S768I変異陽性肺癌の1例, ;;;;;;;;;, Oct. 2018, 58, 6, 632

免疫関連副作用にてニボルマブ中止後も、持続する治療効果を認めた一例, ;;;;;;;;;;, Oct. 2018, 58, 6, 684

ω3脂肪酸代謝物resolvin Eシリーズの肺線維症モデルマウスに及ぼす影響の検討, ;;;;;;;;;;;;, May 2018, 67, 4-5, 655

病理解剖の結果膵原発と考えられた原発不明癌の1例, ;;;;;;;;, Mar. 2019, 649回, 35

SH法によるCDDP投与ではD-マンニトール、フロセミド併用は腎障害予防に必要か?, ;;;;;;, Oct. 2018, 56回, P54

線維筋痛症、全身性強皮症、シェーグレン症候群に合併した気管気管支アミロイドーシスの1例, ;;;;;;;;;, Mar. 2019, 41, 2, 160

肺炎球菌ワクチン接種を契機とした好酸球増多症が疑われた1例, ;;;;;;;;;, Jun. 2019, 651回, 23

肺・尿路結核の治療中に脳・脊髄結核腫を発症した一例, ;;;;;;;;;, Mar. 2019, 8, 増刊, 172

特発性肺線維症に対する抗線維化薬登場後の使用実態, ;;;;;;;;;, Mar. 2019, 8, 増刊, 200

肺線維症モデルマウスにおけるω3脂肪酸代謝物Resolvin Eシリーズの抗炎症効果の検討, ;;;;;;;;;;;;, Mar. 2019, 8, 増刊, 253

当院における間質性肺炎に合併した気胸の臨床的特徴, ;;;;;;;;;;, Mar. 2019, 8, 増刊, 257

悪性腫瘍がサルコイドーシスに及ぼす影響についての当院312例の後方視的検討, ;;;;;;;;;;, Mar. 2019, 8, 増刊, 285

胸水,心嚢液貯留を契機に局所麻酔下胸腔鏡で診断したIgG4関連疾患の一例, ;;;;;;;;;, Jun. 2019, 41, Suppl., S356

重症気管支喘息に対するBenralizumab投与例の検討, ;;;;;;;;, May 2019, 68, 4-5, 590

進行非小細胞肺癌治療における免疫チェックポイント阻害剤と免疫関連有害事象の関連, ;;;;;;;;;;;;;, May 2019, 68, 4-5, 620

全身ステロイド治療を要する好酸球性胃腸炎併存難治性喘息に対してベンラリズマブが有効であった一例, ;;;;;;;;;, Feb. 2020, 69, 1, 72

脈絡膜転移に伴う眼症状を契機に診断された肺腺癌の1例, ;;;;;;;, Nov. 2019, 59, 6, 814

治療に難渋した抗MDA-5抗体陽性皮膚筋炎に伴う急性進行性間質性肺炎の一例, ;;;;;;;;;, Jun. 2020, 69, 4, 282

気管支サーモプラスティ後に生物学的製剤の追加または変更を要した症例の検討, ;;;;;;;, Jun. 2020, 42, Suppl., S262

長期にインフリキシマブを投与中に,非典型的な局所麻酔下胸腔鏡所見を示した結核性胸膜炎の一例, ;;;;;;;;, Jun. 2020, 42, Suppl., S333

早期のMepolizumabとIVIGにより末梢神経障害が改善しステロイドを減量し得た好酸球性多発血管炎性肉芽腫症の2例, ;;;;;;;;;;;;;;;;, Aug. 2020, 9, 増刊, 160

当院の好酸球性多発血管炎性肉芽腫症におけるMepolizumab投与例の検討, ;;;;;;;;;;;;;;;, Aug. 2020, 9, 増刊, 160

小細胞肺癌・1次化学療法の効果予測におけるBiP発現の意義, ;;;;;;;, Aug. 2020, 9, 増刊, 165

多形紅斑を発症したため、Osimertinib減感作療法を行った肺腺癌の1例, ;;;;;;;;;;;, Aug. 2020, 9, 増刊, 174

COPDを有する手術予定患者の術前評価と術後呼吸器合併症の検討, ;;;;;;;;;;;;;;;;;, Aug. 2020, 9, 増刊, 236

インフリキシマブ長期投与中に発症し、非典型的な画像所見を示した肺結核、結核性胸膜炎の一例, ;;;;;;;;;, Aug. 2020, 9, 増刊, 243

重症喘息とCOPDのオーバーラップに対して、デュピルマブの奏効を認めた1例, ;;;;;;;;;, Aug. 2020, 9, 増刊, 278

気管支喘息における新規バイオマーカーとしてのT-cell death-associated gene8, ;;;;;;;;;;;;, Aug. 2020, 9, 増刊, 281

出産後に発症した好酸球性多発血管炎性肉芽腫症にメポリズマブを併用した1例, ;;;;;;;, May 2021, 70, 3, 235

アレルギー性肺アスペルギルス症合併喘息へのベンラリズマブ投与中に非結核性抗酸菌症の増悪を来した1例, ;;;;;;;;;, Jun. 2021, 70, 4, 327

樹状細胞に対する炎症収束性メディエーターResolvinE3の作用の検討, ;;;;;;;;;;;;;, Oct. 2020, 69, 臨時増刊号, 296

ResolvinE1,E3のアレルギー性気道炎症に対する効果の検討(アンコール演題), ;;;;;;;;;;, Apr. 2021, 10, 増刊, 134

ResolvinE3誘導体の樹状細胞に対する抗炎症性作用の解析, ;;;;;;;;;;;;;;;, Apr. 2021, 10, 増刊, 134

好酸球性多発血管炎性肉芽腫症に対するMepolizumabの有効性, ;;;;;;;;;;;;, Apr. 2021, 10, 増刊, 171

好酸球性多発血管炎性肉芽腫症にアレルギー性肺アスペルギルス症と好酸球性副鼻腔炎を同時発症した一例, ;;;;;;;;;;;;;;, Aug. 2021, 70, 6-7, 860

特発性肺線維症患者のNintedanib投与中の抗ANCA抗体陽性腎障害の発症について　多施設共同前向き観察研究, ;;;;;;;;;;;;, Aug. 2021, 70, 6-7, 872

Resolvin E3(RvE3)誘導体の生物学的安定性の解析について, ;;;;;;;;;;;;;;;, Aug. 2021, 70, 6-7, 875

サルベージ手術の適応と実際　原発性肺癌に対するTKI治療後の局所残存・再発病変に対する外科的切除の検討　非切除症例との比較, ;;;;;;;;;;, Oct. 2021, 61, 6, 505

ニボルマブ治療後の7次治療としてのnab-パクリタキセル単剤療法が長期奏効した再発肺大細胞癌の1例, ;;;;;;;;;;;, Oct. 2021, 61, 6, 699

集中治療により救命した妊娠35週発症の粟粒結核の一例, ;;;;;;;;;;;;;;;;;, Sep. 2021, 180回・246回, 12

進行胸腺癌全摘術後多発転移に対してレンバチニブを使用した一例, ;;;;;;;;;;;;, Sep. 2021, 180回・246回, 25

ニボルマブ・イピリムマブ併用療法後にGrade4の皮膚障害が認められた1例, ;;;;;;;;;, Feb. 2022, 71, 1, 65

ICI・TKI・SBRT時代の肺癌の集学的治療と外科手術　原発性肺癌に対するTKI治療症例のサルベージ手術症例と非切除症例との比較, ;;;;;;;;;;;, Apr. 2022, 122回, SY

ニンテタニブが奏功した過敏性肺臓炎の一例, ;;;;;;;;;, May 2022, 71, 3, 260

シングルユースの軟性気管支鏡の有用性の検討, ;;;;;;;;;;;;;;, May 2022, 44, Suppl., S252

気管支結核の治療完遂後、経年的に気管支狭窄が進行し、難治性閉塞性肺炎を来した1例, ;;;;;;;;;;;;, May 2022, 44, Suppl., S266

80歳以上の高齢者の特発性肺線維症に対する抗線維化薬使用状況の解析, ;;;;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 167

Resolvin E3の細胞内シグナル伝達経路に及ぼす影響の解析, ;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 181

第5波のCOVID-19妊婦の臨床的特徴の検討, ;;;;;;;;;, Apr. 2022, 11, 増刊, 190

シングルユース軟性気管支鏡の有用性の検討, ;;;;;;;;;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 192

プロトン感知性Gタンパク質共役型受容体OGR1の塩酸投与によるマウスARDSモデルにおける働き, ;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 203

サルコイドーシスにおける血清NSEの診断的意義, ;;;;;;;;;;;, Apr. 2022, 11, 増刊, 221

病勢悪化によりデキサメタゾンからメチルプレドニゾロンへ変更したCOVID-19の検討, ;;;;;;;;, Apr. 2022, 11, 増刊, 260

ResolvinE1、E2、E3のアレルギー性気道炎症に対する効果の検討, ;;;;;;;;;;, Apr. 2022, 11, 増刊, 282

成人喘息患者における喘息症状及び鼻・副鼻腔炎症状を評価するGスケール問診票の有用性についての検討, ;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 293

気管支喘息と好酸球性副鼻腔炎との併存を診断するためのGスケール問診票の有用性, ;;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 294

抗IL-6Rα抗体治療中に短期間で増悪した肺非結核性抗酸菌症に対して4剤併用初期強化療法が奏功した一例, ;;;;;;;;;, Feb. 2022, 181回・248回, 12

肺移植待機中の緑膿菌感染症に対しトブラマイシン吸入が奏功した一例, ;;;;;;;;;;;;;, Feb. 2022, 181回・248回, 13

アレルギー疾患における免疫細胞による病態形成とその解明　Resolvin E3のマクロファージ内シグナル伝達経路に及ぼす影響の解析, ;;;;;;;;;;;;, Aug. 2022, 71, 6-7, 795

マウスARDSモデルにおけるプロトン感知性Gタンパク質共役型受容体OGR1の働き, ;;;;;;;;;;;, Aug. 2022, 71, 6-7, 879

抗IL-4Rα抗体治療によるアレルゲン特異的IgE陽性数の変化に関する検討, ;;;;;;;, Jun. 2022, 29, 1, 65

重症気管支喘息の喀痰症状におけるDupilumabの有効性, ;;;;;;;;;;;, Mar. 2023, 12, 増刊, 263

ニボルマブ/イピリムマブによるミオパチー,肝障害にミコフェノール酸モフェチルが奏功した肺腺癌の一例, ;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 279

間質性腎炎,IgA腎症による腎機能障害を合併したEGFR変異陽性肺腺癌に対してアファチニブ治療が奏効した1例, ;;;;;;;, Mar. 2023, 12, 増刊, 355

気管支喘息における難治性咳嗽にテゼペルマブが有効であった一例, ;;;;;;;;, Sep. 2023, 184回・256回, 29

Assessment of therapy response in lung cancer with ¹⁸F-α-methyl tyrosine PET., Kaira Kyoichi;Oriuchi Noboru;Yanagitani Noriko;Sunaga Noriaki;Ishizuka Tamotsu;Mori Masatomo;Endo Keigo, AJR. American journal of roentgenology, 195, 5
DOI

Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer., Kaira Kyoichi;Oriuchi Noboru;Shimizu Kimihiro;Imai Hisao;Tominaga Hideyuki;Yanagitani Noriko;Sunaga Noriaki;Hisada Takeshi;Ishizuka Tamotsu;Kanai Yoshikatsu;Oyama Tetsunari;Mori Masatomo;Endo Keigo, Jul. 2010, Nuclear medicine and biology, 37, 8
DOI

Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer., Imai Hisao;Kaira Kyoichi;Oriuchi Noboru;Shimizu Kimihiro;Tominaga Hideyuki;Yanagitani Noriko;Sunaga Noriaki;Ishizuka Tamotsu;Nagamori Shushi;Promchan Kanyarat;Nakajima Takashi;Yamamoto Nobuyuki;Mori Masatomo;Kanai Yoshikatsu, Anticancer research, 30, 12

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer., Sunaga Noriaki;Imai Hisao;Shimizu Kimihiro;Shames David S;Kakegawa Seiichi;Girard Luc;Sato Mitsuo;Kaira Kyoichi;Ishizuka Tamotsu;Gazdar Adi F;Minna John D;Mori Masatomo, Aug. 2011, International journal of cancer, 130, 8
DOI

Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: gene expression associated with metastatic potential in human lung cancer., Nakano Tetsuhiro;Shimizu Kimihiro;Kawashima Osamu;Kamiyoshihara Mitsuhiro;Kakegawa Seiichi;Sugano Masayuki;Ibe Takashi;Nagashima Toshiteru;Kaira Kyoichi;Sunaga Noriaki;Ohtaki Youichi;Atsumi Jun;Takeyoshi Izumi, Aug. 2012, Oncology reports, 28, 5
DOI

Interaction of radiation and gefitinib on a human lung cancer cell line with mutant EGFR gene in vitro., Sato Yumi;Ebara Takeshi;Sunaga Noriaki;Takahashi Takeo;Nakano Takashi, Anticancer research, 32, 11

Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells., Nakajima Yoshimi;Takagi Hitoshi;Kakizaki Satoru;Horiguchi Norio;Sato Ken;Sunaga Noriaki;Mori Masatomo, Anticancer research, 32, 12

Perfusion evaluation of lung cancer: assessment using dual-input perfusion computed tomography., Nakano Sachiko;Gibo Junko;Fukushima Yasuhiro;Kaira Kyoichi;Sunaga Noriaki;Taketomi-Takahashi Ayako;Tsushima Yoshito;Mori Masatomo, Journal of thoracic imaging, 28, 4
DOI

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer., Kaira Kyoichi;Tomizawa Yoshio;Yoshino Reiko;Miura Yosuke;Yoshii Akihiro;Iwasaki Yasuki;Koga Yasuhiko;Ono Akihiro;Hisada Takeshi;Minato Koichi;Sato Koji;Kazama Toshifumi;Ishihara Shinichi;Kohyama Kenya;Fueki Naoto;Saito Ryusei;Sunaga Noriaki, Aug. 2013, Lung cancer (Amsterdam, Netherlands), 82, 1
DOI

Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer., Kaira Kyoichi;Tomizawa Yoshio;Yoshino Reiko;Yoshii Akihiro;Matsuura Masana;Iwasaki Yasuki;Koga Yasuhiko;Ono Akihiro;Nishioka Masaki;Kamide Yosuke;Hisada Takeshi;Ishizuka Tamotsu;Shirai Katsuyuki;Ebara Takeshi;Saitoh Jun-Ichi;Nakano Takashi;Sunaga Noriaki, Sep. 2013, Lung cancer (Amsterdam, Netherlands), 82, 3
DOI

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer., Kaira Kyoichi;Sunose Yutaka;Ohshima Yasuhiro;Ishioka Noriko S;Arakawa Kazuhisa;Ogawa Tetsushi;Sunaga Noriaki;Shimizu Kimihiro;Tominaga Hideyuki;Oriuchi Noboru;Itoh Hideaki;Nagamori Shushi;Kanai Yoshikatsu;Yamaguchi Aiko;Segawa Atsuki;Ide Munenori;Mori Masatomo;Oyama Tetsunari;Takeyoshi Izumi, Oct. 2013, BMC cancer, 13
DOI

Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma., Kaira Kyoichi;Sunose Yutaka;Arakawa Kazuhisa;Sunaga Noriaki;Shimizu Kimihiro;Tominaga Hideyuki;Oriuchi Noboru;Nagamori Shushi;Kanai Yoshikatsu;Oyama Tetsunari;Takeyoshi Izumi, Dec. 2014, Histopathology, 66, 2
DOI

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma., Ishizuka Tamotsu;Hisada Takeshi;Hatori Motoaki;Koike Akio;Hanabuchi Kikuo;Matsuzaki Shinichi;Kamide Yosuke;Utsugi Mitsuyoshi;Aoki Haruka;Yoshino Reiko;Yanagitani Noriko;Koga Yasuhiko;Ono Akihiro;Kaira Kyoichi;Sunaga Noriaki;Dobashi Kunio;Tsuburai Takahiro;Akiyama Kazuo;Yamada Masanobu;Suzuki Kazuhiro;Mori Masatomo, Jul. 2014, Inflammation research : official journal of the European Histamine Research Society ... [et al.], 63, 9
DOI

Acidic pH increases cGMP accumulation through the OGR1/phospholipase C/Ca(2+)/neuronal NOS pathway in N1E-115 neuronal cells., Kotake Mie;Sato Koichi;Mogi Chihiro;Tobo Masayuki;Aoki Haruka;Ishizuka Tamotsu;Sunaga Noriaki;Imai Hisao;Kaira Kyoichi;Hisada Takeshi;Yamada Masanobu;Okajima Fumikazu, Jul. 2014, Cellular signalling, 26, 11
DOI

Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk., Enokida Yasuaki;Shimizu Kimihiro;Kakegawa Seiichi;Atsumi Jun;Takase Yoshiaki;Miyamae Yohei;Nagashima Toshiteru;Ohtaki Yoichi;Kaira Kyoichi;Sunaga Noriaki;Yanagitani Noriko;Yoshino Reiko;Tsunekawa Katsuhiko;Igai Hitoshi;Kamiyoshihara Mitsuhiro;Usui Kengo;Lezhava Alexander;Tomizawa Yoshio;Ishikawa Toshihisa;Murakami Masami;Hayashizaki Yoshihide;Takeyoshi Izumi, Jun. 2014, Biomedical reports, 2, 5
DOI

First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations., Kuwako Tomohito;Imai Hisao;Masuda Tomomi;Miura Yosuke;Seki Kaori;Yoshino Reiko;Kaira Kyoichi;Utsugi Mitsuyoshi;Shimizu Kimihiro;Sunaga Noriaki;Tomizawa Yoshio;Ishihara Shinichi;Ishizuka Takao;Mogi Akira;Hisada Takeshi;Minato Koichi;Takise Atsushi;Saito Ryusei;Yamada Masanobu, Aug. 2015, Cancer chemotherapy and pharmacology, 76, 4
DOI

Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer., Kaira Kyoichi;Sunaga Noriaki;Imai Hisao;Kamide Yosuke;Koga Yasuhiko;Ono Akihiro;Kuwako Tomohito;Masuda Tomomi;Hisada Takeshi;Ishizuka Tamotsu;Yamada Masanobu, Aug. 2015, International journal of clinical oncology, 21, 2
DOI

Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma., Kamide Yosuke;Kaira Kyoichi;Watanabe Takuya;Kuribayashi Shiko;Ozawa Atsushi;Koga Yasuhiko;Ono Akihiro;Sunaga Noriaki;Hisada Takeshi;Oyama Tetsunari;Yamada Masanobu, Nov. 2015, Internal medicine (Tokyo, Japan), 54, 22
DOI

17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice., Yatomi Masakiyo;Hisada Takeshi;Ishizuka Tamotsu;Koga Yasuhiko;Ono Akihiro;Kamide Yosuke;Seki Kaori;Aoki-Saito Haruka;Tsurumaki Hiroaki;Sunaga Noriaki;Kaira Kyoichi;Dobashi Kunio;Yamada Masanobu;Okajima Fumikazu, Physiological reports, 3, 12
DOI

Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case., Imai Hisao;Matsumura Nozomi;Yamazaki Yuichi;Kanayama Yuki;Masuda Tomomi;Kuwako Tomohito;Kamide Yosuke;Tomizawa Taku;Matsumoto Shunichi;Mitsui Takeki;Kaira Kyoichi;Ono Akihiro;Koga Yasuhiko;Shibusawa Nobuyuki;Sunaga Noriaki;Hisada Takeshi;Yokoo Hideaki;Yamada Masanobu, Dec. 2015, Internal medicine (Tokyo, Japan), 54, 24
DOI

Usefulness of 18F-α-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer., Kaira Kyoichi;Higuchi Tetsuya;Sunaga Noriaki;Arisaka Yukiko;Hisada Takeshi;Tominaga Hideyuki;Oriuchi Noboru;Asao Takayuki;Tsushima Yoshihito;Yamada Masanobu, Anticancer research, 36, 12
DOI

Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer., Kaira Kyoichi;Tomizawa Yoshio;Imai Hisao;Sakurai Reiko;Matsuura Masana;Yoshii Akihiro;Ochiai Mai;Kotake Mie;Ebara Takeshi;Saitoh Jun-Ichi;Sunaga Noriaki;Minato Koichi;Saito Ryusei;Hisada Takeshi, Dec. 2016, Cancer chemotherapy and pharmacology, 79, 1
DOI

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer., Imai Hisao;Kuwako Tomohito;Kaira Kyoichi;Masuda Tomomi;Miura Yosuke;Seki Kaori;Sakurai Reiko;Utsugi Mitsuyoshi;Shimizu Kimihiro;Sunaga Noriaki;Tomizawa Yoshio;Ishihara Shinichi;Ishizuka Takao;Mogi Akira;Hisada Takeshi;Minato Koichi;Takise Atsushi;Saito Ryusei;Yamada Masanobu, Feb. 2017, Cancer chemotherapy and pharmacology, 79, 3
DOI

High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma., Miura Yosuke;Kaira Kyoichi;Sakurai Reiko;Imai Hisao;Tomizawa Yoshio;Sunaga Noriaki;Minato Koichi;Hisada Takeshi;Oyama Tetsunari;Yamada Masanobu, May 2017, International journal of clinical oncology, 22, 5
DOI

Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer., Kaira Kyoichi;Yanagitani Noriko;Sunaga Noriaki;Imai Hisao;Ono Akihiro;Koga Yasuhiko;Hisada Takeshi;Ishizuka Tamotsu;Yamada Masanobu, May 2017, Oncology letters, 14, 1
DOI

Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors., Miura Yosuke;Kaira Kyoichi;Sakurai Reiko;Imai Hisao;Tomizawa Yoshio;Sunaga Noriaki;Minato Koichi;Hisada Takeshi;Oyama Tetsunari;Yamada Masanobu, Jun. 2017, Oncology letters, 14, 2
DOI

Metabolic activity by 18F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC., Kaira Kyoichi;Higuchi Tetsuya;Naruse Ichiro;Arisaka Yukiko;Tokue Azusa;Altan Bolag;Suda Satoshi;Mogi Akira;Shimizu Kimihiro;Sunaga Noriaki;Hisada Takeshi;Kitano Shigehisa;Obinata Hideru;Yokobori Takehiko;Mori Keita;Nishiyama Masahiko;Tsushima Yoshihito;Asao Takayuki, Aug. 2017, European journal of nuclear medicine and molecular imaging, 45, 1
DOI

Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature., Saito Yasuyuki;Sawada Yuri;Koga Yasuhiko;Sunaga Noriaki;Tsukagoshi Yusuke;Hachisu Yoshimasa;Osaki Takashi;Sakurai Reiko;Kaira Kyoichi;Ono Akihiro;Sato Ken;Koiso Hiromi;Oyama Tetsunari;Hisada Takeshi;Yamada Masanobu, Sep. 2017, Internal medicine (Tokyo, Japan), 56, 20
DOI

The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome., Hachisu Yoshimasa;Koga Yasuhiko;Sunaga Noriaki;Kashiwagi Chiharu;Sawada Yuri;Saito Yasuyuki;Tsukagoshi Yusuke;Kasahara Norimitsu;Sakurai Reiko;Tsurumaki Hiroaki;Yatomi Masakiyo;Kaira Kyoichi;Ono Akihiro;Maeno Toshitaka;Hisada Takeshi, Nov. 2017, Internal medicine (Tokyo, Japan), 57, 2
DOI

A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer., Sakurai Reiko;Tomizawa Yoshio;Yoshii Akihiro;Miura Yosuke;Tsurumaki Hiroaki;Kaira Kyoichi;Sunaga Noriaki;Kawashima Osamu;Hisada Takeshi;Yamada Masanobu;Saito Ryusei, Nov. 2017, Cancer chemotherapy and pharmacology, 81, 1
DOI

High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin., Miura Yosuke;Kaira Kyoichi;Sakurai Reiko;Sunaga Noriaki;Saito Ryusei;Hisada Takeshi;Yamada Masanobu, Nov. 2017, Lung cancer (Amsterdam, Netherlands), 115
DOI

The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer., Miura Yosuke;Imai Hisao;Sakurai Reiko;Kaira Kyoichi;Sunaga Noriaki;Minato Koichi;Saito Ryusei;Hisada Takeshi, Mar. 2018, Medical oncology (Northwood, London, England), 35, 4
DOI

Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma., Kasahara Norimitsu;Kaira Kyoichi;Bao Pinjie;Higuchi Tetsuya;Arisaka Yukiko;Erkhem-Ochir Bilguun;Sunaga Noriaki;Ohtaki Yoichi;Yajima Toshiki;Kosaka Takayuki;Oyama Tetsunari;Yokobori Takehiko;Asao Takayuki;Nishiyama Masahiko;Tsushima Yoshito;Kuwano Hiroyuki;Shimizu Kimihiro;Mogi Akira, Mar. 2018, Lung cancer (Amsterdam, Netherlands), 119
DOI

Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer., Miura Yosuke;Sunaga Noriaki, Jul. 2018, Cancers, 10, 8
DOI

[The Incidence and Management of Hypersensitivity and Infusion Reactions in an Outpatient Chemotherapy Center]., Sekine Hiromi;Akaiwa Ayumi;Onozawa Yumiko;Kinjo Taeko;Nakamura Hitomi;Nakamura Rie;Nawa Mieko;Yoshida Shizuka;Araki Nobuo;Iizuka Makoto;Shimizu Hiroaki;Sunaga Noriaki;Tsukamoto Norifumi, Gan to kagaku ryoho. Cancer & chemotherapy, 45, 11

Small Cell Lung Cancer with Sarcoidosis in Spontaneous Remission: A Case Report., Sasaki Yumeka;Koga Yasuhiko;Kasahara Norimitsu;Hachisu Yoshimasa;Murata Keisuke;Tsurumaki Hiroaki;Yatomi Masakiyo;Tsukagoshi Yusuke;Sawada Yuri;Sakurai Reiko;Ono Akihiro;Sunaga Noriaki;Kaira Kyoichi;Hirato Junko;Maeno Toshitaka;Dobashi Kunio;Hisada Takeshi, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 85, 5
DOI

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non-small-cell lung cancer., Kaira Kyoichi;Ono Akihiro;Kamide Yosuke;Sunaga Noriaki;Koga Yasuhiko;Saitoh Jun-Ichi;Shirai Katsuyuki;Ebara Takeshi;Hisada Takeshi;Ishizuka Tamotsu, Journal of radiation research, 60, 2
DOI

Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment., Yasuda Masahito;Morimoto Naoko;Yonemoto Yukio;Sunaga Noriaki;Ishikawa Osamu, European journal of dermatology : EJD, 29, 1
DOI

Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1., Kasahara Norimitsu;Sunaga Noriaki;Tsukagoshi Yusuke;Miura Yosuke;Sakurai Reiko;Kitahara Shinsuke;Yokobori Takehiko;Kaira Kyoichi;Mogi Akira;Maeno Toshitaka;Asao Takayuki;Hisada Takeshi, Anticancer research, 39, 3
DOI

Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer., Sunaga Noriaki;Miura Yosuke;Tsukagoshi Yusuke;Kasahara Norimitsu;Masuda Tomomi;Sakurai Reiko;Kaira Kyoichi;Hisada Takeshi, Feb. 2019, Oncology letters, 17, 3
DOI

An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer., Kaira Kyoichi;Imai Hisao;Souma Ryousuke;Sakurai Reiko;Miura Yosuke;Sunaga Noriaki;Kasahara Norimitsu;Tsukagoshi Yusuke;Koga Yasuhiko;Kitahara Shinsuke;Kotake Mie;Minato Koichi;Naruse Ichiro;Fukushima Yasutsugu;Hisada Takeshi;Ishizuka Tamotsu, Anticancer research, 39, 5
DOI

Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin., Sakurai Reiko;Kaira Kyoichi;Miura Yosuke;Sunaga Noriaki;Saito Ryusei;Oyama Tetsunari;Hisada Takeshi;Yamada Masanobu, Jan. 2020, Thoracic cancer, 11, 2
DOI

Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients., Hachisu Yoshimasa;Koga Yasuhiko;Kasama Shu;Kaira Kyoichi;Yatomi Masakiyo;Aoki-Saito Haruka;Tsurumaki Hiroaki;Kamide Yosuke;Sunaga Noriaki;Maeno Toshitaka;Ishizuka Tamotsu;Hisada Takeshi, Dec. 2019, Journal of clinical medicine, 9, 1
DOI

Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study., Kasahara Norimitsu;Sunaga Noriaki;Kuwako Tomohito;Naruse Ichiro;Imai Hisao;Jingu Asuka;Tsukagoshi Yusuke;Masuda Tomomi;Kitahara Shinsuke;Tsurumaki Hiroaki;Yatomi Masakiyo;Hara Kenichiro;Koga Yasuhiko;Sakurai Reiko;Mori Keita;Kaira Kyoichi;Maeno Toshitaka;Asao Takayuki;Hisada Takeshi, Jan. 2020, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 28, 10
DOI

Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC., Imai Hisao;Kaira Kyoichi;Naruse Ichiro;Kasahara Norimitsu;Kamide Yosuke;Ono Akihiro;Masuda Tomomi;Sunaga Noriaki;Minato Koichi;Hisada Takeshi, Anticancer research, 40, 3
DOI

Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment., Kasahara Norimitsu;Imai Hisao;Naruse Ichiro;Tsukagoshi Yusuke;Kotake Mie;Sunaga Noriaki;Kaira Kyoichi;Maeno Toshitaka;Asao Takayuki;Hisada Takeshi, Jun. 2020, Thoracic cancer, 11, 8
DOI

Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations., Masuda Tomomi;Sunaga Noriaki;Kasahara Norimitsu;Takehara Kazutaka;Yatomi Masakiyo;Hara Kenichiro;Koga Yasuhiko;Maeno Toshitaka;Hisada Takeshi, Jun. 2020, Thoracic cancer, 11, 8
DOI

FAM83G Is a Novel Inducer of Apoptosis., Okada Junichi;Sunaga Noriaki;Yamada Eijiro;Saito Tsugumichi;Ozawa Atsushi;Nakajima Yasuyo;Okada Kazuya;Pessin Jeffrey E;Okada Shuichi;Yamada Masanobu, Jun. 2020, Molecules (Basel, Switzerland), 25, 12
DOI

A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia., Wakamatsu Ikuo;Yatomi Masakiyo;Uno Shogo;Oishi Yuko;Ikeuchi Hidekazu;Hanazato Chiharu;Sawada Yuri;Saito Haruka;Yamaguchi Koichi;Kasahara Norimitsu;Miura Yosuke;Tsurumaki Hiroaki;Hara Kenichiro;Koga Yasuhiko;Sunaga Noriaki;Hisada Takeshi;Hiromura Keiju;Maeno Toshitaka, Aug. 2021, Radiology case reports, 16, 11
DOI

Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer., Sunaga Noriaki;Miura Yosuke;Kasahara Norimitsu;Sakurai Reiko, Nov. 2021, Cancers, 13, 23
DOI

Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis., Takehara Kazutaka;Koga Yasuhiko;Hachisu Yoshimasa;Utsugi Mitsuyoshi;Sawada Yuri;Saito Yasuyuki;Yoshimi Seishi;Yatomi Masakiyo;Shin Yuki;Wakamatsu Ikuo;Umetsu Kazue;Kouno Shunichi;Nakagawa Junichi;Sunaga Noriaki;Maeno Toshitaka;Hisada Takeshi, Jan. 2022, Cells, 11, 1
DOI

Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies., Yamaguchi Koichi;Fukushima Yasuhiro;Yamaguchi Aya;Itai Miki;Shin Yuki;Uno Shogo;Muto Sohei;Kouno Shunichi;Tsurumaki Hiroaki;Yatomi Masakiyo;Aoki-Saito Haruka;Hara Kenichiro;Koga Yasuhiko;Sunaga Noriaki;Endo Yukie;Motegi Sei-Ichiro;Nakasatomi Masao;Sakairi Toru;Ikeuchi Hidekazu;Hiromura Keiju;Hisada Takeshi;Tsushima Yoshito;Kuwana Masataka;Maeno Toshitaka, Jan. 2022, Respiratory medicine, 193
DOI

Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer., Miura Yosuke;Kasahara Norimitsu;Sunaga Noriaki, Translational cancer research, 8, Suppl 6
DOI

Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis., Sunaga Noriaki;Koga Yasuhiko;Hachisu Yoshimasa;Yamaguchi Koichi;Aikawa Masaki;Kasahara Norimitsu;Miura Yosuke;Tsurumaki Hiroaki;Yatomi Masakiyo;Sakurai Reiko;Maeno Toshitaka;Hisada Takeshi, May 2022, Canadian respiratory journal, 2022
DOI

The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis., Hachisu Yoshimasa;Koga Yasuhiko;Kasama Shu;Kaira Kyoichi;Uno Shogo;Yatomi Masakiyo;Aoki-Saito Haruka;Tsurumaki Hiroaki;Jingu Asuka;Sunaga Noriaki;Maeno Toshitaka;Hisada Takeshi, Jun. 2022, Medicina (Kaunas, Lithuania), 58, 6
DOI

Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease., Ito Masashi;Koga Yasuhiko;Hachisu Yoshimasa;Murata Keisuke;Sunaga Noriaki;Maeno Toshitaka;Hisada Takeshi, Jun. 2022, Respiratory investigation, 60, 5
DOI

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation., Sato Mari;Yatomi Masakiyo;Wakamatsu Ikuo;Uno Shogo;Hanazato Chiharu;Masuda Tomomi;Yamaguchi Koichi;Aoki-Saito Haruka;Kasahara Norimitsu;Miura Yosuke;Tsurumaki Hiroaki;Hara Kenichiro;Koga Yasuhiko;Sunaga Noriaki;Okada Takuhisa;Ikota Hayato;Hisada Takeshi;Maeno Toshitaka, Feb. 2023, Respiratory medicine case reports, 43
DOI

長期にインフリキシマブを投与中に,非典型的な局所麻酔下胸腔鏡所見を示した結核性胸膜炎の一例, ;;;;;;;;, Jun. 2020, 42, Suppl., S333

サルベージ手術の適応と実際　原発性肺癌に対するTKI治療後の局所残存・再発病変に対する外科的切除の検討　非切除症例との比較, ;;;;;;;;;;, Oct. 2021, 61, 6, 505

ニボルマブ治療後の7次治療としてのnab-パクリタキセル単剤療法が長期奏効した再発肺大細胞癌の1例, ;;;;;;;;;;;, Oct. 2021, 61, 6, 699

ニボルマブ・イピリムマブ併用療法後にGrade4の皮膚障害が認められた1例, ;;;;;;;;;, Feb. 2022, 71, 1, 65

進行胸腺癌全摘術後多発転移に対してレンバチニブを使用した一例, ;;;;;;;;;;;;, Sep. 2021, 180回・246回, 25

抗IL-6Rα抗体治療中に短期間で増悪した肺非結核性抗酸菌症に対して4剤併用初期強化療法が奏功した一例, ;;;;;;;;;, Feb. 2022, 181回・248回, 12

肺移植待機中の緑膿菌感染症に対しトブラマイシン吸入が奏功した一例, ;;;;;;;;;;;;;, Feb. 2022, 181回・248回, 13

間質性肺疾患でオシメルチニブ中止後にゲフィチニブを安全に投与できたEGFR変異陽性進行肺腺癌の一例, ;;;;;;;;;;;;;;, Feb. 2022, 181回・248回, 29

ICI・TKI・SBRT時代の肺癌の集学的治療と外科手術　原発性肺癌に対するTKI治療症例のサルベージ手術症例と非切除症例との比較, ;;;;;;;;;;;, Apr. 2022, 122回, SY

シングルユースの軟性気管支鏡の有用性の検討, ;;;;;;;;;;;;;;, May 2022, 44, Suppl., S252

気管支結核の治療完遂後、経年的に気管支狭窄が進行し、難治性閉塞性肺炎を来した1例, ;;;;;;;;;;;;, May 2022, 44, Suppl., S266

80歳以上の高齢者の特発性肺線維症に対する抗線維化薬使用状況の解析, ;;;;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 167

Resolvin E3の細胞内シグナル伝達経路に及ぼす影響の解析, ;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 181

油性塗料の吸入が原因と考えられたリポイド肺炎の1例, ;;;;;;;;;;;;;;, Jun. 2022, 29, 1, 60

成人喘息患者における喘息症状及び鼻・副鼻腔炎症状を評価するGスケール問診票とAsthma Quality of Life Questionnaireの相関に関しての検討, ;;;;;;;;;;;;, Jun. 2022, 29, 1, 61

抗IL-4Rα抗体治療によるアレルゲン特異的IgE陽性数の変化に関する検討, ;;;;;;;, Jun. 2022, 29, 1, 65

過敏性肺炎パターンを呈した、低温加熱式タバコにより短期間に肺障害が進行した1例, ;;;;;;;;;;;, Jun. 2022, 29, 2, 43

集学的治療により救命した妊娠35週の呼吸不全を呈した粟粒結核の1例, ;;;;;;;;;, Mar. 2023, 12, 増刊, 226

再発胸腺癌に対するレンバチニブ治療の有効性および安全性に関する後方視的検討, ;;;;;;;;;;, Mar. 2023, 12, 増刊, 256

重症気管支喘息の喀痰症状におけるDupilumabの有効性, ;;;;;;;;;;;, Mar. 2023, 12, 増刊, 263

ニボルマブ/イピリムマブによるミオパチー,肝障害にミコフェノール酸モフェチルが奏功した肺腺癌の一例, ;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 279

トリプル吸入製剤におけるリアルワールドデータの解析について, ;;;;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 287

Resolvin E3(RvE3)誘導体の抗炎症性効果の解析, ;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 312

生物学的製剤導入,臨床的寛解　生物学的製剤の自己注射手技指導前後における患者の認識の変化, ;;;;;;;;;;;;;, Aug. 2023, 72, 6-7, 904

炎症収束性脂質メディエーターResolvin E3(RvE3)誘導体の抗炎症性効果, ;;;;;;;;;;;;;, Aug. 2023, 72, 6-7, 949

Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence, Ohtaki Y, Nagashima T, Okano N, Kubo N, Ohtaka T, Sunaga N, Sakurai R, Miura Y, Nakazawa S, Kawatani N, Yazawa T, Yoshikawa R, Narusawa E, Shirabe K, 27 Feb. 2024, Thorac Cancer, Scientific journal
DOI

Glasgow prognostic score and body mass index predict short-term discontinuation of the antifibrotic agents pirfenidone and nintedanib, Takehara K, Koga Y, Hachisu Y, Utsugi M, Sawada Y, Saito Y, Yoshimi S, Yatomi M, Tsurumaki H, Shin Y, Wakamatsu I, Kasahara N, Yamaguchi K, Umetsu K, Kouno S, Nakagawa J, Sunaga N, Maeno T, Hisada T, Mar. 2024, Respir Investig, 62, 3, 388, 394, Scientific journal

A case of primary lung adenocarcinoma with recurrent brain metastasis due to transformation to small cell carcinoma during adjuvant atezolizumab therapy, Kobayashi N, Sunaga N, Yatomi M, Wakamatsu I, Muto S, Ikota H, Yamaguchi R, Ohtaki Y, Nagashima T, Kubo N, Masuda T, Miura Y, Tsurumaki H, Sakurai R, Koga Y, Hisada T, Maeno T., 27 Dec. 2024, Thorac Cancer, Scientific journal
DOI

MISC

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Shigebumi Tanaka,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, Dec. 2008, CANCER SCIENCE, 99, 12, 2380, 2386
DOI

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Shigebumi Tanaka,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, Dec. 2008, CANCER SCIENCE, 99, 12, 2380, 2386
DOI

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer, Noriaki Sunaga,Noboru Oriuchi,Kyoichi Kaira,Noriko Yanagitani,Yoshio Tomizawa,Takeshi Hisada,Tamotsu Ishizuka,Keigo Endo,Masatomo Mori, Feb. 2008, LUNG CANCER, 59, 2, 203, 210
DOI

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer, Noriaki Sunaga,Noboru Oriuchi,Kyoichi Kaira,Noriko Yanagitani,Yoshio Tomizawa,Takeshi Hisada,Tamotsu Ishizuka,Keigo Endo,Masatomo Mori, Feb. 2008, LUNG CANCER, 59, 2, 203, 210
DOI

Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Osamu Kawashima,Hironobu Iijima,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, 2008, PATHOLOGY RESEARCH AND PRACTICE, 204, 8, 553, 561
DOI

Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Osamu Kawashima,Hironobu Iijima,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, 2008, PATHOLOGY RESEARCH AND PRACTICE, 204, 8, 553, 561
DOI

Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma, Kyoichi Kaira,Yutaka Sunose,Kazuhisa Arakawa,Noriaki Sunaga,Kimihiro Shimizu,Hideyuki Tominaga,Noboru Oriuchi,Shushi Nagamori,Yoshikatsu Kanai,Tetsunari Oyama,Izumi Takeyoshi, Jan. 2015, HISTOPATHOLOGY, 66, 2, 234, 243
DOI

Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma, Kyoichi Kaira,Yutaka Sunose,Kazuhisa Arakawa,Noriaki Sunaga,Kimihiro Shimizu,Hideyuki Tominaga,Noboru Oriuchi,Shushi Nagamori,Yoshikatsu Kanai,Tetsunari Oyama,Izumi Takeyoshi, Jan. 2015, HISTOPATHOLOGY, 66, 2, 234, 243
DOI

First-line gefitinib treatment in elderly patients (aged >= 75 years) with non-small cell lung cancer harboring EGFR mutations, Tomohito Kuwako,Hisao Imai,Tomomi Masuda,Yosuke Miura,Kaori Seki,Reiko Yoshino,Kyoichi Kaira,Mitsuyoshi Utsugi,Kimihiro Shimizu,Noriaki Sunaga,Yoshio Tomizawa,Shinichi Ishihara,Takao Ishizuka,Akira Mogi,Takeshi Hisada,Koichi Minato,Atsushi Takise,Ryusei Saito,Masanobu Yamada, Oct. 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 761, 769
DOI

First-line gefitinib treatment in elderly patients (aged >= 75 years) with non-small cell lung cancer harboring EGFR mutations, Tomohito Kuwako,Hisao Imai,Tomomi Masuda,Yosuke Miura,Kaori Seki,Reiko Yoshino,Kyoichi Kaira,Mitsuyoshi Utsugi,Kimihiro Shimizu,Noriaki Sunaga,Yoshio Tomizawa,Shinichi Ishihara,Takao Ishizuka,Akira Mogi,Takeshi Hisada,Koichi Minato,Atsushi Takise,Ryusei Saito,Masanobu Yamada, Oct. 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 761, 769
DOI

Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations, T. Masuda,H. Imai,T. Kuwako,Y. Miura,R. Yoshino,K. Kaira,K. Shimizu,N. Sunaga,Y. Tomizawa,S. Ishihara,A. Mogi,T. Hisada,K. Minato,A. Takise,R. Saito,M. Yamada, Sep. 2015, CLINICAL & TRANSLATIONAL ONCOLOGY, 17, 9, 702, 709
DOI

Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations, T. Masuda,H. Imai,T. Kuwako,Y. Miura,R. Yoshino,K. Kaira,K. Shimizu,N. Sunaga,Y. Tomizawa,S. Ishihara,A. Mogi,T. Hisada,K. Minato,A. Takise,R. Saito,M. Yamada, Sep. 2015, CLINICAL & TRANSLATIONAL ONCOLOGY, 17, 9, 702, 709
DOI

Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma, Yosuke Kamide,Kyoichi Kaira,Takuya Watanabe,Shiko Kuribayashi,Atsushi Ozawa,Yasuhiko Koga,Akihiro Ono,Noriaki Sunaga,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, 2015, INTERNAL MEDICINE, 54, 22, 2905, 2909
DOI

Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma, Yosuke Kamide,Kyoichi Kaira,Takuya Watanabe,Shiko Kuribayashi,Atsushi Ozawa,Yasuhiko Koga,Akihiro Ono,Noriaki Sunaga,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, 2015, INTERNAL MEDICINE, 54, 22, 2905, 2909
DOI

Evaluation of thoracic tumors with F-18-FMT and F-18-FDG PET-CT: A clinicopathological study, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Tomohiro Ishikita,Tetsuya Higuchi,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, Mar. 2009, INTERNATIONAL JOURNAL OF CANCER, 124, 5, 1152, 1160
DOI

Evaluation of thoracic tumors with F-18-FMT and F-18-FDG PET-CT: A clinicopathological study, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Tomohiro Ishikita,Tetsuya Higuchi,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, Mar. 2009, INTERNATIONAL JOURNAL OF CANCER, 124, 5, 1152, 1160
DOI

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study, Yasuo Shimizu,Noriaki Sunaga,Kunio Dobashi,Makoto Fueki,Naoto Fueki,Sohei Makino,Masatomo Mori, Apr. 2009, BMC INFECTIOUS DISEASES, 9
DOI

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study, Yasuo Shimizu,Noriaki Sunaga,Kunio Dobashi,Makoto Fueki,Naoto Fueki,Sohei Makino,Masatomo Mori, Apr. 2009, BMC INFECTIOUS DISEASES, 9
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, Feb. 2009, CANCER SCIENCE, 100, 2, 249, 254
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, Feb. 2009, CANCER SCIENCE, 100, 2, 249, 254
DOI

Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations, Satoshi Morita,Isamu Okamoto,Kunihiko Kobayashi,Koichi Yamazaki,Hajime Asahina,Akira Inoue,Koichi Hagiwara,Noriaki Sunaga,Noriko Yanagitani,Toyoaki Hida,Kimihide Yoshida,Tomonori Hirashima,Kosei Yasumoto,Kenji Sugio,Tetsuya Mitsudomi,Masahiro Fukuoka,Toshihiro Nukiwa, Jul. 2009, CLINICAL CANCER RESEARCH, 15, 13, 4493, 4498
DOI

Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations, Satoshi Morita,Isamu Okamoto,Kunihiko Kobayashi,Koichi Yamazaki,Hajime Asahina,Akira Inoue,Koichi Hagiwara,Noriaki Sunaga,Noriko Yanagitani,Toyoaki Hida,Kimihide Yoshida,Tomonori Hirashima,Kosei Yasumoto,Kenji Sugio,Tetsuya Mitsudomi,Masahiro Fukuoka,Toshihiro Nukiwa, Jul. 2009, CLINICAL CANCER RESEARCH, 15, 13, 4493, 4498
DOI

L-Type Amino Acid Transporter 1 (LAT1) Is Frequently Expressed in Thymic Carcinomas but Is Absent in Thymomas, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, Jun. 2009, JOURNAL OF SURGICAL ONCOLOGY, 99, 7, 433, 438
DOI

L-Type Amino Acid Transporter 1 (LAT1) Is Frequently Expressed in Thymic Carcinomas but Is Absent in Thymomas, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, Jun. 2009, JOURNAL OF SURGICAL ONCOLOGY, 99, 7, 433, 438
DOI

Clinicopathological Features of Patients with Bronchial-Associated Lymphoid Tissue Lymphoma, Hisao Imai,Noriaki Sunaga,Kyoichi Kaira,Osamu Kawashima,Noriko Yanagitani,Koji Sato,Yoshio Tomizawa,Takeshi Hisada,Tamotsu Ishizuka,Junko Hirato,Ryusei Saito,Takashi Nakajima,Masatomo Mori, 2009, INTERNAL MEDICINE, 48, 5, 301, 306
DOI

Clinicopathological Features of Patients with Bronchial-Associated Lymphoid Tissue Lymphoma, Hisao Imai,Noriaki Sunaga,Kyoichi Kaira,Osamu Kawashima,Noriko Yanagitani,Koji Sato,Yoshio Tomizawa,Takeshi Hisada,Tamotsu Ishizuka,Junko Hirato,Ryusei Saito,Takashi Nakajima,Masatomo Mori, 2009, INTERNAL MEDICINE, 48, 5, 301, 306
DOI

CD98 Expression Is Associated with Poor Prognosis in Resected Non-Small-Cell Lung Cancer with Lymph Node Metastases, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Osamu Kawashima,Yosuke Kamide,Tamotsu Ishizuka,Yoshikatsu Kanai,Takashi Nakajima,Masatomo Mori, Dec. 2009, ANNALS OF SURGICAL ONCOLOGY, 16, 12, 3473, 3481
DOI

CD98 Expression Is Associated with Poor Prognosis in Resected Non-Small-Cell Lung Cancer with Lymph Node Metastases, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Osamu Kawashima,Yosuke Kamide,Tamotsu Ishizuka,Yoshikatsu Kanai,Takashi Nakajima,Masatomo Mori, Dec. 2009, ANNALS OF SURGICAL ONCOLOGY, 16, 12, 3473, 3481
DOI

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer, Hisao Imai,Kyoichi Kaira,Noboru Oriuchi,Noriko Yanagitani,Noriaki Sunaga,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, Jun. 2009, HISTOPATHOLOGY, 54, 7, 804, 813
DOI

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer, Hisao Imai,Kyoichi Kaira,Noboru Oriuchi,Noriko Yanagitani,Noriaki Sunaga,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Masatomo Mori, Jun. 2009, HISTOPATHOLOGY, 54, 7, 804, 813
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Takashi Nakajima,Masatomo Mori, Oct. 2009, LUNG CANCER, 66, 1, 120, 126
DOI

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma, Kyoichi Kaira,Noboru Oriuchi,Hisao Imai,Kimihiro Shimizu,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Takashi Nakajima,Masatomo Mori, Oct. 2009, LUNG CANCER, 66, 1, 120, 126
DOI

Correlation of angiogenesis with F-18-FMT and F-18-FDG uptake in non-small cell lung cancer, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Tomohiro Ishikita,Tetsuya Higuchi,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, Apr. 2009, CANCER SCIENCE, 100, 4, 753, 758
DOI

Correlation of angiogenesis with F-18-FMT and F-18-FDG uptake in non-small cell lung cancer, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Tomohiro Ishikita,Tetsuya Higuchi,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, Apr. 2009, CANCER SCIENCE, 100, 4, 753, 758
DOI

F-18-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non-Small Cell Lung Cancer, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Hideyuki Tominaga,Noriko Yanagitani,Noriaki Sunaga,Tamotsu Ishizuka,Yoshikatsu Kanai,Masatomo Mori,Keigo Endo, Nov. 2009, JOURNAL OF NUCLEAR MEDICINE, 50, 11, 1770, 1776
DOI

F-18-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non-Small Cell Lung Cancer, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Hideyuki Tominaga,Noriko Yanagitani,Noriaki Sunaga,Tamotsu Ishizuka,Yoshikatsu Kanai,Masatomo Mori,Keigo Endo, Nov. 2009, JOURNAL OF NUCLEAR MEDICINE, 50, 11, 1770, 1776
DOI

Pulmonary traumatic pneumatocele and hematoma, Kyoichi Kaira,Tamotsu Ishizuka,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Masatomo Mori, Feb. 2009, JAPANESE JOURNAL OF RADIOLOGY, 27, 2, 100, 102
DOI

Pulmonary traumatic pneumatocele and hematoma, Kyoichi Kaira,Tamotsu Ishizuka,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Masatomo Mori, Feb. 2009, JAPANESE JOURNAL OF RADIOLOGY, 27, 2, 100, 102
DOI

PHASE I STUDY OF ORAL S-1 PLUS CISPLATIN WITH CONCURRENT RADIOTHERAPY FOR LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER, Kyoichi Kaira,Noriaki Sunaga,Noriko Yanagitani,Tadayoshi Kawata,Mitsuyoshi Utsugi,Kimihiro Shimizu,Takeshi Ebara,Hidemasa Kawamura,Tetsuo Nonaka,Hitoshi Ishikawa,Hideyuki Sakurai,Tatsuo Suga,Kenichiro Hara,Takeshi Hisada,Tamotsu Ishizuka,Takashi Nakano,Masatomo Mori, Sep. 2009, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75, 1, 109, 114
DOI

PHASE I STUDY OF ORAL S-1 PLUS CISPLATIN WITH CONCURRENT RADIOTHERAPY FOR LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER, Kyoichi Kaira,Noriaki Sunaga,Noriko Yanagitani,Tadayoshi Kawata,Mitsuyoshi Utsugi,Kimihiro Shimizu,Takeshi Ebara,Hidemasa Kawamura,Tetsuo Nonaka,Hitoshi Ishikawa,Hideyuki Sakurai,Tatsuo Suga,Kenichiro Hara,Takeshi Hisada,Tamotsu Ishizuka,Takashi Nakano,Masatomo Mori, Sep. 2009, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75, 1, 109, 114
DOI

Perfusion Evaluation of Lung Cancer: Assessment Using Dual-input Perfusion Computed Tomography, Sachiko Nakano,Junko Gibo,Yasuhiro Fukushima,Kyoichi Kaira,Noriaki Sunaga,Ayako Taketomi-Takahashi,Yoshito Tsushima,Masatomo Mori, Jul. 2013, JOURNAL OF THORACIC IMAGING, 28, 4, 253, 262
DOI

Perfusion Evaluation of Lung Cancer: Assessment Using Dual-input Perfusion Computed Tomography, Sachiko Nakano,Junko Gibo,Yasuhiro Fukushima,Kyoichi Kaira,Noriaki Sunaga,Ayako Taketomi-Takahashi,Yoshito Tsushima,Masatomo Mori, Jul. 2013, JOURNAL OF THORACIC IMAGING, 28, 4, 253, 262
DOI

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer, Kyoichi Kaira,Yutaka Sunose,Yasuhiro Ohshima,Noriko S. Ishioka,Kazuhisa Arakawa,Tetsushi Ogawa,Noriaki Sunaga,Kimihiro Shimizu,Hideyuki Tominaga,Noboru Oriuchi,Hideaki Itoh,Shushi Nagamori,Yoshikatsu Kanai,Aiko Yamaguchi,Atsuki Segawa,Munenori Ide,Masatomo Mori,Tetsunari Oyama,Izumi Takeyoshi, Oct. 2013, BMC CANCER, 13, 482
DOI

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer, Kyoichi Kaira,Yutaka Sunose,Yasuhiro Ohshima,Noriko S. Ishioka,Kazuhisa Arakawa,Tetsushi Ogawa,Noriaki Sunaga,Kimihiro Shimizu,Hideyuki Tominaga,Noboru Oriuchi,Hideaki Itoh,Shushi Nagamori,Yoshikatsu Kanai,Aiko Yamaguchi,Atsuki Segawa,Munenori Ide,Masatomo Mori,Tetsunari Oyama,Izumi Takeyoshi, Oct. 2013, BMC CANCER, 13, 482
DOI

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Reiko Yoshino,Yosuke Miura,Akihiro Yoshii,Yasuki Iwasaki,Yasuhiko Koga,Akihiro Ono,Takeshi Hisada,Koichi Minato,Koji Sato,Toshifumi Kazama,Shinichi Ishihara,Kenya Kohyama,Naoto Fueki,Ryusei Saito,Noriaki Sunaga, Oct. 2013, LUNG CANCER, 82, 1, 103, 108
DOI

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Reiko Yoshino,Yosuke Miura,Akihiro Yoshii,Yasuki Iwasaki,Yasuhiko Koga,Akihiro Ono,Takeshi Hisada,Koichi Minato,Koji Sato,Toshifumi Kazama,Shinichi Ishihara,Kenya Kohyama,Naoto Fueki,Ryusei Saito,Noriaki Sunaga, Oct. 2013, LUNG CANCER, 82, 1, 103, 108
DOI

Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Reiko Yoshino,Akihiro Yoshii,Masana Matsuura,Yasuki Iwasaki,Yasuhiko Koga,Akihiro Ono,Masaki Nishioka,Yosuke Kamide,Takeshi Hisada,Tamotsu Ishizuka,Katsuyuki Shirai,Takeshi Ebara,Jun-ichi Saitoh,Takashi Nakano,Noriaki Sunaga, Dec. 2013, LUNG CANCER, 82, 3, 449, 454
DOI

Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Reiko Yoshino,Akihiro Yoshii,Masana Matsuura,Yasuki Iwasaki,Yasuhiko Koga,Akihiro Ono,Masaki Nishioka,Yosuke Kamide,Takeshi Hisada,Tamotsu Ishizuka,Katsuyuki Shirai,Takeshi Ebara,Jun-ichi Saitoh,Takashi Nakano,Noriaki Sunaga, Dec. 2013, LUNG CANCER, 82, 3, 449, 454
DOI

Comparison of L-type amino acid transporter 1 expression and L-[3-F-18]-alpha-methyl tyrosine uptake in outcome of non-small cell lung cancer, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Hisao Imai,Hideyuki Tominaga,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Tetsunari Oyama,Masatomo Mori,Keigo Endo, Nov. 2010, NUCLEAR MEDICINE AND BIOLOGY, 37, 8, 911, 916
DOI

Comparison of L-type amino acid transporter 1 expression and L-[3-F-18]-alpha-methyl tyrosine uptake in outcome of non-small cell lung cancer, Kyoichi Kaira,Noboru Oriuchi,Kimihiro Shimizu,Hisao Imai,Hideyuki Tominaga,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Yoshikatsu Kanai,Tetsunari Oyama,Masatomo Mori,Keigo Endo, Nov. 2010, NUCLEAR MEDICINE AND BIOLOGY, 37, 8, 911, 916
DOI

Epigenetic Inactivation of the Thyroid Hormone Receptor beta 1 Gene at 3p24.2 in Lung Cancer, Yasuki Iwasaki,Noriaki Sunaga,Yoshio Tomizawa,Hisao Imai,Hironobu Iijima,Noriko Yanagitani,Kazuhiko Horiguchi,Masanobu Yamada,Masatomo Mori, Aug. 2010, ANNALS OF SURGICAL ONCOLOGY, 17, 8, 2222, 2228
DOI

Epigenetic Inactivation of the Thyroid Hormone Receptor beta 1 Gene at 3p24.2 in Lung Cancer, Yasuki Iwasaki,Noriaki Sunaga,Yoshio Tomizawa,Hisao Imai,Hironobu Iijima,Noriko Yanagitani,Kazuhiko Horiguchi,Masanobu Yamada,Masatomo Mori, Aug. 2010, ANNALS OF SURGICAL ONCOLOGY, 17, 8, 2222, 2228
DOI

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer, Kyoichi Kaira,Noriaki Sunaga,Yoshio Tomizawa,Noriko Yanagitani,Kimihiro Shimizu,Hisao Imai,Mitsuyoshi Utsugi,Yasuki Iwasaki,Hironobu Iijima,Hiroaki Tsurumaki,Akihiro Yoshii,Naoto Fueki,Takeshi Hisada,Tamotsu Ishizuka,Ryusei Saito,Masatomo Mori, Jul. 2010, LUNG CANCER, 69, 1, 99, 104
DOI

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer, Kyoichi Kaira,Noriaki Sunaga,Yoshio Tomizawa,Noriko Yanagitani,Kimihiro Shimizu,Hisao Imai,Mitsuyoshi Utsugi,Yasuki Iwasaki,Hironobu Iijima,Hiroaki Tsurumaki,Akihiro Yoshii,Naoto Fueki,Takeshi Hisada,Tamotsu Ishizuka,Ryusei Saito,Masatomo Mori, Jul. 2010, LUNG CANCER, 69, 1, 99, 104
DOI

Protective effect of resolvin E1 on the development of asthmatic airway inflammation, Haruka Aoki,Takeshi Hisada,Tamotsu Ishizuka,Mitsuyoshi Utsugi,Akihiro Ono,Yasuhiko Koga,Noriaki Sunaga,Takashi Nakakura,Fumikazu Okajima,Kunio Dobashi,Masatomo Mori, Sep. 2010, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 400, 1, 128, 133
DOI

Protective effect of resolvin E1 on the development of asthmatic airway inflammation, Haruka Aoki,Takeshi Hisada,Tamotsu Ishizuka,Mitsuyoshi Utsugi,Akihiro Ono,Yasuhiko Koga,Noriaki Sunaga,Takashi Nakakura,Fumikazu Okajima,Kunio Dobashi,Masatomo Mori, Sep. 2010, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 400, 1, 128, 133
DOI

Assessment of Therapy Response in Lung Cancer With F-18-alpha-Methyl Tyrosine PET, Kyoichi Kaira,Noboru Oriuchi,Noriko Yanagitani,Noriaki Sunaga,Tamotsu Ishizuka,Masatomo Mori,Keigo Endo, Nov. 2010, AMERICAN JOURNAL OF ROENTGENOLOGY, 195, 5, 1204, 1211
DOI

Assessment of Therapy Response in Lung Cancer With F-18-alpha-Methyl Tyrosine PET, Kyoichi Kaira,Noboru Oriuchi,Noriko Yanagitani,Noriaki Sunaga,Tamotsu Ishizuka,Masatomo Mori,Keigo Endo, Nov. 2010, AMERICAN JOURNAL OF ROENTGENOLOGY, 195, 5, 1204, 1211
DOI

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer, Kyoichi Kaira,Noriaki Sunaga,Noriko Yanagitani,Hisao Imai,Mitsuyoshi Utsugi,Yasuki Iwasaki,Kimihiro Shimizu,Hironobu Iijima,Hiroaki Tsurumaki,Yoshio Tornizawa,Takeshi Hisada,Tamotsu Ishizuka,Ryusei Saito,Masatomo Mori, May 2010, LUNG CANCER, 68, 2, 253, 257
DOI

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer, Kyoichi Kaira,Noriaki Sunaga,Noriko Yanagitani,Hisao Imai,Mitsuyoshi Utsugi,Yasuki Iwasaki,Kimihiro Shimizu,Hironobu Iijima,Hiroaki Tsurumaki,Yoshio Tornizawa,Takeshi Hisada,Tamotsu Ishizuka,Ryusei Saito,Masatomo Mori, May 2010, LUNG CANCER, 68, 2, 253, 257
DOI

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells, M Sato,MB Vaughan,L Girard,M Peyton,WC Lee,DS Shames,RD Ramirez,N Sunaga,AF Gazdar,JW Shay,JD Minna, Feb. 2006, CANCER RESEARCH, 66, 4, 2116, 2128
DOI

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells, M Sato,MB Vaughan,L Girard,M Peyton,WC Lee,DS Shames,RD Ramirez,N Sunaga,AF Gazdar,JW Shay,JD Minna, Feb. 2006, CANCER RESEARCH, 66, 4, 2116, 2128
DOI

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers, H Iijima,Y Tomizawa,Y Iwasaki,K Sato,N Sunaga,K Dobashi,R Saito,T Nakajima,JD Minna,M Mori, Feb. 2006, INTERNATIONAL JOURNAL OF CANCER, 118, 4, 797, 801
DOI

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers, H Iijima,Y Tomizawa,Y Iwasaki,K Sato,N Sunaga,K Dobashi,R Saito,T Nakajima,JD Minna,M Mori, Feb. 2006, INTERNATIONAL JOURNAL OF CANCER, 118, 4, 797, 801
DOI

Small cell carcinoma of the larynx in a long-term survivor of small-cell lung cancer, K Kaira,T Ishizuka,N Sohara,N Yanagitani,N Sunaga,T Tsuchiya,M Mori, Jun. 2006, JOURNAL OF CLINICAL ONCOLOGY, 24, 18, 2961, 2963
DOI

Small cell carcinoma of the larynx in a long-term survivor of small-cell lung cancer, K Kaira,T Ishizuka,N Sohara,N Yanagitani,N Sunaga,T Tsuchiya,M Mori, Jun. 2006, JOURNAL OF CLINICAL ONCOLOGY, 24, 18, 2961, 2963
DOI

Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with F-18-fluorodeoxyglucose in sarcoidosis patients, Kyoichi Kaira,Noboni Orinchi,Yoshimi Otani,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Keigo Endo,Masatomo Mori, Apr. 2007, CHEST, 131, 4, 1019, 1027
DOI

Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with F-18-fluorodeoxyglucose in sarcoidosis patients, Kyoichi Kaira,Noboni Orinchi,Yoshimi Otani,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Keigo Endo,Masatomo Mori, Apr. 2007, CHEST, 131, 4, 1019, 1027
DOI

Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers, Makoto Suzuki,Hisayuki Shigematsu,David S. Shames,Noriaki Sunaga,Takao Takahashi,Narayan Shivapurkar,Toshihiko Iizasa,John D. Minna,Takehiko Fujisawa,Adi F. Gazdar, Apr. 2007, ANNALS OF SURGICAL ONCOLOGY, 14, 4, 1397, 1404
DOI

Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers, Makoto Suzuki,Hisayuki Shigematsu,David S. Shames,Noriaki Sunaga,Takao Takahashi,Narayan Shivapurkar,Toshihiko Iizasa,John D. Minna,Takehiko Fujisawa,Adi F. Gazdar, Apr. 2007, ANNALS OF SURGICAL ONCOLOGY, 14, 4, 1397, 1404
DOI

A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer, Kyoichi Kaira,Satoshi Tsuchiya,Noriaki Sunaga,Satoru Watanabe,Hisao Imai,Takeshi Hisada,Tamotsu Ishizuka,Ryusei Saito,Masatomo Mori, Feb. 2007, AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 30, 1, 51, 56
DOI

A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer, Kyoichi Kaira,Satoshi Tsuchiya,Noriaki Sunaga,Satoru Watanabe,Hisao Imai,Takeshi Hisada,Tamotsu Ishizuka,Ryusei Saito,Masatomo Mori, Feb. 2007, AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 30, 1, 51, 56
DOI

Pseudomesotheliomatous adenocarcinoma of the lung with synchronous gastric and esophageal cancer, K. Kaira,N. Sunaga,N. Yanagitani,T. Hisada,T. Ishizuka,M. Mori, Dec. 2007, AUSTRALASIAN RADIOLOGY, 51, B265, B267
DOI

Pseudomesotheliomatous adenocarcinoma of the lung with synchronous gastric and esophageal cancer, K. Kaira,N. Sunaga,N. Yanagitani,T. Hisada,T. Ishizuka,M. Mori, Dec. 2007, AUSTRALASIAN RADIOLOGY, 51, B265, B267
DOI

Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: A clinicopathologic study, Kyoichi Kaira,Noboru Oriuchi,Yoshimi Otani,Kimihiro Shimizu,Shigebumi Tanaka,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Kunio Dobashi,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, Nov. 2007, CLINICAL CANCER RESEARCH, 13, 21, 6369, 6378
DOI

Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: A clinicopathologic study, Kyoichi Kaira,Noboru Oriuchi,Yoshimi Otani,Kimihiro Shimizu,Shigebumi Tanaka,Hisao Imai,Noriko Yanagitani,Noriaki Sunaga,Takeshi Hisada,Tamotsu Ishizuka,Kunio Dobashi,Yoshikatsu Kanai,Hitoshi Endou,Takashi Nakajima,Keigo Endo,Masatomo Mori, Nov. 2007, CLINICAL CANCER RESEARCH, 13, 21, 6369, 6378
DOI

Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells, Jayanthi S. Lea,Noriaki Sunaga,Mitsuo Sato,Geetha Kalahasti,David S. Miller,John D. Minna,Carolyn Y. Muller, Jan. 2007, REPRODUCTIVE SCIENCES, 14, 1, 20, 28
DOI

Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells, Jayanthi S. Lea,Noriaki Sunaga,Mitsuo Sato,Geetha Kalahasti,David S. Miller,John D. Minna,Carolyn Y. Muller, Jan. 2007, REPRODUCTIVE SCIENCES, 14, 1, 20, 28
DOI

Expectoration of bronchogenic tumour tissue, K. Kaira,Y. Shimizu,N. Sunaga,T. Hisada,T. Ishizuka,M. Mori, May 2007, INTERNAL MEDICINE JOURNAL, 37, 5, 340A, 342, Others
DOI

Expectoration of bronchogenic tumour tissue, K. Kaira,Y. Shimizu,N. Sunaga,T. Hisada,T. Ishizuka,M. Mori, May 2007, INTERNAL MEDICINE JOURNAL, 37, 5, 340A, 342, Others
DOI

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy, Noriaki Sunaga,Yoshio Tomizawa,Noriko Yanagitani,Hironobu Iijima,Kyoichi Kaira,Kimihiro Shimizu,Shigebumi Tanaka,Tatsuo Suga,Takeshi Hisada,Tamotsu Ishizuka,Ryusei Saito,Kunio Dobashi,Masatomo Mori, Jun. 2007, LUNG CANCER, 56, 3, 383, 389
DOI

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy, Noriaki Sunaga,Yoshio Tomizawa,Noriko Yanagitani,Hironobu Iijima,Kyoichi Kaira,Kimihiro Shimizu,Shigebumi Tanaka,Tatsuo Suga,Takeshi Hisada,Tamotsu Ishizuka,Ryusei Saito,Kunio Dobashi,Masatomo Mori, Jun. 2007, LUNG CANCER, 56, 3, 383, 389
DOI

Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer?, Noriko Yanagitani,Kyoichi Kaira,Noriaki Sunaga,Yoichi Naito,Yoko Koike,Shinichi Ishihara,Tamotsu Ishizuka,Ryusei Saito,Masatomo Mori, Jun. 2007, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 12, 3, 231, 233
DOI

Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer?, Noriko Yanagitani,Kyoichi Kaira,Noriaki Sunaga,Yoichi Naito,Yoko Koike,Shinichi Ishihara,Tamotsu Ishizuka,Ryusei Saito,Masatomo Mori, Jun. 2007, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 12, 3, 231, 233
DOI

Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer, Noriko Yanagitani,Satoshi Tsuchiya,Kyoichi Kaira,Noriaki Sunaga,Yukiko Tsuchiya,Koji Sato,Satoru Watanabe,Shiro Nomura,Shuzo Sakai,Ryusei Saito,Masatomo Mori, Oct. 2007, AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 30, 5, 487, 491
DOI

Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer, Noriko Yanagitani,Satoshi Tsuchiya,Kyoichi Kaira,Noriaki Sunaga,Yukiko Tsuchiya,Koji Sato,Satoru Watanabe,Shiro Nomura,Shuzo Sakai,Ryusei Saito,Masatomo Mori, Oct. 2007, AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 30, 5, 487, 491
DOI

The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer, Sekine\, I,M Sato,N Sunaga,S Toyooka,M Peyton,R Parsons,WD Wang,AF Gazdar,JD Minna, Apr. 2005, ONCOGENE, 24, 16, 2735, 2738
DOI

The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer, Sekine\, I,M Sato,N Sunaga,S Toyooka,M Peyton,R Parsons,WD Wang,AF Gazdar,JD Minna, Apr. 2005, ONCOGENE, 24, 16, 2735, 2738
DOI

DNA methylation-associated inactivation of TGF beta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers, M Suzuki,H Shigematsu,DS Shames,N Sunaga,T Takahashi,N Shivapurkar,T Iizasa,EP Frenkel,JD Minna,T Fujisawa,AF Gazdar, Oct. 2005, BRITISH JOURNAL OF CANCER, 93, 9, 1029, 1037
DOI

DNA methylation-associated inactivation of TGF beta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers, M Suzuki,H Shigematsu,DS Shames,N Sunaga,T Takahashi,N Shivapurkar,T Iizasa,EP Frenkel,JD Minna,T Fujisawa,AF Gazdar, Oct. 2005, BRITISH JOURNAL OF CANCER, 93, 9, 1029, 1037
DOI

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer, Y Tomizawa,H Iijima,N Sunaga,K Sato,A Takise,Y Otani,S Tanaka,T Suga,R Saito,T Ishizuka,K Dobashi,JD Minna,T Nakajima,M Mori, Oct. 2005, CLINICAL CANCER RESEARCH, 11, 19, 6816, 6822
DOI

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer, Y Tomizawa,H Iijima,N Sunaga,K Sato,A Takise,Y Otani,S Tanaka,T Suga,R Saito,T Ishizuka,K Dobashi,JD Minna,T Nakajima,M Mori, Oct. 2005, CLINICAL CANCER RESEARCH, 11, 19, 6816, 6822
DOI

Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: Gene expression associated with metastatic potential in human lung cancer, Tetsuhiro Nakano,Kimihiro Shimizu,Osamu Kawashima,Mitsuhiro Kamiyoshihara,Seiichi Kakegawa,Masayuki Sugano,Takashi Ibe,Toshiteru Nagashima,Kyoichi Kaira,Noriaki Sunaga,Youichi Ohtaki,Jun Atsumi,Izumi Takeyoshi, Nov. 2012, ONCOLOGY REPORTS, 28, 5, 1727, 1735
DOI

Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: Gene expression associated with metastatic potential in human lung cancer, Tetsuhiro Nakano,Kimihiro Shimizu,Osamu Kawashima,Mitsuhiro Kamiyoshihara,Seiichi Kakegawa,Masayuki Sugano,Takashi Ibe,Toshiteru Nagashima,Kyoichi Kaira,Noriaki Sunaga,Youichi Ohtaki,Jun Atsumi,Izumi Takeyoshi, Nov. 2012, ONCOLOGY REPORTS, 28, 5, 1727, 1735
DOI

Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer, K. Kaira,Y. Sunose,K. Arakawa,T. Ogawa,N. Sunaga,K. Shimizu,H. Tominaga,N. Oriuchi,H. Itoh,S. Nagamori,Y. Kanai,A. Segawa,M. Furuya,M. Mori,T. Oyama,I. Takeyoshi, Aug. 2012, BRITISH JOURNAL OF CANCER, 107, 4, 632, 638
DOI

Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer, K. Kaira,Y. Sunose,K. Arakawa,T. Ogawa,N. Sunaga,K. Shimizu,H. Tominaga,N. Oriuchi,H. Itoh,S. Nagamori,Y. Kanai,A. Segawa,M. Furuya,M. Mori,T. Oyama,I. Takeyoshi, Aug. 2012, BRITISH JOURNAL OF CANCER, 107, 4, 632, 638
DOI

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer, Noriaki Sunaga,Hisao Imai,Kimihiro Shimizu,David S. Shames,Seiichi Kakegawa,Luc Girard,Mitsuo Sato,Kyoichi Kaira,Tamotsu Ishizuka,Adi F. Gazdar,John D. Minna,Masatomo Mori, Apr. 2012, INTERNATIONAL JOURNAL OF CANCER, 130, 8, 1733, 1744
DOI

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer, Noriaki Sunaga,Hisao Imai,Kimihiro Shimizu,David S. Shames,Seiichi Kakegawa,Luc Girard,Mitsuo Sato,Kyoichi Kaira,Tamotsu Ishizuka,Adi F. Gazdar,John D. Minna,Masatomo Mori, Apr. 2012, INTERNATIONAL JOURNAL OF CANCER, 130, 8, 1733, 1744
DOI

Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer, M Sato,L Girard,Sekine\, I,N Sunaga,RD Ramirez,C Kamibayashi,JD Minna, Oct. 2003, ONCOGENE, 22, 46, 7243, 7246
DOI

Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer, M Sato,L Girard,Sekine\, I,N Sunaga,RD Ramirez,C Kamibayashi,JD Minna, Oct. 2003, ONCOGENE, 22, 46, 7243, 7246
DOI

Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo, A Yamane,T Kohno,K Ito,N Sunaga,K Aoki,K Yoshimura,H Murakami,Y Nojima,J Yokota, Sep. 2004, CARCINOGENESIS, 25, 9, 1689, 1694
DOI

Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo, A Yamane,T Kohno,K Ito,N Sunaga,K Aoki,K Yoshimura,H Murakami,Y Nojima,J Yokota, Sep. 2004, CARCINOGENESIS, 25, 9, 1689, 1694
DOI

Usefulness of F-18-alpha-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer, Kyoichi Kaira,Tetsuya Higuchi,Noriaki Sunaga,Yukiko Arisaka,Takeshi Hisada,Hideyuki Tominaga,Noboru Oriuchi,Takayuki Asao,Yoshihito Tsushima,Masanobu Yamada, Dec. 2016, ANTICANCER RESEARCH, 36, 12, 6481, 6490
DOI

Usefulness of F-18-alpha-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer, Kyoichi Kaira,Tetsuya Higuchi,Noriaki Sunaga,Yukiko Arisaka,Takeshi Hisada,Hideyuki Tominaga,Noboru Oriuchi,Takayuki Asao,Yoshihito Tsushima,Masanobu Yamada, Dec. 2016, ANTICANCER RESEARCH, 36, 12, 6481, 6490
DOI

Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer, Kyoichi Kaira,Noriaki Sunaga,Hisao Imai,Yosuke Kamide,Yasuhiko Koga,Akihiro Ono,Tomohito Kuwako,Tomomi Masuda,Takeshi Hisada,Tamotsu Ishizuka,Masanobu Yamada, Apr. 2016, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21, 2, 240, 247
DOI

Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer, Kyoichi Kaira,Noriaki Sunaga,Hisao Imai,Yosuke Kamide,Yasuhiko Koga,Akihiro Ono,Tomohito Kuwako,Tomomi Masuda,Takeshi Hisada,Tamotsu Ishizuka,Masanobu Yamada, Apr. 2016, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21, 2, 240, 247
DOI

Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy, Noriaki Sunaga,David S. Shames,Luc Girard,Michael Peyton,Jill E. Larsen,Hisao Imai,Junichi Soh,Mitsuo Sato,Noriko Yanagitani,Kyoichi Kaira,Yang Xie,Adi F. Gazdar,Masatomo Mori,John D. Minna, Feb. 2011, MOLECULAR CANCER THERAPEUTICS, 10, 2, 336, 346
DOI

Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy, Noriaki Sunaga,David S. Shames,Luc Girard,Michael Peyton,Jill E. Larsen,Hisao Imai,Junichi Soh,Mitsuo Sato,Noriko Yanagitani,Kyoichi Kaira,Yang Xie,Adi F. Gazdar,Masatomo Mori,John D. Minna, Feb. 2011, MOLECULAR CANCER THERAPEUTICS, 10, 2, 336, 346
DOI

The role of [F-18]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors, Kyoichi Kaira,Noriaki Sunaga,Tamotsu Ishizuka,Kimihiro Shimizu,Nobuyuki Yamamoto, Nov. 2011, CANCER IMAGING, 11, 1, 195, 201, Book review
DOI

The role of [F-18]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors, Kyoichi Kaira,Noriaki Sunaga,Tamotsu Ishizuka,Kimihiro Shimizu,Nobuyuki Yamamoto, Nov. 2011, CANCER IMAGING, 11, 1, 195, 201, Book review
DOI

Metabolic activity by F-18-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC, Kyoichi Kaira,Tetsuya Higuchi,Ichiro Naruse,Yukiko Arisaka,Azusa Tokue,Bolag Altan,Satoshi Suda,Akira Mogi,Kimihiro Shimizu,Noriaki Sunaga,Takeshi Hisada,Shigehisa Kitano,Hideru Obinata,Takehiko Yokobori,Keita Mori,Masahiko Nishiyama,Yoshihito Tsushima,Takayuki Asao, Jan. 2018, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, 1, 56, 66
DOI

Metabolic activity by F-18-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC, Kyoichi Kaira,Tetsuya Higuchi,Ichiro Naruse,Yukiko Arisaka,Azusa Tokue,Bolag Altan,Satoshi Suda,Akira Mogi,Kimihiro Shimizu,Noriaki Sunaga,Takeshi Hisada,Shigehisa Kitano,Hideru Obinata,Takehiko Yokobori,Keita Mori,Masahiko Nishiyama,Yoshihito Tsushima,Takayuki Asao, Jan. 2018, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, 1, 56, 66
DOI

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka,Takeshi Hisada,Motoaki Hatori,Akio Koike,Kikuo Hanabuchi,Shinichi Matsuzaki,Yosuke Kamide,Mitsuyoshi Utsugi,Haruka Aoki,Reiko Yoshino,Noriko Yanagitani,Yasuhiko Koga,Akihiro Ono,Kyoichi Kaira,Noriaki Sunaga,Kunio Dobashi,Takahiro Tsuburai,Kazuo Akiyama,Masanobu Yamada,Kazuhiro Suzuki,Masatomo Mori, Sep. 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796
DOI

Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka,Takeshi Hisada,Motoaki Hatori,Akio Koike,Kikuo Hanabuchi,Shinichi Matsuzaki,Yosuke Kamide,Mitsuyoshi Utsugi,Haruka Aoki,Reiko Yoshino,Noriko Yanagitani,Yasuhiko Koga,Akihiro Ono,Kyoichi Kaira,Noriaki Sunaga,Kunio Dobashi,Takahiro Tsuburai,Kazuo Akiyama,Masanobu Yamada,Kazuhiro Suzuki,Masatomo Mori, Sep. 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796
DOI

Acidic pH increases cGMP accumulation through the OGR1/phospholipase C/Ca2+/neuronal NOS pathway in N1E-115 neuronal cells, Mie Kotake,Koichi Sato,Chihiro Mogi,Masayuki Tobo,Haruka Aoki,Tamotsu Ishizuka,Noriaki Sunaga,Hisao Imai,Kyoichi Kaira,Takeshi Hisada,Masanobu Yamada,Fumikazu Okajima, Nov. 2014, CELLULAR SIGNALLING, 26, 11, 2326, 2332
DOI

Acidic pH increases cGMP accumulation through the OGR1/phospholipase C/Ca2+/neuronal NOS pathway in N1E-115 neuronal cells, Mie Kotake,Koichi Sato,Chihiro Mogi,Masayuki Tobo,Haruka Aoki,Tamotsu Ishizuka,Noriaki Sunaga,Hisao Imai,Kyoichi Kaira,Takeshi Hisada,Masanobu Yamada,Fumikazu Okajima, Nov. 2014, CELLULAR SIGNALLING, 26, 11, 2326, 2332
DOI

Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer, Kyoichi Kaira,Ichiro Naruse,Hisao Imai,Noriaki Sunaga,Takeshi Hisada,Masahiko Motegi,Takayuki Asao,Masanobu Yamada, 2014, CHEMOTHERAPY, 60, 5-6, 356, 359
DOI

Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer, Kyoichi Kaira,Ichiro Naruse,Hisao Imai,Noriaki Sunaga,Takeshi Hisada,Masahiko Motegi,Takayuki Asao,Masanobu Yamada, 2014, CHEMOTHERAPY, 60, 5-6, 356, 359
DOI

Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma, N. Sunaga,K. Kaira,Y. Tomizawa,K. Shimizu,H. Imai,G. Takahashi,S. Kakegawa,Y. Ohtaki,T. Nagashima,N. Kasahara,O. Kawashima,T. Hisada,R. Saito,M. Yamada, Apr. 2014, BRITISH JOURNAL OF CANCER, 110, 8, 2047, 2053
DOI

Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma, N. Sunaga,K. Kaira,Y. Tomizawa,K. Shimizu,H. Imai,G. Takahashi,S. Kakegawa,Y. Ohtaki,T. Nagashima,N. Kasahara,O. Kawashima,T. Hisada,R. Saito,M. Yamada, Apr. 2014, BRITISH JOURNAL OF CANCER, 110, 8, 2047, 2053
DOI

Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer, Kyoichi Kaira,Noriko Yanagitani,Noriaki Sunaga,Hisao Imai,Akihiro Ono,Yasuhiko Koga,Takeshi Hisada,Tamotsu Ishizuka,Masanobu Yamada, Jul. 2017, ONCOLOGY LETTERS, 14, 1, 1123, 1128
DOI

Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer, Kyoichi Kaira,Noriko Yanagitani,Noriaki Sunaga,Hisao Imai,Akihiro Ono,Yasuhiko Koga,Takeshi Hisada,Tamotsu Ishizuka,Masanobu Yamada, Jul. 2017, ONCOLOGY LETTERS, 14, 1, 1123, 1128
DOI

High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma, Yosuke Miura,Kyoichi Kaira,Reiko Sakurai,Hisao Imai,Yoshio Tomizawa,Noriaki Sunaga,Koichi Minato,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, Oct. 2017, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 5, 872, 879
DOI

High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma, Yosuke Miura,Kyoichi Kaira,Reiko Sakurai,Hisao Imai,Yoshio Tomizawa,Noriaki Sunaga,Koichi Minato,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, Oct. 2017, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 5, 872, 879
DOI

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer, Hisao Imai,Tomohito Kuwako,Kyoichi Kaira,Tomomi Masuda,Yosuke Miura,Kaori Seki,Reiko Sakurai,Mitsuyoshi Utsugi,Kimihiro Shimizu,Noriaki Sunaga,Yoshio Tomizawa,Shinichi Ishihara,Takao Ishizuka,Akira Mogi,Takeshi Hisada,Koichi Minato,Atsushi Takise,Ryusei Saito,Masanobu Yamada, Mar. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 3, 497, 505
DOI

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer, Hisao Imai,Tomohito Kuwako,Kyoichi Kaira,Tomomi Masuda,Yosuke Miura,Kaori Seki,Reiko Sakurai,Mitsuyoshi Utsugi,Kimihiro Shimizu,Noriaki Sunaga,Yoshio Tomizawa,Shinichi Ishihara,Takao Ishizuka,Akira Mogi,Takeshi Hisada,Koichi Minato,Atsushi Takise,Ryusei Saito,Masanobu Yamada, Mar. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 3, 497, 505
DOI

Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Hisao Imai,Reiko Sakurai,Masana Matsuura,Akihiro Yoshii,Mai Ochiai,Mie Kotake,Takeshi Ebara,Jun-ichi Saitoh,Noriaki Sunaga,Koichi Minato,Ryusei Saito,Takeshi Hisada, Jan. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 1, 165, 171
DOI

Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Hisao Imai,Reiko Sakurai,Masana Matsuura,Akihiro Yoshii,Mai Ochiai,Mie Kotake,Takeshi Ebara,Jun-ichi Saitoh,Noriaki Sunaga,Koichi Minato,Ryusei Saito,Takeshi Hisada, Jan. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 1, 165, 171
DOI

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer, H. Yoshioka,N. Katakami,H. Okamoto,Y. Iwamoto,T. Seto,T. Takahashi,N. Sunaga,S. Kudoh,K. Chikamori,M. Harada,H. Tanaka,H. Saito,H. Saka,K. Takeda,N. Nogami,N. Masuda,T. Harada,H. Kitagawa,H. Horio,T. Yamanaka,M. Fukuoka,N. Yamamoto,K. Nakagawa, Feb. 2017, ANNALS OF ONCOLOGY, 28, 2, 285, 291
DOI

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer, H. Yoshioka,N. Katakami,H. Okamoto,Y. Iwamoto,T. Seto,T. Takahashi,N. Sunaga,S. Kudoh,K. Chikamori,M. Harada,H. Tanaka,H. Saito,H. Saka,K. Takeda,N. Nogami,N. Masuda,T. Harada,H. Kitagawa,H. Horio,T. Yamanaka,M. Fukuoka,N. Yamamoto,K. Nakagawa, Feb. 2017, ANNALS OF ONCOLOGY, 28, 2, 285, 291
DOI

Prognostic effect of class III beta-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors, Yosuke Miura,Kyoichi Kaira,Reiko Sakurai,Hisao Imai,Yoshio Tomizawa,Noriaki Sunaga,Koichi Minato,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, Aug. 2017, ONCOLOGY LETTERS, 14, 2, 2369, 2378
DOI

Prognostic effect of class III beta-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors, Yosuke Miura,Kyoichi Kaira,Reiko Sakurai,Hisao Imai,Yoshio Tomizawa,Noriaki Sunaga,Koichi Minato,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, Aug. 2017, ONCOLOGY LETTERS, 14, 2, 2369, 2378
DOI

Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature, Yasuyuki Saito,Yuri Sawada,Yasuhiko Koga,Noriaki Sunaga,Yusuke Tsukagoshi,Yoshimasa Hachisu,Takashi Osaki,Reiko Sakurai,Kyoichi Kaira,Akihiro Ono,Ken Sato,Hiromi Koiso,Tetsunari Oyama,Takeshi Hisada,Masanobu Yamada, 2017, INTERNAL MEDICINE, 56, 20, 2753, 2757, Book review
DOI

Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature, Yasuyuki Saito,Yuri Sawada,Yasuhiko Koga,Noriaki Sunaga,Yusuke Tsukagoshi,Yoshimasa Hachisu,Takashi Osaki,Reiko Sakurai,Kyoichi Kaira,Akihiro Ono,Ken Sato,Hiromi Koiso,Tetsunari Oyama,Takeshi Hisada,Masanobu Yamada, 2017, INTERNAL MEDICINE, 56, 20, 2753, 2757, Book review
DOI

Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case., Hisao Imai,Nozomi Matsumura,Yuichi Yamazaki,Yuki Kanayama,Tomomi Masuda,Tomohito Kuwako,Yosuke Kamide,Taku Tomizawa,Shunichi Matsumoto,Takeki Mitsui,Kyoichi Kaira,Akihiro Ono,Yasuhiko Koga,Nobuyuki Shibusawa,Noriaki Sunaga,Takeshi Hisada,Hideaki Yokoo,Masanobu Yamada, 2015, Internal medicine (Tokyo, Japan), 54, 24, 3171, 6
DOI

Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case., Hisao Imai,Nozomi Matsumura,Yuichi Yamazaki,Yuki Kanayama,Tomomi Masuda,Tomohito Kuwako,Yosuke Kamide,Taku Tomizawa,Shunichi Matsumoto,Takeki Mitsui,Kyoichi Kaira,Akihiro Ono,Yasuhiko Koga,Nobuyuki Shibusawa,Noriaki Sunaga,Takeshi Hisada,Hideaki Yokoo,Masanobu Yamada, 2015, Internal medicine (Tokyo, Japan), 54, 24, 3171, 6
DOI

Lung cancer producing granulocyte colony-stimulating factor and rapid spreading to peritoneal cavity., Kaira K,Ishizuka T,Tanaka H,Tanaka Y,Yanagitani N,Sunaga N,Hisada T,Ishizuka T,Mori M, 2008, J Thorac Oncol.
DOI

Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer., Kaira K,Sunaga N,Yanagitani N,Aoki H,Kawata T,Utsugi M,Shimizu Y,Shimizu K,Hisada T,Ishizuka T,Mori M, 2008, Anticancer Drugs.
DOI

Primary mediastinal synovial sarcoma: a report of 2 cases., Kaira K,Ishizuka T,Sunaga N,Hashimoto K,Yanagitani N,Nonaka T,Ebara T,Hisada T,Mori M, 2008, J Comput Assist Tomogr.
DOI

Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer, ImaiH,Sunaga N,Shimizu Y,Kakegawa S,Shimizu K,Sano T,Ishizuka T,Oyama T,Saito R,Minna JD,Mori M, 2009, International Journal of Immunopathology and Pharmacology, 23, 1, 153, 64

Multiple lung metastases presenting as ground-glass opacities in a pulmonary adenocarcinoma: a case report., Yanagitani N,Kaira K,Ishizuka T,Aoki H,Utsugi M,Shimizu Y,Sunaga N,Endou K,Hisada T,Mori M, 2009, Cases J
DOI

CXCR4+FOXP3+CD25+ lymphocytes accumulate in CXCL12-expressing malignant pleural mesothelioma., Shimizu Y,Dobashi K,Imai H,Sunaga N,Ono A,Sano T,Hikino T,Shimizu K,Tanaka S,Ishizuka T,Utsugi M,Mori M, 2009, Int J Immunopathol Pharmacol.

Laryngeal sarcoidosis detected by FDG positron emission tomography., Kaira K,Ishizuka T,Yanagitani N,Sunaga N,Hisada T,Mori M, 2008, Clin Nucl Med.
DOI

B-cell non-Hodgkin lymphoma presenting as an endobronchial polypoid mass., Kaira K,Ishizuka T,Tanaka H,Tanaka Y,Ishizuka T,Yanagitani N,Sunaga N,Hisada T,Mori M, 2008, J Thorac Oncol.
DOI

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer., Kaira K,Oriuchi N,Imai H,Shimizu K,Yanagitani N,Sunaga N,Hisada T,Tanaka S,Ishizuka T,Kanai Y,Endou H,Nakajima T,Mori M, 2008, Br J Cancer., 8, 4, 742, 8
DOI

Gender and age risks for hoarseness and dysphonia with use of a dry powder fluticasone propionate inhaler in asthma., Ishizuka T,Hisada T,Aoki H,Yanagitani N,Kaira K,Utsugi M,Shimizu Y,Sunaga N,Dobashi K,Mori M, 2007, Allergy Asthma Proc.

Rapid growth of malignant pleural mesothelioma., Kaira K,Dobashi K,Yanagitani N,Sunaga N,Shimizu Y,Hisada T,Ishizuka T,Nakajima T,Mori M, 2007, J Thorac Oncol.
DOI

Coinfection of invasive pulmonary aspergillosis and pneumocystis jiroveci pneumonia in a non-HIV patient., Kaira K,Shinomiya Y,Takahashi Y,Iida T,Yanagitani N,Sunaga N,Hisada T,Ishizuka T,Mori M, 2007, Acta Med Okayama.

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers., Kaira K,Sunaga N,Tomizawa Y,Yanagitani N,Ishizuka T,Saito R,Nakajima T,Mori M, 2007, Int J Oncol., 31, 1, 169, 73

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer., Kaira K,Sunaga N,Yanagitani N,Imai H,Utsugi M,Shimizu Y,Iijima H,Tomizawa Y,Hisada T,Ishizuka T,Saito R,Mori M, 2007, Anticancer Drugs.
DOI

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis., Kaira K,Ishizuka T,Yanagitani N,Sunaga N,Hisada T,Mori M, 2007, Clin Nucl Med.
DOI

A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease., Shimizu Y,Dobashi K,Kobayashi S,Ohki I,Tokushima M,Kusano M,Kawamura O,Shimoyama Y,Utsugi M,Sunaga N,Ishizuka T,Mori M, 2006, Tohoku J Exp Med.
DOI

A case of primary peritoneal serous papillary carcinoma initially presented by massive bilateral pleural effusions., Kaira K,Takise A,Endou K,Yanagitani N,Sunaga N,Mori M, 2006, Eur J Gynaecol Oncol.

Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer., Sunaga N,Miyajima K,Suzuki M,Sato M,White MA,Ramirez RD,Shay JW,Gazdar AF,Minna JD, 2004, Cancer Res., 64, 12, 4277, 85
DOI

RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells., Suzuki M,Sunaga N,Shames DS,Toyooka S,Gazdar AF,Minna JD, 2004, Cancer Res., 64, 9, 3137, 43
DOI

Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo., Yamane A,Shinmura K,Sunaga N,Saitoh T,Yamaguchi S,Shinmura Y,Yoshimura K,Murakami H,Nojima Y,Kohno T,Yokota J, 2003, Carcinogenesis.

Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility., Sunaga N,Kohno T,Yanagitani N,Sugimura H,Kunitoh H,Tamura T,Takei Y,Tsuchiya S,Saito R,Yokota J, 2002, Cancer Epidemiol Biomarkers Prev.

Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1., Yanagitani N,Kohno T,Sunaga N,Kunitoh H,Tamura T,Tsuchiya S,Saito R,Yokota J, 2002, Carcinogenesis.

OGG1 protein suppresses G:C-->T:A mutation in a shuttle vector containing 8-hydroxyguanine in human cells., Sunaga N,Kohno T,Shinmura K,Saitoh T,Matsuda T,Saito R,Yokota J, 2001, Carcinogenesis.
DOI

Physical and transcriptional map of a 311-kb segment of chromosome 18q21, a candidate lung tumor suppressor locus., Yanaihara N,Kohno T,Takakura S,Takei K,Otsuka A,Sunaga N,Takahashi M,Yamazaki M,Tashiro H,Fukuzumi Y,Fujimori Y,Hagiwara K,Tanaka T,Yokota J, 2001, Genomics.
DOI

Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma., Sunaga N,Kohno T,Kolligs FT,Fearon ER,Saito R,Yokota J, 2001, Genes Chromosomes Cancer.
DOI

Weekly CODE chemotherapy with recombinant human granulocyte colony-stimulating factor for relapsed or refractory small cell lung cancer., Sato K,Tsuchiya S,Minato K,Sunaga N,Ishihara SI,Makimoto T,Naruse I,Hoshino H,Watanabe S,Saitoh R,Mori M, 2000, Oncol Rep.

A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer., Ishihara S,Tsuchiya S,Minato K,Watanabe S,Sunaga N,Sato K,Kobayashi G,Hoshino H,Naruse I,Makimoto T,Nomoto T,Takei Y,Fueki N,Takise A,Saito R,Mori M, 2000, Am J Clin Oncol.
DOI

Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer., Sunaga N,Tsuchiya S,Minato K,Watanabe S,Fueki N,Hoshino H,Makimoto T,Ishihara S,Saito R,Mori M, 1999, Oncology.
DOI

Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer., Imai H,Kaira K,Oriuchi N,Shimizu K,Tominaga H,Yanagitani N,Sunaga N,Ishizuka T,Nagamori S,Promchan K,Nakajima T,Yamamoto N,Mori M,Kanai Y, 2010, 30, 12, 4819, 28

A systemic review of PET and biology in lung cancer., Kaira K,Oriuchi N,Sunaga N,Ishizuka T,Shimizu K,Yamamoto N, 2011, Am J Transl Res., 3, 4, 383, 91

Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells., Nakajima Y,Takagi H,Kakizaki S,Horiguchi N,Sato K,Sunaga N,Mori M, 2012, Anticancer Res, 32, 12, 5251, 62

Interaction of Radiation and Gefitinib on a Human Lung Cancer Cell Line with Mutant EGFR Gene In Vitro., Sato Y,Ebara T,Sunaga N,Takahashi T,Nakano T, 2012, Anticancer Res., 32, 11, 4877, 81

FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer., Noriaki Sunaga,Kyoichi Kaira,Takeshi Hisada,Masanobu Yamada, 2013, World Journal of Respirology, 3, 3, 104, 109

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer, Shimizu\, K,Kaira\, K,Tomizawa\, Y,Sunaga\, N,Kawashima\, O,Oriuchi\, N,Tominaga\, H,Nagamori\, S,Kanai\, Y,Yamada\, M,Oyama\, T,Takeyoshi\, I, 2014, BRITISH JOURNAL OF CANCER, 110, 8, 2030, 2039
DOI

Solitary pituitary metastasis resulting from pulmonary large cell neuroendocrine carcinoma., WatanabeT,Kaira K,Mizuide M,Sunaga N,Shibusawa N,Hisada T,Satoh T,Mori M,Yamada M, 2014, World Journal of Respirology, 4, 1, 8-10.

17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice, Yatomi M,Hisada T,Ishizuka T,Koga Y,Ono A,Kamide Y,Seki K,Aoki-Saito H,Tsurumaki H,Sunaga N,Kaira K,Dobashi K,Yamada M,Okajima F, 2015, Physiological Reports, 3, 12, e12628
DOI

Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma, Kasahara\, Norimitsu,Kaira\, Kyoichi,Bao\, Pinjie,Higuchi\, Tetsuya,Arisaka\, Yukiko,Erichem-Ochir\, Bilguun,Sunaga\, Noriaki,Ohtaki\, Yoichi,Yajima\, Toshiki,Kosaka\, Takayuki,Oyama\, Tetsunari,Yokobori\, Takehiko,Asao\, Takayuki,Nishiyama\, Masahiko,Tsushima\, Yoshito,Kuwano\, Hiroyuki,Shimizu\, Kimihiro,Mogi\, Akira, 2018, LUNG CANCER, 119, 71, 77
DOI

A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer, Sakurai\, Reiko,Tomizawa\, Yoshio,Yoshii\, Akihiro,Miura\, Yosuke,Tsurumaki\, Hiroaki,Kaira\, Kyoichi,Sunaga\, Noriaki,Kawashima\, Osamu,Hisada\, Takeshi,Yamada\, Masanobu,Saito\, Ryusei, 2018, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81, 1, 103, 109
DOI

The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome, Hachisu\, Yoshimasa,Koga\, Yasuhiko,Sunaga\, Noriaki,Kashiwagi\, Chiharu,Sawada\, Yuri,Saito\, Yasuyuki,Tsukagoshi\, Yusuke,Kasahara\, Norimitsu,Sakurai\, Reiko,Tsurumaki\, Hiroaki,Yatomi\, Masakiyo,Kaira\, Kyoichi,Ono\, Akihiro,Maeno\, Toshitaka,Hisada\, Takeshi, 2018, INTERNAL MEDICINE, 57, 2, 247, 251
DOI

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer, Sunaga\, N,Kaira\, K,Imai\, H,Shimizu\, K,Nakano\, T,Shames\, D. S,Girard\, L,Soh\, J,Sato\, M,Iwasaki\, Y,Ishizuka\, T,Gazdar\, A. F,Minna\, J. D,Mori\, M, 2013, ONCOGENE, 32, 34, 4034, 4042
DOI

Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk, YASUAKI ENOKIDA,KIMIHIRO SHIMIZU,SEIICHI KAKEGAWA,JUN ATSUMI,YOSHIAKI TAKASE,YOHEI MIYAMAE,TOSHITERU NAGASHIMA,YOICHI OHTAKI,KYOICHI KAIRA,NORIAKI SUNAGA,NORIKO YANAGITANI,REIKO YOSHINO,KATSUHIKO TSUNEKAWA,HITOSHI IGAI,MITSUHIRO KAMIYOSHIHARA,KENGO USUI,ALEXANDER LEZHAVA,YOSHIO TOMIZAWA,TOSHIHISA ISHIKAWA,MASAMI MURAKAMI,YOSHIHIDE HAYASHIZAKI,IZUMI TAKEYOSHI, 2014, Biomedical Reports, 2, 5, 719, 724
DOI

Small-cell lung cancer with voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis: a case report, Kaira K,Okamura T,Takahashi H,Horiguchi N,Sunaga N,Hisada T,Yamada M, 2014, JOURNAL OF MEDICAL CASE REPORTS, 8, 119
DOI

Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status, Ohtaki Y,Shimizu K,Kakegawa S,Nagashima T,Nakano T,Atsumi J,Enokida Y,Igai H,Ibe T,Sugano M,Kamiyoshihara M,Kawashima O,Kaira K,Sunaga N,Takeyoshi I, 2014, Molecular and Clinical Oncology, 2, 2, 187, 196
DOI

Epiregulin as a therapeutic target in non-small-cell lung cancer., Sunaga N,Kaira K, 2015, Lung Cancer:Targets and Therapy, 6, 91, 98
DOI

The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer, Miura\, Yosuke,Imai\, Hisao,Sakurai\, Reiko,Kaira\, Kyoichi,Sunaga\, Noriaki,Minato\, Koichi,Saito\, Ryusei,Hisada\, Takeshi, 2018, MEDICAL ONCOLOGY, 35, 4, 45
DOI

High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin, Miura\, Yosuke,Kaira\, Kyoichi,Sakurai\, Reiko,Sunaga\, Noriaki,Saito\, Ryusei,Hisada\, Takeshi,Yamada\, Masanobu, 2018, LUNG CANCER, 115, 42, 48
DOI

Lung cancer producing granulocyte colony-stimulating factor and rapid spreading to peritoneal cavity., Kaira K,Ishizuka T,Tanaka H,Tanaka Y,Yanagitani N,Sunaga N,Hisada T,Ishizuka T,Mori M, 2008
DOI

Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer., Kaira K,Sunaga N,Yanagitani N,Aoki H,Kawata T,Utsugi M,Shimizu Y,Shimizu K,Hisada T,Ishizuka T,Mori M, 2008
DOI

Primary mediastinal synovial sarcoma: a report of 2 cases., Kaira K,Ishizuka T,Sunaga N,Hashimoto K,Yanagitani N,Nonaka T,Ebara T,Hisada T,Mori M, 2008
DOI

Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer, ImaiH,Sunaga N,Shimizu Y,Kakegawa S,Shimizu K,Sano T,Ishizuka T,Oyama T,Saito R,Minna JD,Mori M, 2009, 23, 1, 153, 64

Multiple lung metastases presenting as ground-glass opacities in a pulmonary adenocarcinoma: a case report., Yanagitani N,Kaira K,Ishizuka T,Aoki H,Utsugi M,Shimizu Y,Sunaga N,Endou K,Hisada T,Mori M, 2009
DOI

胸痛にて発症した神経サルコイドーシスの１例, 柳谷典子,小竹美絵,石塚全,岩崎靖樹,砂長則明,森昌朋, 2009, 47, 12, 1087

CXCR4+FOXP3+CD25+ lymphocytes accumulate in CXCL12-expressing malignant pleural mesothelioma., Shimizu Y,Dobashi K,Imai H,Sunaga N,Ono A,Sano T,Hikino T,Shimizu K,Tanaka S,Ishizuka T,Utsugi M,Mori M, 2009

Laryngeal sarcoidosis detected by FDG positron emission tomography., Kaira K,Ishizuka T,Yanagitani N,Sunaga N,Hisada T,Mori M, 2008
DOI

B-cell non-Hodgkin lymphoma presenting as an endobronchial polypoid mass., Kaira K,Ishizuka T,Tanaka H,Tanaka Y,Ishizuka T,Yanagitani N,Sunaga N,Hisada T,Mori M, 2008
DOI

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer., Kaira K,Oriuchi N,Imai H,Shimizu K,Yanagitani N,Sunaga N,Hisada T,Tanaka S,Ishizuka T,Kanai Y,Endou H,Nakajima T,Mori M, 2008, 8, 4, 742, 8
DOI

Gender and age risks for hoarseness and dysphonia with use of a dry powder fluticasone propionate inhaler in asthma., Ishizuka T,Hisada T,Aoki H,Yanagitani N,Kaira K,Utsugi M,Shimizu Y,Sunaga N,Dobashi K,Mori M, 2007

Rapid growth of malignant pleural mesothelioma., Kaira K,Dobashi K,Yanagitani N,Sunaga N,Shimizu Y,Hisada T,Ishizuka T,Nakajima T,Mori M, 2007
DOI

Coinfection of invasive pulmonary aspergillosis and pneumocystis jiroveci pneumonia in a non-HIV patient., Kaira K,Shinomiya Y,Takahashi Y,Iida T,Yanagitani N,Sunaga N,Hisada T,Ishizuka T,Mori M, 2007

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers., Kaira K,Sunaga N,Tomizawa Y,Yanagitani N,Ishizuka T,Saito R,Nakajima T,Mori M, 2007, 31, 1, 169, 73

A phase I dose-escalation study of S-1 plus carboplatin in patients with advanced non-small-cell lung cancer., Kaira K,Sunaga N,Yanagitani N,Imai H,Utsugi M,Shimizu Y,Iijima H,Tomizawa Y,Hisada T,Ishizuka T,Saito R,Mori M, 2007
DOI

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis., Kaira K,Ishizuka T,Yanagitani N,Sunaga N,Hisada T,Mori M, 2007
DOI

A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease., Shimizu Y,Dobashi K,Kobayashi S,Ohki I,Tokushima M,Kusano M,Kawamura O,Shimoyama Y,Utsugi M,Sunaga N,Ishizuka T,Mori M, 2006
DOI

A case of primary peritoneal serous papillary carcinoma initially presented by massive bilateral pleural effusions., Kaira K,Takise A,Endou K,Yanagitani N,Sunaga N,Mori M, 2006

Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer., Sunaga N,Miyajima K,Suzuki M,Sato M,White MA,Ramirez RD,Shay JW,Gazdar AF,Minna JD, 2004, 64, 12, 4277, 85
DOI

RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells., Suzuki M,Sunaga N,Shames DS,Toyooka S,Gazdar AF,Minna JD, 2004, 64, 9, 3137, 43
DOI

Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo., Yamane A,Shinmura K,Sunaga N,Saitoh T,Yamaguchi S,Shinmura Y,Yoshimura K,Murakami H,Nojima Y,Kohno T,Yokota J, 2003

Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility., Sunaga N,Kohno T,Yanagitani N,Sugimura H,Kunitoh H,Tamura T,Takei Y,Tsuchiya S,Saito R,Yokota J, 2002

Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1., Yanagitani N,Kohno T,Sunaga N,Kunitoh H,Tamura T,Tsuchiya S,Saito R,Yokota J, 2002

OGG1 protein suppresses G:C-->T:A mutation in a shuttle vector containing 8-hydroxyguanine in human cells., Sunaga N,Kohno T,Shinmura K,Saitoh T,Matsuda T,Saito R,Yokota J, 2001
DOI

Physical and transcriptional map of a 311-kb segment of chromosome 18q21, a candidate lung tumor suppressor locus., Yanaihara N,Kohno T,Takakura S,Takei K,Otsuka A,Sunaga N,Takahashi M,Yamazaki M,Tashiro H,Fukuzumi Y,Fujimori Y,Hagiwara K,Tanaka T,Yokota J, 2001
DOI

Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma., Sunaga N,Kohno T,Kolligs FT,Fearon ER,Saito R,Yokota J, 2001
DOI

Weekly CODE chemotherapy with recombinant human granulocyte colony-stimulating factor for relapsed or refractory small cell lung cancer., Sato K,Tsuchiya S,Minato K,Sunaga N,Ishihara SI,Makimoto T,Naruse I,Hoshino H,Watanabe S,Saitoh R,Mori M, 2000

A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer., Ishihara S,Tsuchiya S,Minato K,Watanabe S,Sunaga N,Sato K,Kobayashi G,Hoshino H,Naruse I,Makimoto T,Nomoto T,Takei Y,Fueki N,Takise A,Saito R,Mori M, 2000
DOI

Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer., Sunaga N,Tsuchiya S,Minato K,Watanabe S,Fueki N,Hoshino H,Makimoto T,Ishihara S,Saito R,Mori M, 1999
DOI

肺性肥大性骨関節症を合併した肺癌の1例, 佐藤浩二,岩崎靖樹,小林剛,砂長則明,石原真一,渡辺覚,土屋智,斎藤龍生,森昌朋, 2000

若年者肺癌に合併しゲフィチニブが有効であった肺性肥大性骨関節症の1例, 今井久雄,富澤由雄,石原真一,砂長則明,青木悠,飯島浩宣,岩崎靖樹,渡辺覚,斎藤龍生,森昌朋, 2007

化学療法中に発症したニューモシスチス肺炎の1例, 解良恭一,砂長則明,森昌朋, 2007

TS-1が奏効した抗癌剤多剤抵抗性非小細胞肺癌の1例, 今井久雄,砂長則明,解良恭一,石原真一,青木悠,飯島浩宣,柳谷典子,岩崎靖樹,富澤由雄,斎藤龍生,森昌朋, 2007

サルコイドーシス患者にLarge cell neuroendocrine carcinomaを合併した1例, 柳谷典子,解良恭一,石塚全,青木悠,川田忠嘉,宇津木光克,清水泰生,砂長則明,久田剛志,森昌朋, 2008

GemcitabineとS-1の併用療法にて多発骨転移が著明に改善した高齢者肺癌の1例, 解良恭一,柳谷典子,砂長則明,今井久雄,宇津木光克,川田忠嘉,久田剛志,清水公裕,石塚全,森昌朋, 2009

非特異的間質性肺炎との鑑別が困難であった好酸球浸潤を伴う器質化肺炎の1例, 柳谷典子,石塚全,弘中貢,解良恭一,今井久雄,川田忠嘉,宇津木光克,清水泰生,砂長則明,久田剛志,森昌朋, 2009

Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer., Imai H,Kaira K,Oriuchi N,Shimizu K,Tominaga H,Yanagitani N,Sunaga N,Ishizuka T,Nagamori S,Promchan K,Nakajima T,Yamamoto N,Mori M,Kanai Y, 2010, 30, 12, 4819, 28

A systemic review of PET and biology in lung cancer., Kaira K,Oriuchi N,Sunaga N,Ishizuka T,Shimizu K,Yamamoto N, 2011, 3, 4, 383, 91

Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells., Nakajima Y,Takagi H,Kakizaki S,Horiguchi N,Sato K,Sunaga N,Mori M, 2012, 32, 12, 5251, 62

ベバシズマブを含む化学療法施行中に気胸を発症した肺腺癌の1例, 吉野麗子,砂長則明,岩崎靖樹,久田剛志,石塚全,森昌朋, 2012, 1, 2, 141, 145

Interaction of Radiation and Gefitinib on a Human Lung Cancer Cell Line with Mutant EGFR Gene In Vitro., Sato Y,Ebara T,Sunaga N,Takahashi T,Nakano T, 2012, 32, 11, 4877, 81

FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer., Noriaki Sunaga,Kyoichi Kaira,Takeshi Hisada,Masanobu Yamada, 2013, 3, 3, 104, 109

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer, Shimizu\, K,Kaira\, K,Tomizawa\, Y,Sunaga\, N,Kawashima\, O,Oriuchi\, N,Tominaga\, H,Nagamori\, S,Kanai\, Y,Yamada\, M,Oyama\, T,Takeyoshi\, I, 2014, 110, 8, 2030, 2039
DOI

Solitary pituitary metastasis resulting from pulmonary large cell neuroendocrine carcinoma., WatanabeT,Kaira K,Mizuide M,Sunaga N,Shibusawa N,Hisada T,Satoh T,Mori M,Yamada M, 2014, 4, 1, 8-10.

17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice, Yatomi M,Hisada T,Ishizuka T,Koga Y,Ono A,Kamide Y,Seki K,Aoki-Saito H,Tsurumaki H,Sunaga N,Kaira K,Dobashi K,Yamada M,Okajima F, 2015, 3, 12, e12628
DOI

Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma, Kasahara\, Norimitsu,Kaira\, Kyoichi,Bao\, Pinjie,Higuchi\, Tetsuya,Arisaka\, Yukiko,Erichem-Ochir\, Bilguun,Sunaga\, Noriaki,Ohtaki\, Yoichi,Yajima\, Toshiki,Kosaka\, Takayuki,Oyama\, Tetsunari,Yokobori\, Takehiko,Asao\, Takayuki,Nishiyama\, Masahiko,Tsushima\, Yoshito,Kuwano\, Hiroyuki,Shimizu\, Kimihiro,Mogi\, Akira, 2018, 119, 71, 77
DOI

A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer, Sakurai\, Reiko,Tomizawa\, Yoshio,Yoshii\, Akihiro,Miura\, Yosuke,Tsurumaki\, Hiroaki,Kaira\, Kyoichi,Sunaga\, Noriaki,Kawashima\, Osamu,Hisada\, Takeshi,Yamada\, Masanobu,Saito\, Ryusei, 2018, 81, 1, 103, 109
DOI

The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome, Hachisu\, Yoshimasa,Koga\, Yasuhiko,Sunaga\, Noriaki,Kashiwagi\, Chiharu,Sawada\, Yuri,Saito\, Yasuyuki,Tsukagoshi\, Yusuke,Kasahara\, Norimitsu,Sakurai\, Reiko,Tsurumaki\, Hiroaki,Yatomi\, Masakiyo,Kaira\, Kyoichi,Ono\, Akihiro,Maeno\, Toshitaka,Hisada\, Takeshi, 2018, 57, 2, 247, 251
DOI

外科的肺生検で膠原病肺が疑われた特発性間質性肺炎の1例, 松崎晋一,飯島浩宣,川田忠嘉,柳谷典子,解良恭一,宇津木光克,清水泰生,砂長則明,富澤由雄,久田剛志,石塚全,土橋邦生,田中優子,中里洋一,河端美則,森昌朋, 2008, 67, 528, 534

多発消化管転移を来した低分化肺腺癌の1例, 柳谷典子,石塚全,平戸純子,解良恭一,岩崎靖樹,砂長則明,久田剛志,森昌朋, 2011, 70, 186, 191

慢性閉塞性肺疾患の急性増悪に対するgarenoxacinの臨床効果, 久田剛志,石塚全,青木悠,柳谷典子,小野昭浩,今井久雄,砂長則明,宇津木光克,古賀康彦,岩崎靖樹,吉野麗子,土橋邦生,桑原英眞,森昌朋, 2009, 58, 1808, 1820

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer, Sunaga\, N,Kaira\, K,Imai\, H,Shimizu\, K,Nakano\, T,Shames\, D. S,Girard\, L,Soh\, J,Sato\, M,Iwasaki\, Y,Ishizuka\, T,Gazdar\, A. F,Minna\, J. D,Mori\, M, 2013, 32, 34, 4034, 4042
DOI

Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk, YASUAKI ENOKIDA,KIMIHIRO SHIMIZU,SEIICHI KAKEGAWA,JUN ATSUMI,YOSHIAKI TAKASE,YOHEI MIYAMAE,TOSHITERU NAGASHIMA,YOICHI OHTAKI,KYOICHI KAIRA,NORIAKI SUNAGA,NORIKO YANAGITANI,REIKO YOSHINO,KATSUHIKO TSUNEKAWA,HITOSHI IGAI,MITSUHIRO KAMIYOSHIHARA,KENGO USUI,ALEXANDER LEZHAVA,YOSHIO TOMIZAWA,TOSHIHISA ISHIKAWA,MASAMI MURAKAMI,YOSHIHIDE HAYASHIZAKI,IZUMI TAKEYOSHI, 2014, 2, 5, 719, 724
DOI

Small-cell lung cancer with voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis: a case report, Kaira K,Okamura T,Takahashi H,Horiguchi N,Sunaga N,Hisada T,Yamada M, 2014, 8, 119
DOI

Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status, Ohtaki Y,Shimizu K,Kakegawa S,Nagashima T,Nakano T,Atsumi J,Enokida Y,Igai H,Ibe T,Sugano M,Kamiyoshihara M,Kawashima O,Kaira K,Sunaga N,Takeyoshi I, 2014, 2, 2, 187, 196
DOI

Epiregulin as a therapeutic target in non-small-cell lung cancer., Sunaga N,Kaira K, 2015, 6, 91, 98
DOI

The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer, Miura\, Yosuke,Imai\, Hisao,Sakurai\, Reiko,Kaira\, Kyoichi,Sunaga\, Noriaki,Minato\, Koichi,Saito\, Ryusei,Hisada\, Takeshi, 2018, 35, 4, 45
DOI

High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin, Miura\, Yosuke,Kaira\, Kyoichi,Sakurai\, Reiko,Sunaga\, Noriaki,Saito\, Ryusei,Hisada\, Takeshi,Yamada\, Masanobu, 2018, 115, 42, 48
DOI

Books etc

肺癌における分子標的薬肺癌における分子標的薬, Single work, 2018, 4, Textbook

肺がんの化学療法の効果とPET, Single work, 2008, 2

腫瘍性疾患異所性ホルモン産生腫瘍腫瘍随伴症候群, Contributor, 2009, 3, Textbook

ヒト肺癌におけるWntシグナル伝達経路の異常, Contributor, 2002, 4, Textbook

胸部X線写真読影の基本と注意点, Joint work, 2013, 12

癌患者のモルヒネ使用は,呼吸抑制を促さない?, Joint work, 1999, 2

Presentations

Identification of differentially expressed genes in sphere-forming and adherent A427 cells with CTNNB1/KRAS co-mutations, Noriaki Sunaga, Reiko Sakurai, Kyoichi Kaira, Mitsuo Sato, Takeshi Hisada, The 83rd Annual Meeting of the Japanese Cancer Association, 19 Sep. 2024, 19 Sep. 2024, 21 Sep. 2024, English, Fukuoka, Japan, International conference

Tescalcin overexpression and its relationship to Wnt/β-catenin pathway activation in lung cancer, Noriaki Sunaga, Reiko Sakurai, Kyoichi Kaira, Mitsuo Sato, Takeshi Hisada, The 82nd Annual Meeting of the Japanese Cancer Association, 23 Sep. 2023, 21 Sep. 2023, 23 Sep. 2023, English, Yokohama, Japan, International conference

サルコイドーシスにおける血清NSEの診断的意義, 砂長則明, 古賀康彦, 蜂巣克昌, 山口公一, 相川政紀, 笠原礼光, 三浦陽介, 鶴巻寛朗, 矢冨正清, 櫻井麗子, 前野敏孝, 久田剛志, 第62回日本呼吸器学会学術講演会, 23 Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

原発性肺癌に対するTKI治療後の局所残存・再発病変に対する外科的切除の検討―非切除症例との比較―, 大瀧容一, 清水公裕, 矢島俊樹, 砂長則明, 三浦陽介, 解良恭一, 尾林海, 中澤世識, 河谷菜津子, 矢澤友弘, 調憲, 第62回日本肺癌学会学術集会, 27 Nov. 2021, 26 Nov. 2021, 28 Nov. 2021

ニボルマブ治療後の7次治療としてのnab-パクリタキセル単剤療法が長期奏効した再発肺大細胞癌の1例, 伊藤優志, 三浦陽介, 花里千春, 増田友美, 笠原礼光, 矢冨正清, 鶴巻寛朗, 櫻井麗子, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第62回日本肺癌学会学術集会, 26 Nov. 2021, 26 Nov. 2021, 28 Nov. 2021

AIM2 overexpression and its relationship to KRAS mutations in non-small cell lung cancer, Noriaki Sunaga, Yosuke Miura, Norimitsu Kasahara, Reiko Sakurai, Takeshi Hisada, The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021), 19 Nov. 2021, 17 Nov. 2021, 20 Nov. 2021, Kyoto, Japan, International conference

Successful treatment with durvalumab, etoposide, and cisplatin in relapsed small cell lung cancer: A case report, Miura Y, Wakamatsu I, Uno S, Hanazato C, Masuda T, Kasahara N, Yamaguchi K, Tsurumaki H, Saito H, Yatomi M, Sakurai R, Koga Y, Sunaga N, Hisada, T, Maeno T, The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021), 19 Nov. 2021, 17 Nov. 2021, 20 Nov. 2021, Kyoto, Japan, International conference

A case of thymic cancer treated with chemotherapy of S-1, Sakurai R, Kasahara N, Miura Y, Tsurumaki H, Yatomi M, Koga Y, Sunaga N, Hisada T, Maeno T, The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021), 19 Nov. 2021, 17 Nov. 2021, 20 Nov. 2021, Kyoto, Japan, International conference

Resolvin E3 dampens asthmatic inflammation in a murine model, Sato M, Saito H, Tsurumaki H, Yatomi M, Koga Y, Sunaga N, Dobashi K, Ishizuka T, Shuto S, Maeno T, Hisada T, The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021), 19 Nov. 2021, 17 Nov. 2021, 20 Nov. 2021, Kyoto, Japan, International conference

Analysis of anti-inflammatory effects of Resolvin E3 and its deoxy derivatives, Aoki-Saito H, Saito T2, Sato M, Yatomi M, Koga Y, Tsurumaki H, Yamaguchi A, Yamaguchi K, Miura Y, Sakurai R, Sunaga N, Maeno T, Fukuda H, Ishizuka T, Shuto S, Hisada T, The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021), 19 Nov. 2021, 17 Nov. 2021, 20 Nov. 2021, Kyoto, Japan, International conference

Differential source of early phase discontinuation between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis, Koga Y, Takehara K, Hachisu Y, Utsugi M, Sawada Y, Saito Y, Yoshimi S, Yatomi M, Shin Y, Wakamatsu I, Umetsu K, Kouno S, Sunaga N, Maeno T, Hisada T, The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021), 19 Nov. 2021, 17 Nov. 2021, 20 Nov. 2021, Kyoto, Japan, International conference

Investigation of predictive biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib, Koga Y, Motegi M, Ono A, Hachisu Y, Utsugi M, Sunaga N, Takise A, Sato M, Kuwako T, Osaki T, Ueno M, Yoshimi S, Yamaguchi K, Hisada T, Kaira K, The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021), 19 Nov. 2021, 17 Nov. 2021, 20 Nov. 2021, Kyoto, Japan, International conference

Resolvin E3 attenuates profibrotic factor production via its action on macrophages, Yatomi M, Koga Y, Saito H, Sato M, Tsurumaki H, Miura Y, Hara K, Sunaga N, Maeno T, Shuto S, Hisada T, The 25th Congress of the Asian Pacific Society of Respirology (APSR 2021), 19 Nov. 2021, 17 Nov. 2021, 20 Nov. 2021, Kyoto, Japan, International conference

好酸球性副鼻腔炎を併存した気管支喘息に対するデュピルマブの治療効果, 鶴巻寛朗, 澤田友里, 齋藤悠, 佐藤真季子, 相川政紀, 古賀康彦, 矢冨正清, 原健一郎, 砂長則明, 吉見誠至, 久田剛志, 前野敏孝, 第61回日本呼吸器学会学術講演会, 25 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

好酸球性多発血管炎性肉芽腫症に対するMepolizumabの有効性, 小林頂, 鶴巻寛朗, 齋藤悠, 高野峻一, 佐藤麻里, 相川政紀, 山口公一, 矢冨正清, 原健一郎, 古賀康彦, 砂長則明, 久田剛志, 前野敏孝, 第61回日本呼吸器学会学術講演会, 24 Apr. 2021

脂質メディエーターResolvinの抗線維化効果の解析, 矢冨正清, 古賀康彦, 齋藤悠, 佐藤真季子, 鶴巻寛朗, 原健一郎, 砂長則明, 前野敏孝, 周東智, 久田剛志, 第61回日本呼吸器学会学術講演会, 24 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

COVID-19重症肺炎の治癒過程に,ブラ形成と気胸を発症した60歳代男性の1例, 宇野翔吾, 矢冨正清, 若松郁生, 花里千春, 澤田友里, 高野峻一, 笠原礼光, 三浦陽介, 鶴巻寛朗, 原健一郎, 古賀康彦, 砂長則明, 久田剛志, 前野敏孝, 第61回日本呼吸器学会学術講演会, 24 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

神経内分泌腫瘍の血清マーカー高値の肺腺癌に対して姑息照射後の化学療法と免疫チェックポイント阻害薬の併用療法が著効した一例, 申悠樹, 櫻井麗子, 砂長則明, 豊田正昂, 小林頂, 相川政紀, 佐藤麻里, 高野峻一, 鶴巻寛朗, 原健一郎, 古賀康彦, 久田剛志, 前野敏孝, 第61回日本呼吸器学会学術講演会, 24 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

全身化学療法や免疫チェックポイント阻害剤が奏効したSMARCA4-deficient thoracic sarcomaの一例, 若松郁生, 原健一郎, 宇野翔吾, 花里千春, 澤田友里, 笠原礼光, 三浦陽介, 山口公一, 山口彩, 矢冨正清, 古賀康彦, 砂長則明, 前野敏孝, 第61回日本呼吸器学会学術講演会, 24 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

ドセタキセル+ラムシルマブ併用療法へのペグフィルグラスチム一次予防的投与を検討した第II相試験における高齢者サブグループ解析, 笠原礼光, 砂長則明, 桑子智人, 成清一郎, 今井久雄, 神宮飛鳥, 塚越優介, 増田友美, 北原信介, 鶴巻寛朗, 矢冨正清, 原健一郎, 古賀康彦, 櫻井麗子, 盛啓太, 解良恭一, 前野敏孝, 浅尾高行, 久田剛志, 第61回日本呼吸器学会学術講演会, 24 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

過敏性肺炎パターンを呈した低温加熱式タバコ関連肺損傷と考えられた1例, 豊田正昂, 鶴巻寛朗, 小林頂, 申悠樹, 相川政紀, 佐藤麻里, 高野峻一, 矢冨正清, 原健一郎, 古賀康彦, 砂長則明, 久田剛志, 前野敏孝, 第61回日本呼吸器学会学術講演会, 24 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

特発性肺線維症に対する抗線維化薬治療の継続性について, 竹原和孝, 古賀康彦, 澤田友里, 斎藤康之, 蜂巣克昌, 鶴巻寛朗, 齋藤悠, 矢冨正清, 宇津木光克, 原健一郎, 砂長則明, 前野敏孝, 久田剛志, 第61回日本呼吸器学会学術講演会, 23 Apr. 2021, 23 Apr. 2021

ResolvinE3誘導体の樹状細胞に対する抗炎症性作用の解析, 齋藤悠, 佐藤真季子, 矢冨正清, 古賀康彦, 鶴巻寛朗, 齋藤従道, 宇野翔吾, 若松郁生, 花里千春, 増田友美, 澤田友里, 原健一郎, 砂長則明, 前野敏孝, 周東智, 久田剛志, 第61回日本呼吸器学会学術講演会, 23 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

ResolvinE1,E3のアレルギー性気道炎症に対する効果の検討(アンコール演題), 佐藤真季子, 齋藤悠, 鶴巻寛朗, 矢冨正清, 古賀康彦, 砂長則明, 石塚全, 土橋邦生, 周東智, 前野敏孝, 久田剛志, 第61回日本呼吸器学会学術講演会, 23 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

間質性肺炎の増悪治療に対しての臨床的検討, 高野峻一, 山口公一, 豊田正昂, 原健太郎, 申悠樹, 相川政紀, 佐藤麻里, 鶴巻寛朗, 古賀康彦, 原健一郎, 砂長則明, 前野敏孝, 第61回日本呼吸器学会学術講演会, 23 Apr. 2021, 23 Apr. 2021, 25 Apr. 2021

デュルバルマブ治療中に発症したRS3PE症候群の1例, 鈴木一設高野峻一豊田正昂原健太郎申悠樹相川政紀佐藤,麻里鶴巻寛朗砂長,則明, 第665回日本内科学会関東地方会, Dec. 2020, Domestic conference

出産後に発症した好酸球性多発血管炎性肉芽腫症にメポリズマブを併用した1例, 豊田正昴, 原健一郎, 鶴巻寛朗, 矢富正清, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 日本アレルギー学会関東支部第４回地方会, 28 Nov. 2020, 28 Nov. 2020, 28 Nov. 2020

Wnt/β-catenin経路活性化を介したLGR6過剰発現による肺癌の悪性形質獲得の分子制御機構, 砂長則明三浦陽介伊藤優志増田友美笠原礼光櫻井麗子前野敏孝久田剛志, 第61回日本肺癌学会学術集会, Oct. 2020, Domestic conference

非小細胞肺癌患者を対象としたドセタキセル、ラムシルマブとペグフィルグラスチム併用療法の第II相試験, 笠原礼光砂長則明桑子智人成清一郎今井久雄神宮飛鳥塚越優介増田友美北原信介鶴巻寛朗矢冨正清原健一郎古賀康彦櫻井麗子盛啓太解良恭一前野敏孝浅尾高行久田剛志, 第61回日本肺癌学会学術集会, Oct. 2020, Domestic conference

早期にファビピラビルを投与し良好な転機をたどったCOVID-19の超高齢男性, 申悠樹砂長則明鶴巻寛朗高野峻一相川政紀矢冨正清原健一郎古賀康彦徳江豊前野敏孝, 第241回日本呼吸器学会関東地方会, Sep. 2020, Domestic conference

ECMO管理下でのRemdesivir投与により改善の経過を示したCOVID-19の一例, 堀込瑛介矢冨正清豊田正昂原健太郎宇野翔吾花里千春笠原礼光山口公一鶴巻寛朗原健一郎古賀康彦砂長則明久田剛志前野敏孝, 第241回日本呼吸器学会関東地方会, Sep. 2020, Domestic conference

長期にインフリキシマブを投与中に,非典型的な局所麻酔下胸腔鏡所見を示した結核性胸膜炎の一例, 原健太郎　原健一郎　笛木瑛里　増渕裕朗　鶴巻寛朗　古賀康彦　砂長則明　久田剛志　前野敏孝, 第43回日本呼吸器内視鏡学会学術集会, Jun. 2020, Domestic conference

気管支サーモプラスティ後に生物学的製剤の追加または変更を要した症例の検討, 鶴巻寛朗矢冨正清原健一郎神宮飛鳥古賀康彦砂長則明前野敏孝久田剛志, 第43回日本呼吸器内視鏡学会学術集会, Jun. 2020, Domestic conference

多形紅斑を発症したため、Osimertinib減感作療法を行った肺腺癌の1例, 伊藤優志青木周平笠原礼光山口彩山口公一三浦陽介鶴巻寛朗矢冨正清原健一郎櫻井麗子砂長則明前野敏孝, 第60回日本呼吸器学会学術講演会, 2020

インフリキシマブ長期投与中に発症し、非典型的な画像所見を示した肺結核、結核性胸膜炎の一例, 原健太郎原健一郎鶴巻寛朗大貫祐史増渕裕朗矢冨正清古賀康彦砂長則明久田剛志前野敏孝, 第60回日本呼吸器学会学術講演会, 2020

ResolvinE3のアレルギー性気道炎症に対する作用機序の検討, 佐藤真季子齋藤悠古賀康彦矢冨正清鶴巻寛朗前野敏孝石塚全土橋邦生砂長則明周東智山田正信久田剛志, 第60回日本呼吸器学会学術講演会, 2020

小細胞肺癌・1次化学療法の効果予測におけるBiP発現の意義, 三浦陽介解良恭一櫻井麗子笠原礼光砂長則明前野敏孝斎藤龍生久田剛志, 第60回日本呼吸器学会学術講演会, 2020

COPDを有する手術予定患者の術前評価と術後呼吸器合併症の検討, 若松郁生伊藤優志小林頂原健太郎笛木瑛里大貫祐史青木周平笠原礼光山口彩山口公一三浦陽介鶴巻寛朗矢冨正清原健一郎古賀康彦砂長則明久田剛志前野敏孝, 第60回日本呼吸器学会学術講演会, 2020

早期のMepolizumabとIVIGにより末梢神経障害が改善しステロイドを減量し得た好酸球性多発血管炎性肉芽腫症の2例, 小林頂鶴巻寛朗大貫祐史増渕裕朗笛木瑛里伊藤優志青木周平笠原礼光山口彩山口公一三浦陽介矢冨正清原健一郎古賀康彦砂長則明久田剛志前野敏孝, 第60回日本呼吸器学会学術講演会, 2020

当院の好酸球性多発血管炎性肉芽腫症におけるMepolizumab投与例の検討, 大貫祐史鶴巻寛朗小林頂増渕裕朗笛木瑛里伊藤優志青木周平笠原礼光山口公一三浦陽介矢冨正清原健一郎古賀康彦砂長則明久田剛志前野敏孝, 第60回日本呼吸器学会学術講演会, 2020

気管支喘息における新規バイオマーカーとしてのT-cell death-associated gene8, 鶴巻寛朗齋藤悠古賀康彦矢冨正清佐藤真季子神宮飛鳥笠原礼光三浦陽介山口公一原健一郎砂長則明前野敏孝久田剛志, 第60回日本呼吸器学会学術講演会, 2020

重症喘息とCOPDのオーバーラップに対して、デュピルマブの奏効を認めた1例, 笛木瑛里矢冨正清大貫祐史増渕裕朗鶴巻寛朗原健一郎古賀康彦砂長則明久田剛志前野敏孝, 第60回日本呼吸器学会学術講演会, 2020

レゾルビンEシリーズの抗炎症活性の検討, 矢冨正清古賀康彦齋藤悠佐藤真季子鶴巻寛朗原健一郎砂長,則明前野敏孝久田剛志, 第60回日本呼吸器学会学術講演会, 2020

肺癌脳転移術後早期のOsimertinib再開が原因と思われる薬剤性肺障害を呈した一例, 原健太郎三浦陽介笛木瑛里柏木千春神宮飛鳥鶴巻寛朗矢富正清原健一郎古賀康彦砂長則明久田剛志前野敏孝, 第238回日本呼吸器学会関東地方会, 2020, Domestic conference

肺癌におけるWnt/β-catenin経路の恒常的な活性化によるTescalcinの過剰発現, 砂長則明三浦陽介伊藤優志増田友美笠原礼光櫻井麗子久田剛志, 第60回日本肺癌学会学術集会, Nov. 2019, Domestic conference

Therapeutic significance of dual MEK and p38 inhibition for KRAS-mutated non-small cell lung cancer, Noriaki Sunaga, Yosuke Miura, Reiko Sakurai, Kyoichi Kaira, Takeshi Hisada., 78th Annual Meeting of the Japanese Cancer Association., Sep. 2019, Domestic conference

LGR6 overexpression induced by constitutive activation of the Wnt signaling pathway in NSCLC cells, The 77th Annual Meeting of the Japanese Cancer Association, 2018

Clinical significance of topoisomerase-II expression in amrubicin-treated patients with non-small cell lung cancer., The IASLC 18th World Conference on Lung Cancer, 2017

Clinical significance of topoisomerase-II expression in patients with relapsed HGNEC of the lung treated with AMR., The IASLC 18th World Conference on Lung Cancer, 2017

Combined inhibition of MEK and p38 efficiently inhibits cell growth of KRAS-mutated non-small cell lung cancer., 76th Annual Meeting of the Japanese Cancer Association., 2017

Clinical significance of topoisomerase-II expression in amrubicin-treated patients with non-small cell lung cancer., The IASLC 18th World Conference on Lung Cancer, 2017

Clinical significance of topoisomerase-II expression in patients with relapsed HGNEC of the lung treated with AMR., The IASLC 18th World Conference on Lung Cancer, 2017

Impact of PD-L1 expression on 18F-FDG-PET in pulmonary squamous cell carcinoma., The IASLC 18th World Conference on Lung Cancer, 2017

Combined inhibition of MEK and p38 efficiently inhibits cell growth of KRAS-mutated non-small cell lung cancer., 76th Annual Meeting of the Japanese Cancer Association., 2017

Oncogenic KRAS mutations induce PD-L1 overexpression through MAPK pathway activation in non-small cell lung cancer cells., AACR Annual Meeting 2016, 2016

非小細胞肺癌細胞においてCTNNB1変異により誘導されるLGR6の過剰発現と細胞増殖への関与, 第57回日本肺癌学会学術集会, 2016

Plasma epidermal growth factor receptor mutation (EGFR) testing in advanced non-small-cell lung cancer patients harboring EGFR mutations by chip-based digital PCR system., AACR Annual Meeting 2016, 2016

Oncogenic KRAS mutations induce PD-L1 overexpression through MAPK pathway activation in non-small cell lung cancer cells., AACR Annual Meeting 2016, 2016

N-アセチルシステイン吸入とピルフェニドン治療によりスリガラス陰影の消退と肺機能の改善を認めた特発性肺線維症の１例, 第55回日本呼吸器学会学術講演会, 2015

The polymorphisms of XRCC1 Arg194Trp and the XRCC1Arg399Gln affect the clinical features and the prognosis of MDS., AACR Annual Meeting 2015, 2015

The polymorphisms of XRCC1 Arg194Trp and the XRCC1Arg399Gln affect the clinical features and the prognosis of MDS., AACR Annual Meeting 2015, 2015

Prognostic impact of interleukin-8 expression in oncogenic KRAS-driven lung adenocarcinoma, The 12th Annual Meeting of Japanese Society of medical Oncology., 2014

インフラマソーム構成因子AIM2の肺癌における発現とKRAS変異との関連, 第55回日本肺癌学会総会, 2014

非小細胞肺癌細胞におけるAIM2発現とKRAS遺伝子変異との関連, 第54回日本呼吸器学会学術講演会, 2014

Prognostic impact of interleukin-8 expression in oncogenic KRAS-driven lung adenocarcinoma, The 12th Annual Meeting of Japanese Society of medical Oncology., 2014

非小細胞肺癌におけるエピレグリンの臨床的及び分子生物学的意義, 第５３回日本呼吸器学会学術講演会, 2013

Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to mutations of KRAS or EGFR in lung adenocarcinoma., 18th Congress of the Asian Pacific Society of Respirology, 2013

肺腺癌におけるIL-8発現と臨床病理学的因子、KRAS変異、EGFR変異、予後との関連, 第５４回日本肺癌学会総会, 2013

Clinicopathological and Biological Significance of Epiregulin Expression in Non-Small Cell Lung Cancer, 15th World Conference on Lung Cancer, 2013

Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to mutations of KRAS or EGFR in lung adenocarcinoma., 18th Congress of the Asian Pacific Society of Respirology, 2013

Clinicopathological and Biological Significance of Epiregulin Expression in Non-Small Cell Lung Cancer, 15th World Conference on Lung Cancer, 2013

非小細胞肺癌においてKRAS変異により誘導されるepiregulin過剰発現の意義, 第71回日本癌学会学術総会, 2012

非小細胞肺癌においてKRAS変異により誘導されるepiregulin過剰発現の予後因子及び治療標的としての可能性, 第53回日本肺癌学会総会, 2012

Phase II study of bevacizumab in combination with S-1 plus cisplatin in patients with advanced nonsquamous non-small cell lung cancer., 2012 ASCO Annual Meeting, 2012

非小細胞肺癌におけるEpiregulin過剰発現の意義, 第52回日本呼吸器学会学術講演会, 2012

Phase II study of bevacizumab in combination with S-1 plus cisplatin in patients with advanced nonsquamous non-small cell lung cancer., 2012 ASCO Annual Meeting, 2012

梅肉抽出エキスMK615の非小細胞肺癌細胞に対する細胞増殖及びInterkeukin-8産生の抑制効果, 第51回日本呼吸器学会, 2011

Interleukin-8 overexpression induced by activating mutations in KRAS or EGFR in non-small cell lung cancer, 70th Annual Meeting of the Japanese Cancer Association, 2011

青梅加熱濃縮エキスMK615の非小細胞肺癌細胞に対する細胞増殖抑制能及びIL-8抑制能についての検討, 第５２回日本肺癌学会総会, 2011

Interleukin-8 overexpression induced by activating mutations in KRAS or EGFR in non-small cell lung cancer, 70th Annual Meeting of the Japanese Cancer Association, 2011

非小細胞肺癌におけるEpiregulin発現の臨床病理学的意義とKRAS変異との関連, 第50回日本呼吸器学会学術総会, 2010

既治療肺癌に対するアムルビシン単剤療法の第2相試験, 第50回日本呼吸器学会学術総会, 2010

非小細胞肺癌細胞におけるIL-8発現の臨床病理学的意義及びKRAS変異との関連, 第51回日本肺癌学会, 2010

IL-8 overexpression induced by oncogenic KRAS mutation in non-small cell lung cancer, AACR 100th Annual Meeting 2009, 2009

KRAS遺伝子変異を有する非小細胞肺癌細胞におけるIL-8の過剰発現, 第４９回日本呼吸器学会総会, 2009

CXCL12 and its receptors CXCR4 and CXCR7 as potential molecular targets for lung cancer, AACR 100th Annual Meeting 2009, 2009

進行非小細胞肺癌に対するカルボプラチン+S-1併用化学療法の第II相試験, 第５０回日本肺癌学会総会, 2009

IL-8 overexpression induced by oncogenic KRAS mutation in non-small cell lung cancer, AACR 100th Annual Meeting 2009, 2009

CXCL12 and its receptors CXCR4 and CXCR7 as potential molecular targets for lung cancer, AACR 100th Annual Meeting 2009, 2009

Overexpression of the epiregulin gene and its role in the development of non-small cell lung cancer, 99th AACR Annual Meeting 2008, 2008

KRAS変異陽性非小細胞肺癌細胞でのRNA干渉による変異型KRAS発現の抑制はゲフィチニブ耐性を改善しない, 第４８回日本呼吸器学会総会, 2008

Gefitinib combined survival analysis of the mutation positives from the prospective phase II trials (I-CAMP)., 2008 ASCO Annual Meeting, 2008

EGFR 遺伝子変異を有する進行非小細胞肺癌患者を対象としたgefitinib 治療prospective 試験統合解析, 第４９回日本肺癌学会総会, 2008

Overexpression of the epiregulin gene and its role in the development of non-small cell lung cancer, 99th AACR Annual Meeting 2008, 2008

Gefitinib combined survival analysis of the mutation positives from the prospective phase II trials (I-CAMP)., 2008 ASCO Annual Meeting, 2008

肺癌におけるEpiregulin (EREG) 遺伝子の発現についての検討, 第４７回日本呼吸器学会総会, 2007

肺癌におけるEpiregulin遺伝子の過剰発現と臨床病理学的因子及びKRAS遺伝子変異との関連についての検討, 第４８回日本肺癌学会総会, 2007

Phase II study of the efficacy of gefitinib in patients with non-small cell lung cancer with the EGFR mutations, 2006 ASCO Annual Meeting, 2006

非小細胞肺癌患者におけるゲフィチニブの治療効果の早期予測のためのFDG-PET検査の有用性, 第４７回日本肺癌学会総会, 2006

Phase II study of the efficacy of gefitinib in patients with non-small cell lung cancer with the EGFR mutations, 2006 ASCO Annual Meeting, 2006

Genetic manipulation of immortalized normal human bronchial epithelial cells, AACR 96th Annual Meeting 2005, 2005

Methylation and gene silencing of RRAD gene in lung and breast cancers, AACR 96th Annual Meeting 2005, 2005

RNAi-mediated knockdown of mutant β-catenin inhibits in vitro growth of non-small cell lung cancer, 第４６回日本肺癌学会総会, 2005

肺癌細胞においてDNMT1のノックダウンは癌抑制遺伝子のプロモーターの脱メチル化及び再発現を誘導する, 第４５回日本呼吸器学会総会, 2005

Genetic manipulation of immortalized normal human bronchial epithelial cells, AACR 96th Annual Meeting 2005, 2005

Methylation and gene silencing of RRAD gene in lung and breast cancers, AACR 96th Annual Meeting 2005, 2005

Deregulation of genes related to TGF-s signaling pathway via aberrant methylation in human cancers, 95th AACR annual meeting 2004, 2004

Global profiling of gene expression after 5’-Aza-2-deoxycytidine treatment of lung cancer and normal bronchial epithelial cells identifies new candidate tumor suppressor and oncogenes., 95th AACR annual meeting 2004, 2004

Deregulation of genes related to TGF-s signaling pathway via aberrant methylation in human cancers, 95th AACR annual meeting 2004, 2004

Global profiling of gene expression after 5’-Aza-2-deoxycytidine treatment of lung cancer and normal bronchial epithelial cells identifies new candidate tumor suppressor and oncogenes., 95th AACR annual meeting 2004, 2004

RNAi-mediated knockdown of caveolin-1 and c-myc leads to growth inhibition of human tumor cells, 94th AACR annual meeting, 2003

RNAi-mediated knockdown of caveolin-1 and c-myc leads to growth inhibition of human tumor cells, 94th AACR annual meeting, 2003

80歳以上の高齢者の特発性肺線維症に対する抗線維化薬使用状況の解析, 澤田友里, 古賀康彦, 竹原和孝, 齋藤康之, 蜂巣克昌, 矢冨正清, 宇津木光克, 吉見誠至, 申悠樹, 若松郁夫, 中川純一, 梅津和恵, 高野峻一, 土橋邦生, 砂長則明, 前野敏孝, 久田剛志, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

Resolvin E3の細胞内シグナル伝達経路に及ぼす影響の解析, 矢冨正清, 古賀康彦, 齋藤悠, 佐藤真季子, 山口公一, 山口彩, 伊藤優志, 三浦陽介, 鶴巻寛朗, 原健一郎, 砂長則明, 前野敏孝, 周東智, 久田剛志, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

第5波のCOVID-19妊婦の臨床的特徴の検討, 前野敏孝, 亀田高志, 井上真紀, 三浦陽介, 鶴巻寛朗, 矢冨正清, 古賀康彦, 砂長則明, 柳澤邦雄, 徳江豊, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

シングルユース軟性気管支鏡の有用性の検討, 宇野翔吾, 前野敏孝, 黒岩裕也, 伊藤優志, 申悠樹, 板井美紀, 武藤壮平, 澤田友里, 増田友美, 笠原礼光, 山口公一, 佐藤麻里, 三浦陽介, 鶴巻寛朗, 矢冨正清, 櫻井麗子, 古賀康彦, 砂長則明, 須賀達夫, 久田剛志, 金本匡史, 高澤知紀, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

プロトン感知性Gタンパク質共役型受容体OGR1の塩酸投与によるマウスARDSモデルにおける働き, 齋藤悠, 茂木千尋, 齋藤従道, 鶴巻寛朗, 矢冨正清, 古賀康彦, 佐藤真季子, 山口彩, 山口公一, 砂長則明, 前野敏孝, 石塚全, 岡島史和, 久田剛志, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

病勢悪化によりデキサメタゾンからメチルプレドニゾロンへ変更したCOVID-19の検討, 黒岩裕也, 砂長則明, 古賀康彦, 三浦陽介, 鶴巻寛朗, 矢冨正清, 原健一郎, 前野敏孝, 久田剛志, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

ResolvinE1、E2、E3のアレルギー性気道炎症に対する効果の検討, 佐藤真季子, 青木悠, 鶴巻寛朗, 矢冨正清, 古賀康彦, 砂長則明, 石塚全, 土橋邦生, 周東智, 前野敏孝, 久田剛志, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

成人喘息患者における喘息症状及び鼻・副鼻腔炎症状を評価するGスケール問診票の有用性についての検討, 武藤壮平, 鶴巻寛朗, 石塚全, 澤田友里, 相川政紀, 佐藤麻里, 佐藤真季子, 齋藤悠, 矢冨正清, 原健一郎, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

気管支喘息と好酸球性副鼻腔炎との併存を診断するためのGスケール問診票の有用性, 鶴巻寛朗, 武藤壮平, 石塚全, 佐藤麻里, 相川政紀, 澤田友里, 齋藤悠, 佐藤真季子, 古賀康彦, 矢冨正清, 原健一郎, 砂長則明, 吉見誠至, 前野敏孝, 久田剛志, 第62回日本呼吸器学会学術講演会, Apr. 2022, 22 Apr. 2022, 24 Apr. 2022, Japanese, Japan, Domestic conference

S-1が奏効した胸腺癌の一例, 櫻井麗子三浦陽介鶴巻寛朗矢冨正清砂長則明久田剛志前野敏孝, 第63回日本肺癌学会学術集会, 03 Dec. 2022, 01 Dec. 2022, 03 Dec. 2022, Domestic conference

当院におけるオンコマインDx Target TestマルチCDxシステムの現状と課題, 三浦陽介櫻井麗子鶴巻寛朗矢冨正清砂長則明久田剛志前野敏孝, 第63回日本肺癌学会学術集会, 01 Dec. 2022, 01 Dec. 2022, 03 Dec. 2022, Domestic conference

再発胸腺癌に対するレンバチニブ治療の有効性および安全性に関する後方視的検討, 砂長則明, 三浦陽介, 櫻井麗子, 相川政紀, 増田友美, 佐藤麻理, 鶴巻寛朗, 矢冨正清, 古賀康彦, 前野敏孝, 久田剛志, 第63回日本呼吸器学会学術講演会, 28 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

EGFR変異陽性非小細胞肺癌に対するアファチニブ治療の後方視的検討, 原健太郎, 砂長則明, 横田暢, 宇野翔吾, 武藤壮平, 相川政紀, 澤田友里, 佐藤麻理, 三浦陽介, 鶴巻寛朗, 矢冨正清, 櫻井麗子, 古賀康彦, 前野敏孝, 久田剛志, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

当院における1次治療オシメルチニブ投与後のアファチニブ治療の後方視的検討, 横田暢, 三浦陽介, 砂長則明, 増渕裕朗, 佐藤麻理, 鶴巻寛朗, 矢冨正清, 櫻井麗子, 古賀康彦, 久田剛志, 前野敏孝, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

間質性腎炎，IgA腎症による腎機能障害を合併したEGFR変異陽性肺腺癌に対してアファチニブ治療が奏効した1例, 櫻井麗子, 三浦陽介, 鶴巻寛朗, 矢冨正清, 古賀康彦, 砂長則明, 久田剛志, 前野敏孝, 第63回日本呼吸器学会学術講演会, 30 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

ニボルマブ/イピリムマブによるミオパチー，肝障害にミコフェノール酸モフェチルが奏功した肺腺癌の一例, 前野敏孝, 原健太郎, 宇野翔吾, 武藤壮平, 澤田友里, 増田友美, 増渕裕朗, 三浦陽介, 鶴巻寛朗, 矢冨正清, 櫻井麗子, 古賀康彦, 砂長則明, 久田剛志, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

乾癬患者における睡眠時無呼吸症候群の合併に関する検討, 澤田英, 前野敏孝, 三浦陽介, 鶴巻寛朗, 矢冨正清, 古賀康彦, 砂長則明, 久田剛志, 第63回日本呼吸器学会学術講演会, 30 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

集学的治療により救命した妊娠35週の呼吸不全を呈した粟粒結核の1例, 神戸美欧, 矢冨正清, 三浦陽介, 鶴巻寛朗, 古賀康彦, 砂長則明, 日下田大輔, 亀田高志, 久田剛志, 前野敏孝, 第63回日本呼吸器学会学術講演会, 28 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

トリプル吸入製剤におけるリアルワールドデータの解析について, 星野裕紀, 古賀康彦, 宇野翔吾, 若松郁生, 原健太郎, 武藤壮平, 澤田友里, 増渕裕朗, 櫻井麗子, 佐藤麻里, 三浦陽介, 鶴巻寛朗, 矢冨正清, 原健一郎, 砂長則明, 前野敏孝, 久田剛志, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

生物学的製剤の自己注射手技指導を受ける患者の認識調査, 鶴巻寛朗, 吉田静香, 高村裕紀, 吉田佑貴, 武藤壮平, 矢冨正清, 齋藤悠, 佐藤真季子, 原健一郎, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

重症気管支喘息の喀痰症状におけるDupilumabの有効性, 吉田佑貴, 鶴巻寛朗, 吉見誠至, 武藤壮平, 相川政紀, 澤田友里, 三浦陽介, 矢冨正清, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

Resolvin E 3（RvE3）誘導体の抗炎症性効果の解析, 齋藤悠, 矢冨正清, 齋藤従道, 古賀康彦, 鶴巻寛朗, 佐藤真季子, 藤原広一, 福田隼, 砂長則明, 前野敏孝, 石塚全, 周東智, 久田剛志, 第63回日本呼吸器学会学術講演会, 30 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese, Japan, Domestic conference

オシメルチニブ耐性EGFR変異陽性肺腺癌の髄膜癌腫症に対してアファチニブが奏効した1例, 田上法幸, 櫻井麗子, 神澤佑実, 山内創聖, 三浦陽介, 鶴巻寛朗, 矢冨正清, 古賀康彦, 砂長則明, 久田剛志, 前野敏孝, 第251回日本呼吸器学会関東地方会, 10 Sep. 2022, 10 Sep. 2022, 10 Sep. 2022, Japanese, Japan, Domestic conference

ニンテダニブが皮下・縦隔気腫の治療遷延に影響を及ぼした特発性肺線維症の亜急性増悪の一例, 星野裕紀, 古賀康彦, 武藤壮平, 宇野翔吾, 伊藤優志, 佐藤麻里, 若松郁生, 三浦陽介, 鶴巻寛朗, 矢冨正清, 砂長則明, 久田剛志, 前野敏孝, 第251回日本呼吸器学会関東地方会, 10 Sep. 2022, 10 Sep. 2022, 10 Sep. 2022, Japanese, Japan, Domestic conference

アファチニブが奏効したEGFR L858R/L747V複合変異陽性肺腺癌の１例, 神澤佑実, 砂長則明, 神戸美欧, 澤田英, 宇野翔吾, 若松郁生, 武藤壮平, 佐藤麻里, 三浦陽介, 鶴巻寛朗, 矢冨正清, 櫻井麗子, 古賀康彦, 前野敏孝, 久田剛志, 第252回日本呼吸器学会関東地方会, 05 Nov. 2022, 05 Nov. 2022, 05 Nov. 2022, Japanese, Japan, Domestic conference

マウスARDSモデルにおけるプロトン感知性Gタンパク質共役型受容体OGR1の働き, 齋藤悠, 茂木千尋, 齋藤従道, 鶴巻寛朗, 矢冨正清, 古賀康彦, 佐藤真季子, 砂長則明, 前野敏孝, 石塚全, 岡島史和, 久田剛志, 第71回日本アレルギー学会学術大会, 09 Oct. 2022, 07 Oct. 2022, 09 Oct. 2022, Japanese, Japan, Domestic conference

Resolvin E3のマクロファージ内シグナル伝達経路に及ぼす影響の解析, 矢冨正清, 古賀康彦, 齋藤悠, 佐藤真季子, 山口公一, 山口彩, 三浦陽介, 鶴巻寛朗, 原健一郎, 砂長則明, 前野敏孝, 周東智, 久田剛志, 第71回日本アレルギー学会学術大会, 07 Oct. 2022, 07 Oct. 2022, 09 Oct. 2022, Japanese, Japan, Domestic conference

気管支喘息における喘息症状及び鼻・副鼻腔炎症状を評価するGスケール問診票と呼吸機能との関係性の検討, 武藤壮平, 鶴巻寛朗, 石塚全, 澤田友里, 相川政紀, 佐藤麻里, 佐藤真季子, 齋藤悠, 矢冨正清, 原健一郎, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第71回日本アレルギー学会学術大会, 07 Oct. 2022, 07 Oct. 2022, 09 Oct. 2022, Japanese, Japan, Domestic conference

気管支喘息におけるDupilumab投与前後のアレルゲン特異的IgEの変化, 鶴巻寛朗, 武藤壮平, 澤田友里, 相川政紀, 佐藤麻里, 齋藤悠, 佐藤真季子, 矢冨正清, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第71回日本アレルギー学会学術大会, 08 Oct. 2022, 07 Oct. 2022, 09 Oct. 2022, Japanese, Japan, Domestic conference

ニボルマブ、イピリムマブによるPD-1 ミオパチー、肝障害にミコフェノール酸モフェチルが奏功した肺腺癌の一例, 田村　翠, 前野敏孝, 板井美紀, 申　悠樹, 澤田友里, 増田友美, 笠原礼光, 櫻井麗子, 三浦陽介, 鶴巻寛朗, 矢冨正清, 古賀康彦, 砂長則明, 久田剛志, 第249回日本呼吸器学会関東地方会, 21 May 2022, 21 May 2022, 21 May 2022, Japanese, Japan, Domestic conference

進行胸腺癌に対するレンバチニブ治療中の空洞形成が発症に関与したと考えられた肺アスペルギルス症の1 例, 沼賀早紀 , 三浦陽介, 伊藤優志, 宇野翔吾, 武藤壮平, 佐藤麻里, 鶴巻寛朗, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第249回日本呼吸器学会関東地方会, 21 May 2022, 21 May 2022, 21 May 2022, Japanese, Japan, Domestic conference

下顎骨腫瘍に対する術後放射線治療後に発症した気管気管支軟骨炎の一例, 原健一郎, 矢冨正清, 鶴巻寛朗, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第249回日本呼吸器学会関東地方会, 21 May 2022, 21 May 2022, 21 May 2022, Japanese, Japan, Domestic conference

放射線照射後に増悪した肺Mycobacterium avium complex 症の1 例, 伊藤優志, 吉井明弘, 三浦陽介, 鶴巻寛朗, 矢冨正清, 古賀康彦, 砂長則明, 前野敏孝, 久田剛志, 第249回日本呼吸器学会関東地方会, 21 May 2022, 21 May 2022, 21 May 2022, Japanese, Japan, Domestic conference

アミオダロン内服中に発症した自己免疫性肺胞蛋白症の1 例, 望月隆汰, 齋藤康之, 小林　頂, 笛木瑛里, 鈴木邦明, 石原真一, 小林裕幸, 砂長則明, 前野敏孝, 久田剛志, 第249回日本呼吸器学会関東地方会, 21 May 2022, 21 May 2022, 21 May 2022, Japanese, Japan, Domestic conference

小細胞肺癌治療経過中にニューモシスチス肺炎及び血小板減少を発症し,集学的治療により救命しえた1例, 山内創聖, 矢冨正清, 神戸美欧, 澤田英, 横田揚, 佐藤麻里, 古賀康彦, 砂長則明, 久田剛志, 前野敏孝, 第681回日本内科学会関東地方会, 22 Oct. 2022, 22 Oct. 2022, 22 Oct. 2022, Japanese, Japan, Domestic conference

LOX has a possibility of being a therapeutic target through the mechanism of oncogene-induced cellular senescence, Nao Muraki, Nozomi Kawabe, Ichidai Tanaka, Noriaki Sunaga, Mitsuo Sato, The 82nd Annual Meeting of the Japanese Cancer Association, 22 Sep. 2023, 21 Sep. 2023, 23 Sep. 2023, English, Yokohama, Japan, International conference

Gene A, upregulated by mutant KRAS, is a potential therapeutic target for lung cancer, Nozomi Kawabe, Nao Muraki, Ichidai Tanaka, Noriaki Sunaga, Mitsuo Sato, The 82nd Annual Meeting of the Japanese Cancer Association, 23 Sep. 2023, 21 Sep. 2023, 23 Sep. 2023, English, Yokohama, Japan, International conference

Dupilumabの初回および切り替え投与における質問票を用いた症状変化の検討, 吉田佑貴、鶴巻寛朗、吉見誠至、武藤壮平、相川政紀、澤田友里、三浦陽介、矢冨正清、原健一郎、古賀康彦、砂長則明、前野敏孝、久田剛志, 第72回日本アレルギー学会学術大会, 20 Oct. 2023, 20 Oct. 2023, 22 Oct. 2023, Japanese, Japan, Domestic conference

生物学的製剤の自己注射手技指導前後における患者の認識の変化, 鶴巻寛朗、西川佳子、吉田静香、高村裕紀、吉田佑貴、武藤壮平、矢冨正清、齋藤悠、佐藤真季子、原健一郎、古賀康彦、砂長則明、前野敏孝、久田剛志, 第72回日本アレルギー学会学術大会, 22 Oct. 2023, 20 Oct. 2023, 22 Oct. 2023, Japanese, Japan, Domestic conference

炎症収束性脂質メディエーターResolvin E 3（RvE3）誘導体の抗炎症性効果, 齋藤悠、齋藤従道、矢冨正清、鶴巻寛朗、古賀康彦、佐藤真季子、武藤壮平、宇野翔吾、砂長則明、前野敏孝、石塚全、福田隼、周東智、久田剛志, 第72回日本アレルギー学会学術大会, 22 Oct. 2023, 20 Oct. 2023, 22 Oct. 2023, Japanese, Japan, Domestic conference

EGFR変異陽性非小細胞肺癌に対する一次治療としてのアファチニブ単剤療法の有効性に関する後方視的検討, 砂長則明、三浦陽介、櫻井麗子、横田　暢、増田友美、鶴巻寛朗、矢冨正清、古賀康彦1、大瀧容一、永島宗晃、久保　亘輝、岡野　奈緒子、前野敏孝、久田剛志, 第64回日本肺癌学会学術集会, 02 Nov. 2023, 02 Nov. 2023, 04 Nov. 2023, Japanese, Japan, Domestic conference

高感度多遺伝子検査システムMINtSに用いる気管支鏡検査で採取した細胞診検体の特徴, 藤田一喬、各務博、朝比奈肇、砂長則明、岡藤浩平、仲地一郎、長島広相、福原達朗、石川暢久、原田敏之、杉坂淳、小林国彦、萩原弘一, 第64回日本肺癌学会学術集会, 02 Nov. 2023, 02 Nov. 2023, 04 Nov. 2023, Japanese, Japan, Domestic conference

IB-IIIA期NSCLCの術後補助化学療法の実際と今後, 大瀧容一、永島宗晃、河谷菜津子、矢澤友弘、成澤英司、吉川良平、砂長則明、三浦陽介、櫻井麗子、前野敏孝、調憲, 第64回日本肺癌学会学術集会, 03 Nov. 2023, 02 Nov. 2023, 04 Nov. 2023, Japanese, Japan, Domestic conference

当院における胸腺癌に対するレンバチニブの使用経験, 櫻井麗子、砂長則明、三浦陽介、増田友美、鶴巻寛朗、矢冨正清、古賀康彦、前野敏孝、久田剛志, 第64回日本肺癌学会学術集会, 03 Nov. 2023, 02 Nov. 2023, 04 Nov. 2023, Japanese, Japan, Domestic conference

デュルバルマブ/エトポシド/シスプラチン療法で長期に病勢制御が得られた再発小細胞肺癌の1例, 三浦陽介、増田友美、鶴巻寛朗、矢冨正清、櫻井麗子、古賀康彦、砂長則明、久田剛志、前野敏孝, 第64回日本肺癌学会学術集会, 03 Nov. 2023, 02 Nov. 2023, 04 Nov. 2023, Japanese, Japan, Domestic conference

非腫瘍性呼吸器疾患における血清NSEの意義, 砂長則明、古賀康彦、相川政紀、三浦陽介、鶴巻寛朗、矢冨正清、櫻井麗子、前野敏孝、久田剛志, 第64回日本呼吸器学会学術講演会, 06 Apr. 2024, 05 Apr. 2024, 07 Apr. 2024, Japanese, Japan, Domestic conference

RvE3のマクロファージ細胞MAPK/p38/CREBシグナル伝達経路に及ぼす影響の解析, 矢冨正清、古賀康彦、齋藤悠、佐藤真季子、鶴巻寛朗、三浦陽介、砂長則明、前野敏孝、周東智、久田剛志, 第64回日本呼吸器学会学術講演会, 06 Apr. 2024, 05 Apr. 2024, 07 Apr. 2024, Japanese, Japan, Domestic conference

当院における肺がんドライバー遺伝子マルチコンパニオン診断の実施状況と課題, 三浦陽介、砂長則明、櫻井麗子、久田剛志、前野敏孝, 第64回日本呼吸器学会学術講演会, 05 Apr. 2024, 05 Apr. 2024, 07 Apr. 2024, Japanese, Japan, Domestic conference

アテゾリズマブ術後補助療法中に小細胞癌への形質転換による脳転移再発を来した肺腺癌の一例, 小林夏緒、砂長則明、若松郁生、武藤壮平、増田友美、三浦陽介、鶴巻寛朗、矢冨正清、櫻井麗子、古賀康彦、前野敏孝、久田剛志, 第64回日本呼吸器学会学術講演会, 07 Apr. 2024, 05 Apr. 2024, 07 Apr. 2024, Japanese, Japan, Domestic conference

特発性肺線維症（IPF）患者における終末期療養場所の検討, 佐藤真季子、古賀康彦、蜂巣克昌、竹原和孝、若松郁生、申悠樹、齋藤悠、鶴巻寛朗、矢冨正清、砂長則明、前野敏孝、久田剛志, 第64回日本呼吸器学会学術講演会, 07 Apr. 2024, 05 Apr. 2024, 07 Apr. 2024, Japanese, Japan, Domestic conference

Awards

Department of Defense US Army Medical Research and Material Command, Fiscal Year 2003 Breast Cancer Research Program Award: Postdoctoral Award, 2003, Publisher

2010

Research Projects

Competitive research funding

Molecular abnormalities in the development of lung cancer, Grant-in-Aid for Scientific Research, Competitive research funding

Academic Contribution

Academic society etc, Feb. 2014, 9999

Social Contribution

Academic Contribution

日本呼吸器学会代議員, Academic society etc, Feb. 2014, 9999, International academic contribution

日本肺癌学会評議員, Academic society etc, Dec. 2022, 9999, International academic contribution

Researcher Database

Researcher Profile and Settings

Researcher

Name

Profile and Settings

Name

Foreign language

Use in presentation

Use in publication

Affiliation

Education

Association Memberships

Research Experience

Research Activities

Research Areas

Research Interests

Research Themes

Published Papers

MISC

Books etc

Presentations

Awards

Research Projects

Academic Contribution

Social Contribution

Academic Contribution